Gene,Gene synonym,Ensembl,Gene description,Uniprot,Chromosome,Position,Protein class,Biological process,Molecular function,Disease involvement,Evidence,HPA evidence,UniProt evidence,NeXtProt evidence,RNA tissue specificity,RNA tissue distribution,RNA tissue specificity score,RNA tissue specific nTPM,RNA single cell type specificity,RNA single cell type distribution,RNA single cell type specificity score,RNA single cell type specific nTPM,RNA cancer specificity,RNA cancer distribution,RNA cancer specificity score,RNA cancer specific FPKM,RNA brain regional specificity,RNA brain regional distribution,RNA brain regional specificity score,RNA brain regional specific nTPM,RNA blood cell specificity,RNA blood cell distribution,RNA blood cell specificity score,RNA blood cell specific nTPM,RNA blood lineage specificity,RNA blood lineage distribution,RNA blood lineage specificity score,RNA blood lineage specific nTPM,RNA cell line specificity,RNA cell line distribution,RNA cell line specificity score,RNA cell line specific nTPM,RNA mouse brain regional specificity,RNA mouse brain regional distribution,RNA mouse brain regional specificity score,RNA mouse brain regional specific nTPM,RNA pig brain regional specificity,RNA pig brain regional distribution,RNA pig brain regional specificity score,RNA pig brain regional specific nTPM,Antibody,Reliability (IH),Reliability (Mouse Brain),Reliability (IF),Subcellular location,Secretome location,CCD Protein,CCD Transcript,Blood concentration - Conc. blood IM [pg/L],Blood concentration - Conc. blood MS [pg/L],Subcellular main location,Subcellular additional location,Antibody RRID,Pathology prognostics - Breast cancer,Pathology prognostics - Cervical cancer,Pathology prognostics - Colorectal cancer,Pathology prognostics - Endometrial cancer,Pathology prognostics - Glioma,Pathology prognostics - Head and neck cancer,Pathology prognostics - Liver cancer,Pathology prognostics - Lung cancer,Pathology prognostics - Melanoma,Pathology prognostics - Ovarian cancer,Pathology prognostics - Pancreatic cancer,Pathology prognostics - Prostate cancer,Pathology prognostics - Renal cancer,Pathology prognostics - Stomach cancer,Pathology prognostics - Testis cancer,Pathology prognostics - Thyroid cancer,Pathology prognostics - Urothelial cancer,Tissue RNA - adipose tissue [nTPM],Tissue RNA - adrenal gland [nTPM],Tissue RNA - amygdala [nTPM],Tissue RNA - appendix [nTPM],Tissue RNA - basal ganglia [nTPM],Tissue RNA - bone marrow [nTPM],Tissue RNA - breast [nTPM],Tissue RNA - cerebellum [nTPM],Tissue RNA - cerebral cortex [nTPM],Tissue RNA - cervix [nTPM],Tissue RNA - choroid plexus [nTPM],Tissue RNA - colon [nTPM],Tissue RNA - duodenum [nTPM],Tissue RNA - endometrium 1 [nTPM],Tissue RNA - epididymis [nTPM],Tissue RNA - esophagus [nTPM],Tissue RNA - fallopian tube [nTPM],Tissue RNA - gallbladder [nTPM],Tissue RNA - heart muscle [nTPM],Tissue RNA - hippocampal formation [nTPM],Tissue RNA - hypothalamus [nTPM],Tissue RNA - kidney [nTPM],Tissue RNA - liver [nTPM],Tissue RNA - lung [nTPM],Tissue RNA - lymph node [nTPM],Tissue RNA - medulla oblongata [nTPM],Tissue RNA - midbrain [nTPM],Tissue RNA - olfactory bulb [nTPM],Tissue RNA - ovary [nTPM],Tissue RNA - pancreas [nTPM],Tissue RNA - parathyroid gland [nTPM],Tissue RNA - pituitary gland [nTPM],Tissue RNA - placenta [nTPM],Tissue RNA - pons [nTPM],Tissue RNA - prostate [nTPM],Tissue RNA - rectum [nTPM],Tissue RNA - retina [nTPM],Tissue RNA - salivary gland [nTPM],Tissue RNA - seminal vesicle [nTPM],Tissue RNA - skeletal muscle [nTPM],Tissue RNA - skin 1 [nTPM],Tissue RNA - small intestine [nTPM],Tissue RNA - smooth muscle [nTPM],Tissue RNA - spinal cord [nTPM],Tissue RNA - spleen [nTPM],Tissue RNA - stomach 1 [nTPM],Tissue RNA - testis [nTPM],Tissue RNA - thalamus [nTPM],Tissue RNA - thymus [nTPM],Tissue RNA - thyroid gland [nTPM],Tissue RNA - tongue [nTPM],Tissue RNA - tonsil [nTPM],Tissue RNA - urinary bladder [nTPM],Tissue RNA - vagina [nTPM],Tissue RNA - white matter [nTPM],Cell RNA - A-431 [nTPM],Cell RNA - A549 [nTPM],Cell RNA - AF22 [nTPM],Cell RNA - AN3-CA [nTPM],Cell RNA - ASC diff [nTPM],Cell RNA - ASC TERT1 [nTPM],Cell RNA - BEWO [nTPM],Cell RNA - BJ [nTPM],Cell RNA - BJ hTERT+ [nTPM],Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM],Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM],Cell RNA - CACO-2 [nTPM],Cell RNA - CAPAN-2 [nTPM],Cell RNA - Daudi [nTPM],Cell RNA - EFO-21 [nTPM],Cell RNA - fHDF/TERT166 [nTPM],Cell RNA - GAMG [nTPM],Cell RNA - HaCaT [nTPM],Cell RNA - HAP1 [nTPM],Cell RNA - HBEC3-KT [nTPM],Cell RNA - HBF TERT88 [nTPM],Cell RNA - HDLM-2 [nTPM],Cell RNA - HEK 293 [nTPM],Cell RNA - HEL [nTPM],Cell RNA - HeLa [nTPM],Cell RNA - Hep G2 [nTPM],Cell RNA - HHSteC [nTPM],Cell RNA - HL-60 [nTPM],Cell RNA - HMC-1 [nTPM],Cell RNA - HSkMC [nTPM],Cell RNA - hTCEpi [nTPM],Cell RNA - hTEC/SVTERT24-B [nTPM],Cell RNA - hTERT-HME1 [nTPM],Cell RNA - hTERT-RPE1 [nTPM],Cell RNA - HUVEC TERT2 [nTPM],Cell RNA - JURKAT [nTPM],Cell RNA - K-562 [nTPM],Cell RNA - Karpas-707 [nTPM],Cell RNA - LHCN-M2 [nTPM],Cell RNA - MCF7 [nTPM],Cell RNA - MOLT-4 [nTPM],Cell RNA - NB-4 [nTPM],Cell RNA - NTERA-2 [nTPM],Cell RNA - OE19 [nTPM],Cell RNA - PC-3 [nTPM],Cell RNA - REH [nTPM],Cell RNA - RH-30 [nTPM],Cell RNA - RPMI-8226 [nTPM],Cell RNA - RPTEC TERT1 [nTPM],Cell RNA - RT4 [nTPM],Cell RNA - SCLC-21H [nTPM],Cell RNA - SH-SY5Y [nTPM],Cell RNA - SiHa [nTPM],Cell RNA - SK-BR-3 [nTPM],Cell RNA - SK-MEL-30 [nTPM],Cell RNA - SuSa [nTPM],Cell RNA - T-47d [nTPM],Cell RNA - THP-1 [nTPM],Cell RNA - TIME [nTPM],Cell RNA - U-138 MG [nTPM],Cell RNA - U-2 OS [nTPM],Cell RNA - U-2197 [nTPM],Cell RNA - U-251 MG [nTPM],Cell RNA - U-266/70 [nTPM],Cell RNA - U-266/84 [nTPM],Cell RNA - U-698 [nTPM],Cell RNA - U-87 MG [nTPM],Cell RNA - U-937 [nTPM],Cell RNA - WM-115 [nTPM],Blood RNA - basophil [nTPM],Blood RNA - classical monocyte [nTPM],Blood RNA - eosinophil [nTPM],Blood RNA - gdT-cell [nTPM],Blood RNA - intermediate monocyte [nTPM],Blood RNA - MAIT T-cell [nTPM],Blood RNA - memory B-cell [nTPM],Blood RNA - memory CD4 T-cell [nTPM],Blood RNA - memory CD8 T-cell [nTPM],Blood RNA - myeloid DC [nTPM],Blood RNA - naive B-cell [nTPM],Blood RNA - naive CD4 T-cell [nTPM],Blood RNA - naive CD8 T-cell [nTPM],Blood RNA - neutrophil [nTPM],Blood RNA - NK-cell [nTPM],Blood RNA - non-classical monocyte [nTPM],Blood RNA - plasmacytoid DC [nTPM],Blood RNA - T-reg [nTPM],Blood RNA - total PBMC [nTPM],Brain RNA - amygdala [nTPM],Brain RNA - basal ganglia [nTPM],Brain RNA - cerebellum [nTPM],Brain RNA - cerebral cortex [nTPM],Brain RNA - hippocampal formation [nTPM],Brain RNA - hypothalamus [nTPM],Brain RNA - medulla oblongata [nTPM],Brain RNA - midbrain [nTPM],Brain RNA - olfactory bulb [nTPM],Brain RNA - pons [nTPM],Brain RNA - spinal cord [nTPM],Brain RNA - thalamus [nTPM],Brain RNA - white matter [nTPM],Single Cell Type RNA - Adipocytes [nTPM],Single Cell Type RNA - Alveolar cells type 1 [nTPM],Single Cell Type RNA - Alveolar cells type 2 [nTPM],Single Cell Type RNA - Astrocytes [nTPM],Single Cell Type RNA - B-cells [nTPM],Single Cell Type RNA - Basal keratinocytes [nTPM],Single Cell Type RNA - Basal prostatic cells [nTPM],Single Cell Type RNA - Basal respiratory cells [nTPM],Single Cell Type RNA - Basal squamous epithelial cells [nTPM],Single Cell Type RNA - Bipolar cells [nTPM],Single Cell Type RNA - Breast glandular cells [nTPM],Single Cell Type RNA - Breast myoepithelial cells [nTPM],Single Cell Type RNA - Cardiomyocytes [nTPM],Single Cell Type RNA - Cholangiocytes [nTPM],Single Cell Type RNA - Club cells [nTPM],Single Cell Type RNA - Collecting duct cells [nTPM],Single Cell Type RNA - Cone photoreceptor cells [nTPM],Single Cell Type RNA - Cytotrophoblasts [nTPM],Single Cell Type RNA - dendritic cells [nTPM],Single Cell Type RNA - Distal enterocytes [nTPM],Single Cell Type RNA - Distal tubular cells [nTPM],Single Cell Type RNA - Ductal cells [nTPM],Single Cell Type RNA - Early spermatids [nTPM],Single Cell Type RNA - Endometrial ciliated cells [nTPM],Single Cell Type RNA - Endometrial stromal cells [nTPM],Single Cell Type RNA - Endothelial cells [nTPM],Single Cell Type RNA - Enteroendocrine cells [nTPM],Single Cell Type RNA - Erythroid cells [nTPM],Single Cell Type RNA - Excitatory neurons [nTPM],Single Cell Type RNA - Exocrine glandular cells [nTPM],Single Cell Type RNA - Extravillous trophoblasts [nTPM],Single Cell Type RNA - Fibroblasts [nTPM],Single Cell Type RNA - Gastric mucus-secreting cells [nTPM],Single Cell Type RNA - Glandular and luminal cells [nTPM],Single Cell Type RNA - granulocytes [nTPM],Single Cell Type RNA - Granulosa cells [nTPM],Single Cell Type RNA - Hepatic stellate cells [nTPM],Single Cell Type RNA - Hepatocytes [nTPM],Single Cell Type RNA - Hofbauer cells [nTPM],Single Cell Type RNA - Horizontal cells [nTPM],Single Cell Type RNA - Inhibitory neurons [nTPM],Single Cell Type RNA - Intestinal goblet cells [nTPM],Single Cell Type RNA - Ionocytes [nTPM],Single Cell Type RNA - Kupffer cells [nTPM],Single Cell Type RNA - Langerhans cells [nTPM],Single Cell Type RNA - Late spermatids [nTPM],Single Cell Type RNA - Leydig cells [nTPM],Single Cell Type RNA - Macrophages [nTPM],Single Cell Type RNA - Melanocytes [nTPM],Single Cell Type RNA - Microglial cells [nTPM],Single Cell Type RNA - monocytes [nTPM],Single Cell Type RNA - Muller glia cells [nTPM],Single Cell Type RNA - NK-cells [nTPM],Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM],Single Cell Type RNA - Oligodendrocytes [nTPM],Single Cell Type RNA - Pancreatic endocrine cells [nTPM],Single Cell Type RNA - Paneth cells [nTPM],Single Cell Type RNA - Peritubular cells [nTPM],Single Cell Type RNA - Plasma cells [nTPM],Single Cell Type RNA - Prostatic glandular cells [nTPM],Single Cell Type RNA - Proximal enterocytes [nTPM],Single Cell Type RNA - Proximal tubular cells [nTPM],Single Cell Type RNA - Respiratory ciliated cells [nTPM],Single Cell Type RNA - Rod photoreceptor cells [nTPM],Single Cell Type RNA - Sertoli cells [nTPM],Single Cell Type RNA - Skeletal myocytes [nTPM],Single Cell Type RNA - Smooth muscle cells [nTPM],Single Cell Type RNA - Spermatocytes [nTPM],Single Cell Type RNA - Spermatogonia [nTPM],Single Cell Type RNA - Squamous epithelial cells [nTPM],Single Cell Type RNA - Suprabasal keratinocytes [nTPM],Single Cell Type RNA - Syncytiotrophoblasts [nTPM],Single Cell Type RNA - T-cells [nTPM],Single Cell Type RNA - Theca cells [nTPM],Single Cell Type RNA - Undifferentiated cells [nTPM],Single Cell Type RNA - Urothelial cells [nTPM]
AC213203.1,,ENSG00000268674,,P0DMU3,Unmapped,35407-35916,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Tissue enriched,Detected in single,5.0,brain: 1.9,Not detected,Not detected,,,,,,,Region enhanced,Detected in single,,cerebellum: 1.9,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,"HPA043267, HPA043292, HPA077864",Uncertain,,Approved,Intermediate filaments,,,,,,Intermediate filaments,,"HPA043267: , HPA043292: , HPA077864: AB_2686862",,,,,,,,,,,,,,,,,,0.0,0.0,0.2,0.0,0.2,0.0,0.0,1.9,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.3,0.1,0.1,0.0,0.0,0.3,,0.0,0.7,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.4,0.0,0.0,0.0,0.0,0.0,,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,1.9,0.2,0.1,0.3,0.3,0.1,0.1,0.7,0.0,0.4,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
ADAMTS20,GON-1,ENSG00000173157,ADAM metallopeptidase with thrombospondin type 1 motif 20,P59510,12,43353866-43552203,"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins",,"Hydrolase, Metalloprotease, Protease",Cancer-related genes,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,5.0,brain: 3.2,Group enriched,Detected in some,4.0,Bipolar cells: 5.1;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 11.1,Not detected,Not detected,,,Group enriched,Detected in some,5.0,medulla oblongata: 2.4;midbrain: 1.0;pons: 3.2;white matter: 1.4,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,Karpas-707: 3.6;NB-4: 1.6;NTERA-2: 2.8;SuSa: 2.2;U-266/70: 4.0;U-266/84: 2.2,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA027608, HPA027609",Uncertain,,,,Secreted to extracellular matrix,,,,,,,"HPA027608: AB_10600098, HPA027609: AB_10599024",unprognostic (3.18e-2),,,unprognostic (1.19e-1),unprognostic (1.91e-2),unprognostic (2.04e-1),,unprognostic (9.61e-2),unprognostic (3.29e-1),unprognostic (6.67e-2),unprognostic (2.26e-1),,unprognostic (1.05e-4),unprognostic (7.42e-2),unprognostic (2.02e-1),unprognostic (9.81e-3),unprognostic (2.57e-1),0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,2.4,1.0,0.0,0.0,0.0,0.0,0.0,0.5,3.2,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,3.6,0.1,0.0,0.0,1.6,2.8,0.0,0.1,0.0,0.0,0.9,0.0,0.0,0.0,0.4,0.0,0.0,0.0,2.2,0.7,0.0,0.0,0.0,0.3,0.0,0.0,4.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.4,0.0,0.4,2.4,1.0,0.0,3.2,0.0,0.2,1.4,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,5.1,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.1,0.0,0.0,0.0,0.8,0.0,2.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,16.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.1,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.1,0.0,0.0,0.0,0.0
AMZ1,KIAA1950,ENSG00000174945,Archaelysin family metallopeptidase 1,Q400G9,7,2679522-2775500,"Enzymes, Predicted intracellular proteins",,"Hydrolase, Metalloprotease, Protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,9.0,brain: 7.8,Cell type enriched,Detected in some,5.0,Oligodendrocyte precursor cells: 104.5,Low cancer specificity,Detected in some,,,Low region specificity,Detected in many,,,Immune cell enhanced,Detected in single,,memory B-cell: 1.2,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in some,,BEWO: 7.0;MCF7: 7.5;SK-BR-3: 5.2;T-47d: 27.7,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA020233,Uncertain,,,,,,,,,,,HPA020233: AB_1844818,unprognostic (9.08e-3),unprognostic (1.66e-1),unprognostic (3.23e-3),unprognostic (1.81e-1),unprognostic (5.72e-2),unprognostic (7.79e-2),unprognostic (2.02e-2),unprognostic (3.42e-1),unprognostic (1.98e-1),unprognostic (7.16e-3),unprognostic (1.08e-1),unprognostic (1.21e-1),unprognostic (3.64e-9),unprognostic (1.60e-3),unprognostic (1.60e-1),unprognostic (1.44e-1),unprognostic (1.13e-1),0.0,0.0,7.8,0.2,6.3,0.4,0.1,3.7,4.8,0.9,0.0,0.0,0.1,0.9,0.0,0.0,0.3,0.1,0.1,3.9,2.0,0.0,0.8,0.5,0.2,3.9,3.9,5.4,0.2,0.1,0.0,0.6,0.8,4.2,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.1,0.7,0.8,0.4,0.0,0.6,6.5,0.0,0.0,0.0,0.3,0.1,0.3,2.1,0.0,0.0,0.0,0.0,0.0,0.0,7.0,2.3,3.4,1.6,2.2,0.0,1.0,0.6,0.2,2.2,0.2,0.0,0.0,0.0,1.6,0.4,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,1.5,0.0,7.5,0.0,0.7,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.1,0.0,0.1,5.2,0.0,0.1,27.7,0.0,0.0,0.1,0.1,0.1,0.1,1.0,0.2,0.0,0.6,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,7.8,6.3,3.7,4.8,3.9,2.0,3.9,3.9,5.4,4.2,0.8,6.5,2.1,0.1,0.0,0.5,14.4,0.9,0.0,0.1,0.0,0.0,0.8,0.3,0.3,3.3,0.0,0.0,0.0,4.2,0.3,1.6,0.0,0.0,0.0,18.8,0.5,1.6,0.4,0.0,0.0,6.1,0.0,9.8,0.3,0.0,0.3,0.0,0.0,0.0,0.0,1.8,0.0,10.6,0.2,0.0,0.0,1.9,9.9,0.0,1.7,1.8,5.6,0.0,0.0,0.0,104.5,20.7,0.4,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.7,0.0,0.2,0.4,0.0,0.3,0.0,0.1,0.1,0.8,0.0,0.0,0.1
ANKRD34C,,ENSG00000235711,Ankyrin repeat domain 34C,P0C6C1,15,79293285-79298235,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,6.0,brain: 4.9,Group enriched,Detected in some,4.0,Excitatory neurons: 3.0;Inhibitory neurons: 1.8,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,17.0,SCLC-21H: 8.5,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA045329,,,Approved,Mitochondria,,,,,,Mitochondria,,HPA045329: AB_2679291,unprognostic (3.20e-1),,,unprognostic (1.08e-1),unprognostic (1.52e-2),,,,,,unprognostic (1.81e-1),,unprognostic (3.42e-3),unprognostic (5.31e-2),unprognostic (2.48e-1),,,0.1,0.1,1.4,0.0,0.5,0.0,0.0,2.1,1.9,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.7,2.7,0.0,0.0,0.1,0.0,2.0,3.8,0.4,0.0,0.2,0.0,0.7,0.0,2.7,0.0,0.0,0.5,0.0,0.0,0.1,0.7,0.0,0.0,0.1,0.0,0.0,0.0,4.9,0.0,0.0,0.0,0.0,0.0,0.0,3.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.1,8.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.5,2.1,1.9,0.7,2.7,2.0,3.8,0.4,2.7,0.1,4.9,3.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
ANKRD63,,ENSG00000230778,Ankyrin repeat domain 63,C9JTQ0,15,40281444-40282586,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,101.0,brain: 20.2,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in many,,basal ganglia: 20.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HEK 293: 1.9;THP-1: 1.4,Region enhanced,Detected in many,,basal ganglia: 56.7,,,,,HPA066743,,,Approved,Mitochondria,,,,,,Mitochondria,,HPA066743: ,,,,,unprognostic (9.36e-2),,,,,unprognostic (7.45e-2),,,,unprognostic (8.32e-2),unprognostic (4.42e-1),,,0.0,0.0,2.5,0.0,20.2,0.0,0.0,0.0,8.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,1.2,6.1,0.1,0.0,0.0,0.0,5.9,0.6,5.6,0.0,0.0,0.0,0.0,0.0,5.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,2.9,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.9,0.9,0.4,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.6,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.1,0.5,0.0,0.1,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,20.2,0.0,8.8,1.2,6.1,5.9,0.6,5.6,5.1,0.0,2.9,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BARHL1,,ENSG00000125492,BarH like homeobox 1,Q9BZE3,9,132582606-132590252,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,334.0,brain: 34.3,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,102.0,SCLC-21H: 16.9,Group enriched,Detected in some,5.0,cerebellum: 3.2;midbrain: 2.4;pons and medulla: 1.1,Region enhanced,Detected in many,,cerebellum: 5.8,HPA004809,Enhanced,,,,,,,,,,,HPA004809: AB_1078266,,,,,unprognostic (2.29e-1),,,,,unprognostic (6.42e-2),unprognostic (8.07e-2),,,unprognostic (9.31e-2),,,,0.0,0.0,0.5,0.0,2.4,0.0,0.0,19.5,6.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.5,0.0,0.0,0.0,0.0,23.6,8.3,0.0,0.0,0.0,0.0,0.0,0.0,34.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,3.0,0.1,0.0,0.0,0.0,0.0,0.0,20.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.9,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,2.4,19.5,6.2,0.0,3.5,23.6,8.3,0.0,34.3,0.1,3.0,20.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHLHA9,BHLHF42,ENSG00000205899,Basic helix-loop-helix family member a9,Q7RTU4,17,1270444-1271815,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Developmental protein, DNA-binding",Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,13.0,brain: 1.6,Not detected,Not detected,,,Cancer enhanced,Detected in single,,testis cancer: 0.6,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,unprognostic (9.27e-2),,,,,,,unprognostic (2.63e-1),,,,unprognostic (2.99e-1),unprognostic (7.74e-2),,,0.0,0.0,0.2,0.0,0.2,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.2,0.0,0.1,0.0,0.0,1.0,0.3,0.1,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,1.6,0.5,0.2,1.0,0.3,0.1,1.4,0.0,0.6,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BHLHE23,"bA305P22.3, Beta4, BHLHB4",ENSG00000125533,Basic helix-loop-helix family member e23,Q8NDY6,20,63005927-63007035,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,4.0,brain: 1.0,Cell type enriched,Detected in single,32.0,Cardiomyocytes: 3.3,Cancer enriched,Detected in single,11.0,testis cancer: 0.5,Region enriched,Detected in single,5.0,medulla oblongata: 1.0,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,21.0,MOLT-4: 13.9,Not detected,Not detected,,,,,,,HPA030575,Uncertain,,,,,,,,,,,HPA030575: AB_10601459,,,,,,,,,,,,,,,unprognostic (1.74e-1),,,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,13.9,0.5,0.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.0,1.0,0.2,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BLID,BRCC2,ENSG00000259571,"BH3-like motif containing, cell death inducer",Q8IZY5,11,122115340-122116215,Predicted intracellular proteins,Apoptosis,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,27.0,brain: 8.7,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,GAMG: 1.9;hTEC/SVTERT24-B: 1.0;hTERT-RPE1: 1.0;LHCN-M2: 1.4;U-87 MG: 1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1.3,0.0,2.9,0.0,0.0,1.5,1.6,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,8.7,0.0,0.0,0.0,0.0,3.6,2.4,0.3,0.1,0.0,0.0,0.0,0.0,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,5.8,0.0,0.1,0.0,0.3,0.2,0.3,0.0,0.9,0.5,0.2,0.1,0.0,0.0,0.0,0.0,0.4,1.9,0.0,0.0,0.5,0.5,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,1.0,0.9,1.0,0.1,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.4,0.3,0.0,0.1,0.4,0.0,0.0,0.0,1.7,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3,2.9,1.5,1.6,0.9,8.7,3.6,2.4,0.3,2.6,1.9,2.2,5.8,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0
BSX,BSX1,ENSG00000188909,Brain specific homeobox,Q3C1V8,11,122977570-122981834,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Activator, DNA-binding",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,38.0,brain: 9.6,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,hypothalamus: 9.6;pons: 4.5;thalamus: 2.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in single,5.0,hypothalamus: 4.5,Region enriched,Detected in single,10.0,hypothalamus: 3.4,HPA015654,Uncertain,,,,,,,,,,,HPA015654: AB_1845470,,,,,,,,,,,,,,,,,,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.6,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,4.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,9.6,0.0,1.1,0.0,4.5,0.0,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
BTBD17,"BTBD17A, LGALS3BPL, TANGO10A",ENSG00000204347,BTB domain containing 17,A6NE02,17,74356416-74361868,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,10.0,brain: 5.1,Cell type enriched,Detected in some,6.0,Horizontal cells: 28.6,Cancer enriched,Detected in some,5.0,glioma: 9.5,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,20.0,AF22: 2.9;NTERA-2: 3.8;SCLC-21H: 11.4,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA025022,Approved,,,,Secreted in brain,,,,,,,HPA025022: AB_2067352,,,,,unprognostic (2.63e-1),,,,,unprognostic (2.77e-1),unprognostic (4.82e-5),,,unprognostic (3.89e-2),unprognostic (2.55e-1),unprognostic (9.89e-3),,0.0,0.5,2.6,0.0,2.5,0.0,0.0,1.8,3.3,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,2.1,4.4,0.0,0.0,0.0,0.0,2.3,3.0,1.6,0.0,0.2,0.0,0.2,0.0,2.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.1,0.4,0.3,5.1,0.0,0.2,0.0,0.0,0.0,0.0,2.2,0.0,0.0,2.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.8,0.0,0.0,0.3,0.0,0.0,0.0,0.0,11.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.6,2.5,1.8,3.3,2.1,4.4,2.3,3.0,1.6,2.9,1.5,5.1,2.2,0.0,0.0,0.0,4.2,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,4.2,0.0,0.0,0.0,4.2,0.0,0.6,0.0,0.0,0.0,0.9,0.0,0.0,0.1,4.2,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.6,0.1,0.0,0.0,0.0,0.0,3.6,0.0,0.0,0.0,0.0,0.0,1.3,0.0,3.5,0.3,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.2,0.6,0.5,0.0,0.0,0.0,0.1,0.0,0.0,0.0
C4orf50,FLJ46481,ENSG00000181215,Chromosome 4 open reading frame 50,Q6ZRC1,4,5897373-6200555,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,20.0,brain: 4.4,Group enriched,Detected in some,4.0,Excitatory neurons: 12.7;Inhibitory neurons: 5.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,,,,,,,,,,,,,,unprognostic (7.02e-3),unprognostic (6.55e-3),unprognostic (2.35e-1),unprognostic (1.09e-1),unprognostic (1.19e-1),unprognostic (6.64e-3),unprognostic (1.11e-1),unprognostic (4.35e-2),unprognostic (9.94e-5),unprognostic (4.31e-2),unprognostic (4.86e-3),unprognostic (2.61e-1),unprognostic (2.88e-6),unprognostic (3.29e-1),unprognostic (2.23e-1),unprognostic (2.47e-2),unprognostic (4.68e-2),0.0,0.0,2.7,0.0,4.4,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.6,0.0,0.0,0.0,0.0,1.4,0.3,2.7,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.8,0.2,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,4.4,0.0,2.5,2.7,0.6,1.4,0.3,2.7,1.5,0.0,0.8,0.7,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,12.7,0.0,0.0,0.1,0.0,0.1,0.0,0.6,0.0,0.0,0.0,1.7,5.4,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.5,0.1,0.0,1.1,0.4,0.0,0.1,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,2.1,0.0,0.0
CACNG8,,ENSG00000142408,Calcium voltage-gated channel auxiliary subunit gamma 8,Q8WXS5,19,53962937-53990215,"FDA approved drug targets, Predicted membrane proteins, Transporters","Calcium transport, Ion transport, Transport","Calcium channel, Ion channel, Voltage-gated channel",FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,39.0,brain: 36.2,Group enriched,Detected in many,7.0,Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7,Cancer enriched,Detected in single,5.0,glioma: 1.6,Low region specificity,Detected in many,,,Immune cell enriched,Detected in single,9.0,basophil: 5.5,Lineage enriched,Detected in single,26.0,granulocytes: 5.5,Group enriched,Detected in some,5.0,AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA041351,Enhanced,,,,,,,,,,,HPA041351: AB_10796666,unprognostic (7.01e-2),unprognostic (6.27e-2),unprognostic (3.06e-1),unprognostic (5.29e-4),unprognostic (9.66e-2),unprognostic (2.17e-2),unprognostic (1.38e-1),unprognostic (9.40e-3),unprognostic (6.13e-2),unprognostic (2.03e-1),unprognostic (7.63e-2),unprognostic (2.58e-1),unprognostic (2.82e-8),unprognostic (1.10e-1),unprognostic (1.35e-1),unprognostic (1.63e-1),unprognostic (1.17e-1),0.0,0.0,10.5,0.1,10.3,0.2,0.0,0.0,36.2,0.0,0.0,0.0,0.1,0.1,0.1,0.0,0.1,0.1,0.0,31.1,4.1,0.0,0.0,0.0,0.1,1.6,1.7,10.5,0.0,0.0,0.3,0.6,0.0,4.9,0.1,0.0,0.9,0.1,0.0,0.4,0.2,0.1,0.1,0.8,0.1,0.2,0.6,5.1,0.0,0.1,0.2,0.0,0.0,0.0,10.1,0.0,2.4,7.2,0.2,0.0,0.1,0.1,0.1,0.4,0.0,0.1,0.5,0.4,0.0,0.2,0.0,0.3,0.2,0.0,0.1,0.0,0.0,1.0,2.7,0.7,0.1,1.1,0.0,23.7,0.3,0.0,0.1,0.3,8.4,2.4,0.1,0.1,0.2,0.0,0.1,0.0,0.0,1.5,0.3,3.0,0.0,0.0,0.0,0.0,0.1,0.1,1.5,0.1,0.1,0.0,0.2,0.2,0.0,14.9,0.1,1.3,0.0,0.0,0.1,0.0,0.0,2.3,0.0,0.1,5.5,0.1,0.6,0.1,0.0,0.1,0.1,0.1,0.1,0.0,0.2,0.1,0.1,0.2,0.1,0.0,0.1,0.1,0.0,10.5,10.3,0.0,36.2,31.1,4.1,1.6,1.7,10.5,4.9,0.8,5.1,10.1,3.6,0.0,0.0,5.9,0.4,1.7,1.5,0.0,0.0,6.9,0.1,1.5,3.3,0.0,0.7,1.8,0.0,0.0,0.0,0.4,0.0,1.9,2.3,0.7,1.0,6.4,0.0,2.7,61.9,0.0,0.0,0.6,0.0,1.0,0.0,0.0,5.7,0.0,0.1,50.5,66.0,0.3,0.0,0.8,2.1,1.7,0.0,0.5,0.0,0.0,0.3,1.1,1.0,29.7,4.3,0.2,0.1,0.4,0.0,1.5,0.1,0.2,2.6,1.7,0.0,3.8,1.0,6.2,7.1,0.0,1.1,0.1,0.6,0.5,0.9,1.3
CALHM1,FAM26C,ENSG00000185933,Calcium homeostasis modulator 1,Q8IU99,10,103453240-103458900,"Predicted membrane proteins, Transporters","Calcium transport, Ion transport, Sensory transduction, Taste, Transport","Calcium channel, Ion channel",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.3,Group enriched,Detected in some,4.0,Excitatory neurons: 1.6;NK-cells: 1.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6,Not detected,Not detected,,,Not detected,Not detected,,,HPA061816,Enhanced,,,,,,,,,,,HPA061816: ,unprognostic (2.46e-1),unprognostic (2.66e-1),unprognostic (2.38e-1),unprognostic (1.30e-1),unprognostic (5.65e-3),unprognostic (3.44e-2),,unprognostic (2.86e-2),unprognostic (1.67e-2),unprognostic (2.51e-1),unprognostic (1.40e-1),unprognostic (3.44e-1),unprognostic (2.21e-8),unprognostic (1.96e-1),unprognostic (1.37e-1),unprognostic (1.06e-1),unprognostic (1.38e-2),0.0,0.0,0.7,0.1,0.8,0.1,0.0,1.2,1.1,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.9,1.5,0.8,0.0,0.0,0.0,1.8,1.1,0.8,0.0,0.1,0.0,0.1,0.0,2.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.1,0.0,0.0,0.7,0.0,0.0,0.0,0.4,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,1.1,1.6,0.1,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.7,0.8,1.2,1.1,0.9,1.5,1.8,1.1,0.8,2.3,0.2,0.7,1.6,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,1.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CENPVL2,CENPVP2,ENSG00000283093,Centromere protein V like 2,P0DPI3,X,51681212-51682831,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 2.5,Not detected,Not detected,,,,,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1.1,0.0,2.5,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,2.0,0.0,0.0,0.0,0.0,1.0,0.9,0.6,0.0,0.0,0.0,0.2,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.8,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,2.5,0.0,1.1,0.3,2.0,1.0,0.9,0.6,0.6,0.4,2.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
CLEC19A,,ENSG00000261210,C-type lectin domain containing 19A,Q6UXS0,16,19285731-19322145,Predicted secreted proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,4.0,brain: 3.0,Group enriched,Detected in some,4.0,Microglial cells: 6.5;Respiratory ciliated cells: 2.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Low region specificity,Detected in all,,,,,,,,Secreted in brain,,,,,,,,,,,unprognostic (3.19e-1),,,,unprognostic (3.72e-1),,unprognostic (1.11e-1),unprognostic (1.82e-2),unprognostic (1.20e-1),,unprognostic (1.53e-1),,,,0.0,0.0,2.7,0.0,1.7,0.0,0.0,1.3,1.9,0.0,0.6,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,2.3,0.2,0.0,0.0,0.1,0.0,0.6,1.2,3.0,0.0,0.0,0.0,0.0,0.0,0.5,0.2,0.0,0.2,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.2,0.1,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.2,0.4,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,1.7,1.3,1.9,2.3,0.2,0.6,1.2,3.0,0.5,0.0,0.6,0.9,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,6.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1
CREG2,,ENSG00000175874,Cellular repressor of E1A stimulated genes 2,Q8IUH2,2,101345550-101387503,Predicted secreted proteins,,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,35.0,brain: 29.8,Cell type enhanced,Detected in some,,Excitatory neurons: 66.0;Inhibitory neurons: 27.6;Oligodendrocytes: 12.0,Low cancer specificity,Detected in many,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CACO-2: 2.5;HaCaT: 6.3;HeLa: 2.5;OE19: 7.1;PC-3: 2.4;RT4: 1.7,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,HPA038224,Enhanced,,,,Secreted in brain,,,,,,,HPA038224: AB_10673167,unprognostic (5.09e-2),unprognostic (3.78e-3),unprognostic (4.10e-3),unprognostic (8.15e-3),unprognostic (5.63e-3),unprognostic (9.68e-3),unprognostic (4.52e-8),unprognostic (3.86e-4),unprognostic (1.39e-1),unprognostic (6.49e-2),unprognostic (1.90e-2),unprognostic (7.69e-2),unprognostic (5.41e-3),unprognostic (4.44e-2),unprognostic (2.91e-1),unprognostic (8.26e-3),unprognostic (7.77e-2),0.0,0.1,10.4,0.0,17.1,0.1,0.0,0.0,27.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.3,0.1,0.1,29.8,6.2,0.0,0.0,0.0,0.0,3.8,0.9,17.8,0.0,0.0,0.2,0.2,0.0,5.6,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,2.1,0.0,0.0,0.0,0.0,0.1,0.7,15.3,0.3,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,1.4,0.0,0.0,0.0,0.0,6.3,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.3,0.1,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,7.1,2.4,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,10.4,17.1,0.0,27.0,29.8,6.2,3.8,0.9,17.8,5.6,0.0,2.1,15.3,0.0,0.0,0.0,2.9,0.0,0.0,0.6,0.5,0.0,0.8,0.1,0.1,0.9,0.0,0.4,1.8,0.0,0.0,0.0,0.0,0.0,0.0,5.3,0.2,0.0,0.5,0.0,0.0,66.0,0.2,0.0,0.2,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,27.6,0.1,2.0,0.0,0.0,6.5,0.0,0.2,0.0,6.5,0.0,0.8,0.0,2.5,12.0,2.8,0.0,0.0,0.0,0.3,0.0,0.0,0.8,0.5,0.0,0.2,0.1,1.5,5.6,0.5,0.0,0.1,0.0,0.2,0.0,1.5
CRYBA1,CRYB1,ENSG00000108255,Crystallin beta A1,P05813,17,29246859-29254494,"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins",,Eye lens protein,Cataract,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,8.0,brain: 2.2,Group enriched,Detected in some,4.0,Extravillous trophoblasts: 1.1;Syncytiotrophoblasts: 2.9,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,AF22: 3.2;BEWO: 4.1;SuSa: 1.0,Group enriched,Detected in some,7.0,hippocampal formation: 2.7;hypothalamus: 1.2;thalamus: 1.2,Low region specificity,Detected in all,,,HPA022016,Supported,,,,,,,,,,,HPA022016: AB_2732426,unprognostic (2.89e-2),unprognostic (1.57e-1),unprognostic (8.75e-2),unprognostic (1.37e-1),unprognostic (9.62e-2),unprognostic (4.27e-3),unprognostic (2.08e-1),unprognostic (5.60e-2),unprognostic (2.52e-2),unprognostic (9.90e-2),unprognostic (5.85e-3),unprognostic (2.83e-1),unprognostic (2.09e-6),unprognostic (1.18e-1),unprognostic (1.86e-2),unprognostic (4.31e-2),unprognostic (6.84e-3),0.0,0.0,0.5,0.1,0.7,0.1,0.0,1.3,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.3,0.0,0.0,0.0,0.0,0.9,0.6,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,3.2,0.0,0.0,0.0,4.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.7,1.3,0.6,0.2,0.3,0.9,0.6,0.0,1.0,0.3,0.7,2.2,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.3,0.0,1.1,0.0,0.5,0.4,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,2.9,0.1,0.0,0.0,0.0
DBX2,FLJ16139,ENSG00000185610,Developing brain homeobox 2,Q6ZNG2,12,45014672-45051099,"Predicted intracellular proteins, Transcription factors",,DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,11.0,brain: 8.3,Group enriched,Detected in some,9.0,Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1,Cancer enriched,Detected in single,32.0,glioma: 4.5,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA065045, HPA066053",Uncertain,,Approved,"Nucleoplasm,Nuclear membrane,Vesicles",,,,,,"Nucleoplasm, Nuclear membrane",Vesicles,"HPA065045: , HPA066053: AB_2685605",unprognostic (1.13e-4),,,unprognostic (9.99e-2),unprognostic (7.82e-3),unprognostic (5.24e-2),,,,unprognostic (5.62e-2),unprognostic (1.51e-1),unprognostic (9.22e-2),,unprognostic (4.76e-2),unprognostic (1.64e-1),unprognostic (5.19e-1),,0.4,0.0,3.6,0.0,3.5,0.0,0.2,3.6,3.7,0.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.3,3.5,0.1,0.0,0.0,0.0,7.3,4.2,2.3,0.0,0.0,0.0,0.0,0.0,5.4,0.0,0.0,0.0,0.1,0.0,0.0,0.4,0.0,0.0,8.3,0.0,0.0,0.6,5.3,0.0,0.2,0.2,0.0,0.0,0.1,7.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.6,3.5,3.6,3.7,3.3,3.5,7.3,4.2,2.3,5.4,8.3,5.3,7.4,0.0,0.0,0.0,11.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.2,0.0,0.0,0.0,0.7,0.0,0.0,0.9,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,5.1,0.0,0.4,0.0,0.0,0.0,0.0,0.0
DLX2,TES-1,ENSG00000115844,Distal-less homeobox 2,Q07687,2,172099438-172102900,"Predicted intracellular proteins, Transcription factors","Differentiation, Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.7,Cell type enhanced,Detected in some,,dendritic cells: 6.5;Early spermatids: 6.9;Gastric mucus-secreting cells: 5.6;Inhibitory neurons: 10.0;Melanocytes: 5.4,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,7.0,AN3-CA: 79.7;HEK 293: 50.8,Region enhanced,Detected in many,,olfactory bulb: 29.4,Region enriched,Detected in many,5.0,olfactory bulb: 23.2,HPA056965,,,Approved,Nuclear speckles,,,,,,Nuclear speckles,,HPA056965: AB_2683291,unprognostic (8.12e-2),unprognostic (3.56e-1),unprognostic (2.48e-2),unprognostic (1.28e-2),unprognostic (4.07e-1),unprognostic (2.13e-1),unprognostic (8.60e-3),unprognostic (3.03e-2),unprognostic (2.41e-1),unprognostic (8.74e-2),unprognostic (3.53e-2),unprognostic (3.01e-1),unprognostic (6.69e-10),unprognostic (9.38e-2),unprognostic (2.47e-1),unprognostic (2.41e-1),unprognostic (7.95e-3),0.0,0.3,0.9,0.0,1.0,0.1,0.2,0.0,0.6,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,1.7,0.0,0.0,0.0,0.0,0.2,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.7,0.1,0.0,0.0,0.0,0.0,0.7,1.0,0.0,0.5,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.0,79.7,0.5,0.3,2.2,4.3,1.0,0.7,0.2,0.5,0.2,0.0,2.4,2.0,3.8,4.1,2.6,0.3,0.2,0.1,50.8,1.3,8.8,2.0,0.2,0.4,0.3,0.0,3.7,0.1,0.5,0.3,0.0,2.0,0.6,0.0,0.5,0.2,0.1,0.6,0.1,0.0,1.1,0.0,0.4,0.0,0.1,0.1,2.8,0.0,2.1,1.2,5.0,1.3,0.6,0.4,0.4,5.5,0.0,3.0,0.5,0.1,0.1,0.5,4.7,0.1,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,1.0,0.0,0.6,0.2,1.7,0.2,0.0,0.4,0.2,0.0,1.0,0.1,1.4,0.0,0.0,0.0,1.3,1.8,0.2,0.9,0.6,0.0,3.1,3.6,0.4,0.0,0.2,0.0,0.0,0.4,6.5,1.0,0.0,0.0,6.9,1.6,0.3,0.5,0.0,0.0,0.1,0.0,0.3,0.2,5.6,1.1,0.0,0.0,0.0,0.0,0.5,0.0,10.0,1.1,0.0,0.0,0.3,0.1,0.0,1.8,5.4,1.0,0.0,0.2,0.0,0.0,0.1,0.0,1.2,0.0,0.4,0.1,1.3,0.0,0.1,0.0,0.0,0.3,1.5,0.9,0.7,1.6,0.0,0.4,1.5,0.2,0.6,0.0
DRAXIN,"C1orf187, FLJ34999, Neucrin",ENSG00000162490,Dorsal inhibitory axon guidance protein,Q8NBI3,1,11691710-11725857,Predicted secreted proteins,Wnt signaling pathway,Developmental protein,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 4.0,Cell type enhanced,Detected in some,,dendritic cells: 5.5;NK-cells: 3.1;T-cells: 4.6,Group enriched,Detected in some,6.0,glioma: 5.1;testis cancer: 2.8,Low region specificity,Detected in many,,,Immune cell enhanced,Detected in single,,basophil: 2.5,Lineage enriched,Detected in single,4.0,granulocytes: 2.5,Cell line enriched,Detected in some,4.0,NTERA-2: 27.9,Low region specificity,Detected in some,,,Low region specificity,Detected in many,,,HPA014302,Uncertain,,,,Secreted in brain,,,,,,,HPA014302: AB_1853084,unprognostic (5.28e-2),unprognostic (2.73e-1),unprognostic (6.58e-2),unprognostic (4.95e-2),unprognostic (2.51e-1),unprognostic (1.85e-1),unprognostic (1.37e-2),unprognostic (1.84e-2),unprognostic (1.49e-1),unprognostic (1.17e-1),unprognostic (1.51e-2),unprognostic (7.47e-2),unprognostic (5.16e-6),unprognostic (4.65e-2),unprognostic (1.15e-1),unprognostic (8.52e-2),unprognostic (5.08e-1),0.0,0.0,1.7,0.2,1.5,0.5,0.0,1.1,1.3,0.0,0.6,0.0,0.1,0.2,0.1,0.0,0.1,0.1,0.0,1.3,4.0,0.0,0.0,0.1,0.2,2.7,0.7,1.5,0.0,0.1,0.0,0.0,0.0,0.8,0.0,0.0,0.1,0.7,0.0,0.1,0.2,0.1,0.0,0.6,0.1,0.0,0.3,3.0,0.0,0.1,0.0,0.1,0.0,0.0,1.2,0.0,0.0,3.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,2.6,0.0,0.9,0.0,0.9,0.0,0.1,0.0,0.1,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.0,0.4,0.0,5.7,0.0,0.2,0.0,0.1,0.0,0.2,2.1,0.3,27.9,0.0,0.1,6.4,0.2,0.0,0.0,0.0,1.8,0.7,0.1,0.0,0.1,4.6,0.0,0.2,0.2,0.1,1.2,0.0,0.0,0.1,0.1,0.0,0.0,0.5,0.4,2.5,0.3,0.1,0.5,0.1,0.2,0.1,0.1,0.3,0.0,0.2,0.2,0.2,0.8,0.2,0.2,0.1,0.2,0.1,1.7,1.5,1.1,1.3,1.3,4.0,2.7,0.7,1.5,0.8,0.6,3.0,1.2,0.1,0.0,0.5,0.0,1.2,0.5,2.9,0.6,0.0,0.7,0.4,0.4,1.1,1.5,0.1,0.0,2.1,0.1,5.5,0.1,0.0,0.1,0.7,0.4,0.4,0.6,0.0,0.0,0.4,0.2,0.2,0.6,0.0,0.4,1.3,0.1,1.1,0.2,0.4,0.0,0.5,0.7,0.0,0.8,1.9,2.1,0.6,1.2,1.8,0.0,0.3,0.2,3.1,1.5,0.4,0.2,0.2,0.0,1.5,2.1,0.0,0.1,0.0,0.7,0.0,2.3,0.7,0.6,1.7,0.0,0.3,0.0,4.6,0.1,0.1,2.2
DRD3,,ENSG00000151577,Dopamine receptor D3,P35462,3,114127580-114199407,"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer","FDA approved drug targets, Schizophrenia",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,7.0,brain: 5.5,Group enriched,Detected in some,12.0,Early spermatids: 6.2;Late spermatids: 19.6,Not detected,Not detected,,,Group enriched,Detected in some,5.0,basal ganglia: 5.5;cerebral cortex: 2.1;hypothalamus: 3.9,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in some,5.0,basal ganglia: 7.4,Region enriched,Detected in many,10.0,basal ganglia: 17.9,,,,,,,,,,,,,,,,,,unprognostic (2.32e-1),,,,,,,,,,,,,0.0,0.0,0.1,0.0,5.5,0.0,0.0,0.0,2.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.9,0.0,0.0,0.0,0.0,0.3,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.7,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.1,5.5,0.0,2.1,0.1,3.9,0.3,0.2,0.5,0.7,0.1,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.2,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,19.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
EN2,,ENSG00000164778,Engrailed homeobox 2,P19622,7,155458129-155464831,"Disease related genes, Predicted intracellular proteins, Transcription factors",,"Developmental protein, DNA-binding","Autism, Autism spectrum disorder",Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,20.0,brain: 18.1,Group enriched,Detected in some,4.0,Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7,Cancer enhanced,Detected in many,,melanoma: 6.3,Region enhanced,Detected in many,,cerebellum: 18.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9,Region enriched,Detected in some,8.0,cerebellum: 27.8,Region enriched,Detected in some,5.0,cerebellum: 52.3,"HPA045646, HPA069809",,,Supported,"Nucleoplasm,Nucleoli,Nucleoli fibrillar center",,No,No,,,Nucleoplasm,"Nucleoli, Nucleoli fibrillar center","HPA045646: AB_2679404, HPA069809: AB_2686205",unprognostic (2.44e-3),unprognostic (1.71e-2),unprognostic (4.89e-2),unprognostic (7.99e-3),prognostic unfavorable (1.74e-6),unprognostic (2.54e-1),unprognostic (8.02e-2),unprognostic (7.00e-2),unprognostic (1.15e-1),unprognostic (9.87e-3),unprognostic (1.07e-1),unprognostic (1.94e-1),unprognostic (1.03e-13),unprognostic (4.91e-3),unprognostic (2.72e-1),unprognostic (2.24e-1),unprognostic (5.64e-3),0.1,0.1,0.1,0.0,0.3,0.0,0.1,18.1,0.5,0.1,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.1,0.4,0.0,0.0,0.0,0.0,0.7,4.4,0.0,0.7,0.3,0.5,0.1,0.0,5.6,0.0,0.0,0.0,0.0,0.0,0.4,0.3,0.0,0.0,0.2,0.0,0.0,0.9,1.7,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.8,0.7,41.1,15.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,6.1,0.0,1.4,0.0,9.0,0.0,0.0,0.0,25.1,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.8,0.0,0.3,5.5,0.0,0.0,0.0,0.0,2.0,0.0,3.2,0.0,0.1,0.3,0.0,0.0,3.0,0.0,12.9,0.0,0.0,2.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,18.1,0.5,0.1,0.4,0.7,4.4,0.0,5.6,0.2,1.7,1.9,0.3,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.8,0.8,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.7,3.6,0.6,0.2,0.0,0.0,0.0,0.2,0.0,0.4,0.0,8.7,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.9,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.9,0.4,1.5,0.6,0.0,0.1,0.0,0.1,0.3,0.0,0.0
F8A2,,ENSG00000274791,Coagulation factor VIII associated 2,P23610,X,155382115-155383230,"Disease related genes, Predicted intracellular proteins",,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,116.0,brain: 11.6,Cell type enhanced,Detected in single,,Melanocytes: 1.8,Not detected,Not detected,,,Region enriched,Detected in many,4.0,medulla oblongata: 11.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (2.04e-2),,,,,unprognostic (5.07e-1),,,,unprognostic (8.70e-2),,,,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.6,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.4,0.0,0.0,11.6,1.0,0.0,1.5,0.0,2.7,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0
FAM237B,,ENSG00000283267,Family with sequence similarity 237 member B,A0A1B0GVD1,7,90316503-90321308,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.6,Group enriched,Detected in some,7.0,Endometrial ciliated cells: 1.6;Respiratory ciliated cells: 1.5,,,,,Region enriched,Detected in single,6.0,hypothalamus: 1.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,hypothalamus: 1.6;thalamus: 4.9,Low region specificity,Detected in all,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,1.6,0.1,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.1,0.4,0.0,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,1.6,0.2,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0
FAM240A,,ENSG00000283473,Family with sequence similarity 240 member A,A0A1B0GVK7,3,46612435-46626543,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.9,Cell type enhanced,Detected in single,,Breast glandular cells: 2.2,,,,,Region enhanced,Detected in single,,cerebral cortex: 1.9,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,0.0,0.1,0.0,0.3,0.0,0.4,0.4,1.9,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.1,0.0,0.5,0.0,0.0,0.1,0.7,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.4,1.9,0.5,0.1,0.1,0.0,0.3,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FAM246A,,ENSG00000286102,Family with sequence similarity 246 member A,A0A494C0Y3,22,21360601-21361299,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,No human protein/transcript evidence,Tissue enriched,Detected in single,10.0,brain: 1.0,Not detected,Not detected,,,,,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.6,0.2,0.1,0.0,0.0,0.0,,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.4,0.1,0.2,0.6,0.2,0.1,1.0,0.2,0.2,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FERD3L,"bHLHa31, N-TWIST, NATO3",ENSG00000146618,Fer3 like bHLH transcription factor,Q96RJ6,7,19144782-19145421,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","DNA-binding, Repressor",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,27.0,brain: 5.3,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,4.0,cerebral cortex: 1.7;medulla oblongata: 1.8;midbrain: 5.3;pons: 2.3;white matter: 1.3,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,109.0,SCLC-21H: 10.9,Not detected,Not detected,,,Region enriched,Detected in some,16.0,midbrain: 20.2,HPA043494,Uncertain,,,,,,,,,,,HPA043494: AB_10964193,,,,,,,,,,,,,,,,,,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.2,1.7,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.5,0.2,0.0,0.0,0.0,0.0,1.8,5.3,0.3,0.0,0.0,0.0,0.0,0.1,2.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.1,0.4,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.2,1.7,0.5,0.2,1.8,5.3,0.3,2.3,0.5,0.4,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FGF3,"HBGF-3, INT2",ENSG00000186895,Fibroblast growth factor 3,P11487,11,69809968-69819416,"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins",Differentiation,"Developmental protein, Growth factor, Mitogen","Cancer-related genes, Disease variant, Proto-oncogene",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,32.0,brain: 3.1,Not detected,Not detected,,,Cancer enhanced,Detected in many,,endometrial cancer: 5.4,Region enriched,Detected in single,4.0,cerebellum: 3.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in some,,basal ganglia: 3.1,Not detected,Not detected,,,HPA012692,Enhanced,,,,Secreted in brain,,,,,,,HPA012692: AB_1848526,,,,unprognostic (6.42e-3),,,,,,unprognostic (7.82e-2),unprognostic (1.89e-1),,,unprognostic (3.61e-1),unprognostic (7.75e-2),,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,0.1,0.0,0.0,0.1,0.7,0.0,0.7,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FOXB1,"FKH5, HFKH-5",ENSG00000171956,Forkhead box B1,Q99853,15,60004234-60061730,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,29.0,brain: 18.9,Cell type enriched,Detected in some,4.0,Early spermatids: 32.5,Cancer enhanced,Detected in some,,endometrial cancer: 1.2,Low region specificity,Detected in many,,,Immune cell enriched,Detected in single,5.0,T-reg: 1.1,Lineage enriched,Detected in single,12.0,T-cells: 1.1,Cell line enhanced,Detected in some,,AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6,Region enhanced,Detected in many,,hypothalamus: 6.6,Low region specificity,Detected in many,,,HPA073369,,,Approved,"Nucleoplasm,Mitochondria",,,,,,"Nucleoplasm, Mitochondria",,HPA073369: AB_2686597,unprognostic (1.69e-1),unprognostic (3.33e-2),unprognostic (1.14e-1),unprognostic (7.40e-3),unprognostic (1.33e-3),unprognostic (1.17e-2),,unprognostic (1.47e-2),unprognostic (5.32e-4),unprognostic (1.06e-1),unprognostic (9.21e-2),unprognostic (3.21e-1),unprognostic (8.12e-9),unprognostic (8.74e-2),unprognostic (1.74e-1),,unprognostic (9.38e-2),0.0,0.0,4.2,0.0,2.6,0.0,0.0,6.1,0.7,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,18.9,0.0,0.0,0.0,0.2,10.1,6.6,0.1,0.0,0.0,0.0,0.0,0.2,5.5,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,7.9,0.0,0.2,0.6,11.9,0.0,0.0,0.0,0.0,0.0,0.0,4.5,2.5,0.0,6.6,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,14.7,10.7,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.6,0.0,0.0,0.0,0.0,1.1,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.1,0.0,4.2,2.6,6.1,0.7,0.1,18.9,10.1,6.6,0.1,5.5,7.9,11.9,4.5,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.7,0.1,0.1,0.0,0.0,32.5,7.0,0.3,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,3.6,0.0,1.3,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,6.8,0.3,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,4.8,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.0
FOXB2,bA159H20.4,ENSG00000204612,Forkhead box B2,Q5VYV0,9,77019655-77020953,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,48.0,brain: 4.7,Not detected,Not detected,,,Cancer enhanced,Detected in single,,prostate cancer: 0.6,Region enriched,Detected in some,5.0,hypothalamus: 4.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,8.0,NTERA-2: 1.3,Region enriched,Detected in single,11.0,hypothalamus: 1.1,Group enriched,Detected in many,4.0,basal ganglia: 3.3;hypothalamus: 6.5;medulla oblongata: 2.8;midbrain: 2.8;spinal cord: 5.1,HPA067947,Approved,,,,,,,,,,,HPA067947: AB_2685930,,,,,,,,,,unprognostic (2.02e-1),,unprognostic (8.58e-2),,,unprognostic (2.62e-1),,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,4.7,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.3,4.7,1.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FOXD4L3,FOXD6,ENSG00000187559,Forkhead box D4 like 3,Q6VB84,9,68302867-68305084,"Predicted intracellular proteins, Transcription factors",,DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.6,Cell type enriched,Detected in single,5.0,monocytes: 1.0,Not detected,Not detected,,,Region enhanced,Detected in some,,hippocampal formation: 1.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA012836,Uncertain,,Approved,Nucleoplasm,,,,,,Nucleoplasm,,HPA012836: AB_2105429,,unprognostic (7.93e-4),,,unprognostic (8.71e-2),,,,,unprognostic (7.04e-2),,,,unprognostic (4.75e-2),,,,0.0,0.0,0.1,0.2,0.2,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,1.6,0.1,0.0,0.0,0.0,0.1,0.2,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.2,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,1.2,1.6,0.1,0.2,0.0,0.2,0.3,0.0,0.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FOXD4L4,"bA460E7.2, FOXD4L2",ENSG00000184659,Forkhead box D4 like 4,Q8WXT5,9,65736555-65738784,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,4.0,brain: 1.2,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA012836,Uncertain,,Approved,Nucleoplasm,,,,,,Nucleoplasm,,HPA012836: AB_2105429,unprognostic (6.92e-2),unprognostic (5.48e-2),,,unprognostic (5.19e-2),,,,,,unprognostic (7.78e-2),,unprognostic (7.93e-3),unprognostic (7.14e-2),,,,0.1,0.0,0.1,0.0,0.2,0.0,0.1,0.3,1.2,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,1.2,0.2,0.0,0.1,0.0,0.0,0.5,0.3,0.1,0.0,0.0,0.0,0.1,0.0,0.7,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.3,1.2,1.2,0.2,0.5,0.3,0.1,0.7,0.0,0.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FOXD4L5,bA15J10.2,ENSG00000204779,Forkhead box D4 like 5,Q5VV16,9,65282101-65285209,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.2,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Low cell line specificity,Detected in some,,,,,,,,,,,HPA012836,Uncertain,,Approved,Nucleoplasm,,,,,,Nucleoplasm,,HPA012836: AB_2105429,unprognostic (8.26e-2),unprognostic (6.95e-3),,,,,,,,,unprognostic (1.58e-1),,,unprognostic (5.76e-2),unprognostic (2.57e-1),,,0.1,0.2,0.2,0.0,0.6,0.0,0.1,1.0,1.2,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.0,0.0,0.0,1.0,0.2,0.1,0.0,0.1,0.1,0.6,0.5,0.3,0.0,0.0,0.1,0.1,0.1,0.7,0.0,0.0,0.7,0.1,0.0,0.1,0.4,0.1,0.0,0.1,0.1,0.1,0.2,0.2,0.1,0.1,0.0,0.0,0.0,0.0,1.0,0.3,0.3,0.2,0.9,0.1,0.1,1.0,0.2,0.0,0.0,0.0,0.2,0.1,0.6,0.1,0.0,0.1,0.0,0.5,0.0,0.0,0.9,0.5,0.5,0.3,0.2,0.0,0.5,0.8,0.0,0.2,0.0,0.1,0.3,0.0,0.0,0.9,0.3,0.0,0.2,0.1,0.3,0.2,0.1,0.2,0.2,0.6,0.2,0.2,0.4,0.4,0.8,0.2,0.1,0.0,0.5,0.2,1.1,0.1,0.1,0.6,0.3,0.3,0.2,0.5,0.1,0.0,0.6,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.6,1.0,1.2,1.0,0.2,0.6,0.5,0.3,0.7,0.1,0.2,1.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1
FOXD4L6,,ENSG00000273514,Forkhead box D4 like 6,Q3SYB3,9,41126435-41128681,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.8,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in some,,hippocampal formation: 1.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA012836,Uncertain,,Approved,Nucleoplasm,,,,,,Nucleoplasm,,HPA012836: AB_2105429,,unprognostic (2.41e-1),,,unprognostic (3.41e-1),,,,,,,,,unprognostic (3.61e-1),,,,0.0,0.0,0.2,0.1,0.3,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.6,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.3,0.0,1.6,1.8,0.0,0.1,0.0,0.6,0.3,0.0,0.0,0.5,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
FREM3,,ENSG00000183090,FRAS1 related extracellular matrix 3,P0C091,4,143577302-143700675,Predicted secreted proteins,Cell adhesion,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.2,Cell type enhanced,Detected in some,,Astrocytes: 1.6;Excitatory neurons: 9.7;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 2.1,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,basal ganglia: 3.1;hypothalamus: 2.8;thalamus: 4.4,,,,,HPA041641,Uncertain,,,,Secreted to extracellular matrix,,,,,,,HPA041641: AB_2677592,unprognostic (1.19e-2),,,unprognostic (4.09e-9),unprognostic (3.09e-3),unprognostic (2.74e-1),,unprognostic (1.66e-1),unprognostic (4.74e-2),unprognostic (1.98e-1),unprognostic (1.91e-1),unprognostic (2.68e-1),unprognostic (2.17e-1),unprognostic (1.46e-1),unprognostic (2.30e-1),unprognostic (7.11e-3),unprognostic (3.24e-1),0.0,0.0,0.6,0.0,0.9,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.7,0.0,0.0,0.4,0.0,0.1,0.2,1.2,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.4,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.9,0.0,0.7,0.5,0.7,0.1,0.2,1.2,0.3,0.0,0.6,0.1,0.0,0.0,0.0,1.6,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.6,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,1.0,0.2,0.6,0.3,0.0,0.0,9.7,0.0,0.0,0.0,0.0,0.2,0.0,0.3,0.0,0.0,0.0,0.0,3.6,0.0,0.0,0.0,0.0,0.9,0.3,0.1,0.0,1.0,0.0,0.0,0.0,4.5,2.1,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.5,0.0,0.0,0.0,0.1,0.1,0.0,0.0
GABRA6,,ENSG00000145863,Gamma-aminobutyric acid type A receptor subunit alpha6,Q16445,5,161547063-161702593,"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins","Ion transport, Transport","Chloride channel, Ion channel, Ligand-gated ion channel, Receptor",FDA approved drug targets,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,109.0,brain: 68.4,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,12.0,cerebellum: 68.4;pons: 21.5,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in some,40.0,cerebellum: 1073.8,Region enriched,Detected in some,37.0,cerebellum: 262.3,CAB022462,Approved,,,,,,,,,,,CAB022462: ,,,,,,,,,,,,,,,,unprognostic (3.79e-2),,0.0,0.1,0.1,0.0,0.3,0.0,0.0,68.4,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.4,0.0,0.0,0.0,0.0,0.3,3.7,0.0,0.0,0.0,0.0,0.0,0.0,21.5,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.6,0.3,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,68.4,2.2,0.1,0.4,0.3,3.7,0.0,21.5,0.3,0.3,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GBX2,,ENSG00000168505,Gastrulation brain homeobox 2,P52951,2,236165236-236168386,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,44.0,brain: 11.0,Cell type enriched,Detected in single,4.0,Early spermatids: 2.8,Group enriched,Detected in some,6.0,glioma: 1.7;testis cancer: 6.6,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AF22: 47.5;BEWO: 8.3;PC-3: 14.2;TIME: 7.7,Region enhanced,Detected in single,,thalamus: 1.3,Group enriched,Detected in some,4.0,midbrain: 2.5;pons: 2.7;thalamus: 6.4,HPA067809,,,Approved,Nucleoplasm,,Yes,,,,Nucleoplasm,,HPA067809: AB_2685900,unprognostic (5.30e-2),unprognostic (1.15e-1),unprognostic (7.09e-2),unprognostic (1.59e-1),unprognostic (2.91e-2),unprognostic (4.49e-2),unprognostic (2.14e-2),unprognostic (1.72e-2),unprognostic (2.91e-1),unprognostic (8.13e-2),unprognostic (6.99e-2),unprognostic (3.55e-4),unprognostic (8.69e-7),unprognostic (2.08e-1),unprognostic (1.01e-2),unprognostic (5.47e-2),unprognostic (9.39e-4),0.0,0.0,1.4,0.0,1.4,0.0,0.0,2.5,0.8,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,7.5,0.0,0.0,0.0,0.0,4.8,5.1,0.1,0.0,0.0,0.0,0.1,0.1,3.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.0,0.0,0.2,11.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,2.6,0.9,47.5,1.8,0.0,0.0,8.3,0.7,0.0,1.3,0.0,1.1,0.0,0.0,0.9,0.0,1.4,0.0,0.4,0.1,0.3,0.0,4.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.5,3.9,0.0,3.4,0.0,0.6,1.2,0.0,0.4,1.2,0.0,14.2,0.0,5.1,0.0,0.4,0.0,0.6,0.3,1.6,0.0,0.5,1.5,0.0,0.0,7.7,0.4,0.0,0.0,3.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,1.4,2.5,0.8,0.4,7.5,4.8,5.1,0.1,3.3,2.7,11.0,1.7,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.7,0.0,0.0,0.3,0.0,0.0,0.0,0.0
GJA9,"CX58, CX59, GJA10",ENSG00000131233,Gap junction protein alpha 9,P57773,1,38874069-38881587,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.3,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,GAMG: 1.0,,,,,Low region specificity,Detected in all,,,HPA067850,Uncertain,,,,,,,,,,,HPA067850: AB_2685910,unprognostic (2.00e-1),unprognostic (8.78e-2),,,unprognostic (4.55e-2),unprognostic (2.66e-1),,unprognostic (4.79e-2),unprognostic (1.20e-2),unprognostic (1.95e-1),unprognostic (1.75e-1),unprognostic (2.75e-2),unprognostic (1.90e-2),unprognostic (2.63e-1),,unprognostic (4.11e-3),unprognostic (2.32e-2),0.1,0.1,0.4,0.0,0.4,0.0,0.0,0.1,0.5,0.1,0.0,0.2,0.2,0.0,0.0,0.4,0.1,0.1,0.5,0.2,0.1,0.1,0.0,0.0,0.1,1.3,0.3,0.1,0.1,0.1,0.0,0.2,0.0,0.7,0.2,0.2,0.4,0.2,0.0,0.1,0.5,0.1,0.0,0.0,0.1,0.2,0.8,0.5,0.0,0.2,0.0,0.0,0.2,0.3,0.9,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.2,0.1,0.0,0.1,0.3,0.2,0.0,0.0,0.3,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.1,0.1,0.0,0.1,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.1,0.3,0.1,0.1,0.2,0.0,0.0,0.0,0.2,0.0,0.4,0.4,0.1,0.5,0.2,0.1,1.3,0.3,0.1,0.7,0.0,0.5,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GPR101,,ENSG00000165370,G protein-coupled receptor 101,Q96P66,X,137023929-137033995,"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,128.0,brain: 12.7,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in many,,basal ganglia: 12.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in many,,hypothalamus: 38.3,Low region specificity,Detected in many,,,HPA001084,Uncertain,,,,,,,,,,,HPA001084: AB_1078920,,,,,,,,,,,,,,,,,,0.0,0.0,2.7,0.0,12.7,0.0,0.0,0.4,3.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,10.5,0.0,0.0,0.0,0.0,1.7,0.5,0.7,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.7,12.7,0.4,3.4,0.1,10.5,1.7,0.5,0.7,1.7,0.9,5.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GPR139,PGR3,ENSG00000180269,G protein-coupled receptor 139,Q6DWJ6,16,20028239-20073890,"G-protein coupled receptors, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,8.0,brain: 4.2,Cell type enhanced,Detected in single,,Oligodendrocyte precursor cells: 1.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA046596,Uncertain,,,,,,,,,,,HPA046596: AB_2679713,,,,,unprognostic (2.94e-1),,,,,,,,,,,,,0.0,0.0,1.4,0.0,2.5,0.5,0.0,0.3,0.3,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,4.2,3.5,0.1,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,3.3,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,2.5,0.3,0.3,0.0,1.6,4.2,3.5,0.1,1.4,0.5,3.3,0.6,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GPR151,"GALR4, PGR7",ENSG00000173250,G protein-coupled receptor 151,Q8TDV0,5,146513103-146516190,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,37.0,brain: 9.8,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in single,37.0,midbrain: 9.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in many,19.0,thalamus: 30.6,Region enriched,Detected in single,9.0,thalamus: 4.7,HPA065728,,Supported,,,,,,,,,,HPA065728: ,,,,,unprognostic (2.09e-1),,,,,unprognostic (2.30e-1),,,,unprognostic (1.14e-1),unprognostic (1.32e-2),,,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,9.8,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.2,0.2,0.1,0.0,0.1,9.8,0.1,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0
GPR21,,ENSG00000188394,G protein-coupled receptor 21,Q99679,9,123033667-123035665,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Low tissue specificity,Detected in single,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,,,,,HPA041651,Uncertain,,,,,,,,,,,HPA041651: AB_10794673,,,,,,,,,,,,,unprognostic (9.22e-3),,,unprognostic (1.46e-1),,0.6,0.0,0.0,0.5,0.7,0.1,0.3,0.0,1.5,0.6,0.0,0.2,0.1,0.9,0.2,0.5,0.4,0.5,0.3,0.5,0.2,0.2,0.0,0.2,0.9,0.0,0.0,0.4,0.4,0.0,0.1,0.0,0.8,0.6,0.1,0.5,0.4,0.1,0.2,0.1,0.2,0.1,0.9,0.0,0.2,0.2,0.0,0.0,0.0,0.3,0.3,0.3,0.3,0.4,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,1.5,0.5,0.2,0.0,0.0,0.4,0.6,0.0,0.0,0.7,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GPR26,,ENSG00000154478,G protein-coupled receptor 26,Q8NDV2,10,123666355-123697399,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,21.0,brain: 7.0,Cell type enriched,Detected in some,6.0,Excitatory neurons: 11.4,Cancer enriched,Detected in single,13.0,breast cancer: 0.7,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,11.0,SCLC-21H: 1.0,Low region specificity,Detected in many,,,Region enhanced,Detected in many,,cerebral cortex: 62.7,HPA062736,Enhanced,,,,,,,,,,,HPA062736: AB_2684855,unprognostic (4.15e-2),,,,unprognostic (5.75e-2),unprognostic (3.42e-1),,unprognostic (2.12e-1),,,unprognostic (9.09e-2),unprognostic (9.98e-2),unprognostic (2.12e-2),unprognostic (1.16e-2),unprognostic (1.12e-1),,,0.0,0.0,1.1,0.0,1.5,0.0,0.0,0.0,4.5,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.6,2.0,0.0,0.0,0.0,0.0,2.0,7.0,1.3,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.1,3.4,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,1.5,0.0,4.5,5.6,2.0,2.0,7.0,1.3,1.0,0.6,3.4,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.4,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.9,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.5,0.0,0.0,0.1,0.0,0.0,0.0,0.0
GPR45,"PSP24, PSP24A",ENSG00000135973,G protein-coupled receptor 45,Q9Y5Y3,2,105241743-105243467,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.6,Group enriched,Detected in some,51.0,Early spermatids: 4.2;Late spermatids: 6.1,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,9.0,BEWO: 1.3;U-2 OS: 4.2,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA055940,Uncertain,,,,,,,,,,,HPA055940: AB_2682977,unprognostic (3.80e-3),unprognostic (5.92e-2),unprognostic (2.19e-3),unprognostic (4.71e-1),unprognostic (1.01e-1),unprognostic (2.17e-1),unprognostic (6.87e-2),unprognostic (2.21e-1),unprognostic (1.13e-1),unprognostic (3.96e-1),unprognostic (1.61e-3),unprognostic (1.11e-2),unprognostic (3.13e-4),unprognostic (2.25e-1),unprognostic (2.76e-1),unprognostic (1.39e-1),unprognostic (3.99e-2),0.0,0.0,0.7,0.0,0.4,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,1.1,0.0,0.1,0.0,0.0,0.7,0.4,0.5,0.0,0.1,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.7,1.6,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.1,0.0,0.1,0.0,0.0,4.2,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.4,0.0,0.9,0.7,1.1,0.7,0.4,0.5,0.5,0.2,1.6,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,6.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GRID2IP,,ENSG00000215045,Grid2 interacting protein,A4D2P6,7,6497462-6551436,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,28.0,brain: 26.8,Cell type enhanced,Detected in some,,Excitatory neurons: 2.8;Inhibitory neurons: 2.9;Oligodendrocyte precursor cells: 4.5,Low cancer specificity,Detected in some,,,Region enhanced,Detected in many,,thalamus: 26.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,4.0,REH: 3.6,Group enriched,Detected in many,5.0,cerebellum: 22.4;thalamus: 7.2,Low region specificity,Detected in all,,,HPA045381,,,Approved,Plasma membrane,,,,,,Plasma membrane,,HPA045381: AB_10962495,unprognostic (1.77e-1),unprognostic (2.64e-1),unprognostic (3.39e-4),unprognostic (1.19e-3),unprognostic (5.52e-2),unprognostic (2.50e-2),unprognostic (2.82e-1),unprognostic (2.37e-2),unprognostic (1.92e-3),unprognostic (2.06e-3),unprognostic (1.64e-1),unprognostic (3.40e-2),unprognostic (3.38e-2),unprognostic (5.54e-2),unprognostic (8.08e-2),unprognostic (1.87e-1),unprognostic (3.17e-1),0.0,0.4,6.3,0.1,4.6,0.2,0.2,10.1,1.5,0.1,0.0,0.3,0.4,0.1,0.0,0.3,0.2,0.1,0.1,0.3,7.2,0.1,0.0,0.2,0.1,3.2,10.4,0.0,0.2,0.5,0.5,0.9,0.0,5.9,0.5,0.1,0.5,0.5,0.3,0.0,0.7,0.3,0.0,0.0,0.3,0.5,0.3,26.8,0.2,0.3,0.0,0.1,0.1,0.2,1.4,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.1,0.2,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.2,0.0,0.2,0.3,0.0,0.1,0.3,0.0,3.6,0.1,0.1,0.0,0.1,0.0,0.4,0.0,0.3,0.0,0.1,0.8,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,6.3,4.6,10.1,1.5,0.3,7.2,3.2,10.4,0.0,5.9,0.0,26.8,1.4,0.0,0.0,0.0,0.7,0.1,0.0,0.2,0.0,0.6,0.1,0.2,0.1,1.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.5,0.5,0.1,0.0,0.1,0.0,0.4,2.8,0.0,0.1,0.0,0.5,0.2,0.0,0.0,0.0,0.0,0.1,0.0,2.9,0.1,0.0,0.0,0.0,0.7,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.5,1.3,0.1,0.0,0.0,0.3,0.2,0.4,0.1,0.0,1.0,0.0,0.0,0.1,0.8,0.2,1.2,0.0,0.0,0.1,0.9,0.1,0.2
GRIFIN,,ENSG00000275572,Galectin-related inter-fiber protein,A4D1Z8,7,2474844-2476894,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.0,Cell type enhanced,Detected in single,,Astrocytes: 1.3,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in some,,,,,,,,,,,,,,,,,,,,unprognostic (1.18e-2),,,unprognostic (2.98e-2),,unprognostic (1.36e-3),unprognostic (2.29e-1),unprognostic (1.68e-2),unprognostic (4.31e-1),unprognostic (2.92e-2),unprognostic (1.73e-1),,,0.3,0.1,0.4,0.0,0.4,0.2,0.0,1.0,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.3,0.0,0.0,0.0,0.1,0.8,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.2,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.4,1.0,0.4,0.7,0.3,0.8,1.0,0.0,1.0,0.2,1.0,0.5,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GRIN2B,"GluN2B, NMDAR2B",ENSG00000273079,Glutamate ionotropic receptor NMDA type subunit 2B,Q13224,12,13437942-13982002,"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins","Ion transport, Transport","Ion channel, Ligand-gated ion channel, Receptor","Disease variant, Epilepsy, FDA approved drug targets, Mental retardation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,89.0,brain: 38.3,Group enriched,Detected in some,4.0,Excitatory neurons: 625.2;Inhibitory neurons: 882.5,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CACO-2: 1.3;NTERA-2: 1.6;RPTEC TERT1: 1.2,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA069762,Approved,,,,,,,,,,,HPA069762: AB_2686192,unprognostic (2.01e-2),unprognostic (4.07e-2),unprognostic (7.89e-2),unprognostic (3.77e-3),unprognostic (3.39e-3),unprognostic (9.36e-2),unprognostic (5.92e-2),unprognostic (1.77e-2),unprognostic (6.85e-2),unprognostic (2.24e-1),unprognostic (4.68e-2),unprognostic (4.12e-2),unprognostic (4.48e-5),unprognostic (2.43e-1),unprognostic (8.76e-2),unprognostic (1.63e-1),unprognostic (2.37e-1),0.2,0.0,12.5,0.0,16.5,0.0,0.0,0.0,38.3,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,14.6,0.0,0.1,0.0,0.1,2.6,0.0,21.8,0.0,0.0,0.0,0.0,0.0,4.1,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.4,2.9,0.0,0.0,0.0,0.0,0.0,0.0,7.7,0.0,0.2,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.5,16.5,0.0,38.3,31.0,14.6,2.6,0.0,21.8,4.1,0.0,2.9,7.7,0.1,0.0,0.0,15.3,0.0,0.0,0.0,0.0,0.0,8.8,0.7,0.5,3.1,0.0,0.0,0.0,0.0,0.0,0.0,2.6,1.9,0.0,35.0,0.3,0.1,0.4,0.0,0.0,625.2,0.0,0.0,0.2,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,882.5,0.5,0.0,0.0,0.0,35.8,0.0,0.0,0.0,14.0,0.0,0.1,0.0,173.4,9.9,0.0,0.1,0.4,0.0,0.2,0.0,0.1,0.0,1.8,0.0,0.1,0.2,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.4,0.1
GRM2,"GPRC1B, mGlu2, MGLUR2",ENSG00000164082,Glutamate metabotropic receptor 2,Q14416,3,51707068-51718613,"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,11.0,brain: 6.4,Cell type enhanced,Detected in some,,Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5,Cancer enriched,Detected in single,4.0,testis cancer: 1.3,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,6.0,SCLC-21H: 6.5,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA027868, HPA065166",Approved,Supported,,,,,,,,,,"HPA027868: , HPA065166: AB_2685425",unprognostic (1.01e-1),unprognostic (8.61e-4),unprognostic (7.66e-2),unprognostic (7.29e-3),unprognostic (1.98e-1),unprognostic (3.68e-2),unprognostic (7.10e-2),unprognostic (1.27e-1),unprognostic (1.39e-2),unprognostic (2.05e-1),unprognostic (4.45e-1),unprognostic (1.74e-1),unprognostic (1.37e-2),unprognostic (1.35e-1),unprognostic (1.82e-1),unprognostic (2.93e-2),unprognostic (1.19e-2),0.2,0.0,0.9,0.0,2.3,0.4,0.1,0.0,2.5,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.1,1.8,0.6,0.0,0.0,0.1,0.0,4.6,0.9,2.1,0.0,0.1,0.0,0.1,0.0,6.4,0.1,0.0,0.4,0.1,0.0,0.3,0.4,0.1,0.0,0.0,0.2,0.0,0.6,0.9,0.1,0.1,0.0,0.0,0.1,0.0,3.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.5,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,2.3,0.0,2.5,1.8,0.6,4.6,0.9,2.1,6.4,0.0,0.9,3.4,0.4,0.0,0.0,1.6,0.1,0.0,0.0,0.0,0.0,2.6,0.5,0.9,1.1,0.0,0.0,0.0,6.2,0.0,0.3,0.1,0.0,0.0,0.3,0.1,0.1,1.5,0.0,0.0,16.2,0.0,0.0,0.1,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,1.0,0.0,0.4,0.0,1.0,0.8,0.0,0.0,0.4,0.0,0.3,0.0,0.1,0.0,2.0,0.0,0.2,0.1,3.5,1.1,0.2,0.3,0.0,0.1,0.2,0.0,0.1
GRM4,"GPRC1D, mGlu4, MGLUR4",ENSG00000124493,Glutamate metabotropic receptor 4,Q14833,6,34018643-34155622,"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,84.0,brain: 73.2,Cell type enhanced,Detected in some,,Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0,Cancer enhanced,Detected in some,,testis cancer: 1.7,Group enriched,Detected in all,6.0,cerebellum: 73.2;pons: 21.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,BEWO: 7.6;SCLC-21H: 18.2,Region enhanced,Detected in all,,cerebellum: 79.1,Region enriched,Detected in many,5.0,cerebellum: 138.8,CAB022096,Enhanced,,,,,,,,,,,CAB022096: ,unprognostic (1.29e-1),unprognostic (1.01e-1),unprognostic (1.03e-1),unprognostic (7.00e-2),unprognostic (4.03e-2),unprognostic (8.36e-2),unprognostic (9.05e-3),unprognostic (3.56e-1),unprognostic (9.45e-2),unprognostic (2.08e-2),unprognostic (6.21e-3),unprognostic (2.44e-1),unprognostic (2.15e-11),unprognostic (5.32e-2),unprognostic (9.16e-2),unprognostic (6.57e-2),unprognostic (3.07e-1),0.0,0.2,3.1,0.0,8.1,0.0,0.0,73.2,4.5,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,2.3,2.0,0.0,0.0,0.0,0.0,4.4,7.9,2.4,0.1,0.7,0.0,0.5,0.0,21.2,0.1,0.0,0.8,0.0,0.0,0.0,0.1,0.2,0.1,1.0,0.0,0.0,0.8,6.6,0.0,0.0,0.0,0.1,0.0,0.1,3.2,0.0,0.0,0.0,0.0,0.0,0.0,7.6,0.1,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.2,0.1,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,18.2,0.1,0.0,0.0,0.0,0.1,0.2,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,8.1,73.2,4.5,2.3,2.0,4.4,7.9,2.4,21.2,1.0,6.6,3.2,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,5.3,0.0,0.0,2.3,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,3.7,0.4,0.1,0.2,3.0,0.0,9.5,0.0,0.1,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,10.8,1.1,0.0,0.3,0.3,2.4,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.5,0.5,0.0,0.1,0.0,0.0,0.3,0.0,0.1,0.1,0.7,0.0,0.0,0.1,0.9,5.0,0.0,0.0,0.1,0.4,0.0,0.3,0.1
GSG1L2,,ENSG00000214978,GSG1 like 2,A8MUP6,17,9802386-9822071,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.5,Not detected,Not detected,,,Cancer enriched,Detected in single,95.0,renal cancer: 4.7,Region enhanced,Detected in single,,cerebral cortex: 1.5,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,1.5,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
GSX1,"Gsh-1, GSH1",ENSG00000169840,GS homeobox 1,Q9H4S2,13,27792483-27794768,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,40.0,brain: 5.0,Not detected,Not detected,,,Cancer enriched,Detected in single,29.0,glioma: 3.9,Region enriched,Detected in some,5.0,hypothalamus: 5.0,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected,Not detected,,,HPA047096,,,Approved,"Nucleoplasm,Golgi apparatus,Cytosol",,,,,,Golgi apparatus,"Nucleoplasm, Cytosol",HPA047096: AB_2679929,,,,,unprognostic (1.62e-1),,,,,,,,,,,,,0.0,0.0,0.4,0.0,0.3,0.0,0.0,0.1,0.3,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,5.0,0.0,0.0,0.0,0.0,0.4,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.3,0.1,0.3,0.2,5.0,0.4,0.1,0.2,0.2,0.1,1.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
H4C6,"H4, H4/c, H4FC, HIST1H4F",ENSG00000274618,H4 clustered histone 6,P62805,6,26240393-26240793,"Disease related genes, Predicted intracellular proteins",,DNA-binding,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,7.0,brain: 6.4,Not detected,Not detected,,,Cancer enhanced,Detected in some,,ovarian cancer: 1.2,Group enriched,Detected in many,4.0,cerebral cortex: 6.4;pons: 2.8;white matter: 4.9,Low immune cell specificity,Detected in many,,,Low lineage specificity,Detected in all,,,Cell line enhanced,Detected in some,,MOLT-4: 4.5;REH: 1.9,,,,,,,,,HPA042201,Supported,,,,,,,,25000000.0,,,HPA042201: AB_2677898,,,,,,,,,,unprognostic (1.47e-1),,,,unprognostic (1.17e-2),unprognostic (2.05e-1),,,0.0,0.0,0.4,0.0,0.4,0.9,0.0,0.4,6.4,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.7,0.2,0.0,0.0,0.0,0.3,0.7,0.8,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.2,1.1,0.7,0.0,0.0,0.0,0.1,0.0,4.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.4,0.0,0.0,0.3,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.9,4.5,0.6,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,2.8,3.5,3.0,2.4,2.3,5.5,3.9,4.0,3.8,6.9,3.2,2.3,10.7,2.1,2.0,6.4,1.1,1.5,0.4,0.4,0.4,6.4,0.7,0.2,0.7,0.8,0.0,2.8,1.0,1.1,4.9,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0
HCRT,"OX, PPOX",ENSG00000161610,Hypocretin neuropeptide precursor,O43612,17,42184060-42185452,"Disease related genes, Human disease related genes, Predicted secreted proteins",,Neuropeptide,Disease variant,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,1460.0,brain: 352.2,Cell type enhanced,Detected in some,,Collecting duct cells: 1.8;Enteroendocrine cells: 3.0;Kupffer cells: 1.6;Oligodendrocyte precursor cells: 2.0;Proximal enterocytes: 1.6,Cancer enhanced,Detected in single,,glioma: 0.5,Group enriched,Detected in many,6.0,amygdala: 104.6;hypothalamus: 352.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in some,5.0,hypothalamus: 93.5,Region enriched,Detected in some,21.0,hypothalamus: 25.3,"HPA064801, CAB079778",Enhanced,Supported,,,Secreted to blood,,,,,,,"CAB079778: , HPA064801: ",,,unprognostic (3.34e-2),,unprognostic (7.76e-5),,,,,unprognostic (3.21e-2),unprognostic (3.01e-2),,unprognostic (2.20e-2),unprognostic (1.41e-1),unprognostic (1.23e-1),,,0.1,0.0,104.6,0.1,1.2,0.1,0.0,0.5,1.2,0.0,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,352.2,0.0,0.0,0.0,0.0,0.5,2.8,0.3,0.0,0.0,0.0,0.1,0.0,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,40.2,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.2,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.1,0.1,0.0,0.2,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.5,0.1,0.0,0.2,0.1,0.5,0.3,0.2,0.3,0.1,0.6,0.3,0.3,0.0,0.1,0.0,0.0,0.1,0.0,104.6,1.2,0.5,1.2,0.3,352.2,0.5,2.8,0.3,2.7,0.1,40.2,0.6,0.5,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.2,0.2,0.1,0.3,0.0,0.0,1.8,0.0,0.0,1.2,0.3,0.0,0.0,0.0,0.5,0.1,0.1,3.0,0.0,0.3,0.0,0.0,0.4,0.0,0.0,0.0,0.1,0.7,0.2,0.6,0.0,0.4,0.8,0.0,1.6,1.0,0.2,0.0,0.3,0.0,1.0,0.8,0.1,0.0,2.0,0.3,0.4,0.1,0.0,0.4,0.0,1.6,0.6,0.0,0.5,0.0,0.0,0.0,0.0,0.6,0.0,0.1,0.1,0.9,0.1,0.9,0.1
HCRTR1,OX1R,ENSG00000121764,Hypocretin receptor 1,O43613,1,31617686-31632518,"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.3,Cell type enhanced,Detected in some,,Early spermatids: 1.1;Inhibitory neurons: 1.0;Late spermatids: 4.1,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA014018,Approved,,,,,,,,,,,HPA014018: AB_1854810,unprognostic (2.96e-2),unprognostic (2.34e-2),unprognostic (7.86e-3),unprognostic (3.72e-3),unprognostic (2.42e-1),unprognostic (3.45e-3),unprognostic (2.54e-5),unprognostic (3.58e-2),unprognostic (4.17e-2),unprognostic (1.19e-1),unprognostic (2.28e-1),unprognostic (2.93e-1),unprognostic (3.77e-3),unprognostic (2.16e-2),unprognostic (1.02e-1),unprognostic (1.43e-1),unprognostic (1.07e-1),0.3,0.9,0.3,0.0,0.1,0.4,0.2,0.2,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.3,0.0,1.1,0.1,0.0,0.0,0.1,0.9,1.8,0.0,0.0,0.0,0.0,0.3,0.5,2.3,0.0,0.0,0.1,0.1,0.0,0.6,0.2,0.1,0.0,0.1,0.1,0.0,0.1,1.9,0.0,0.5,0.1,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.2,0.2,0.0,1.1,0.9,1.8,0.0,2.3,0.1,1.9,0.9,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.3,0.0,0.0,0.9,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.0,1.0,0.0,0.0,0.0,0.0,4.1,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.2,0.0,0.1,0.0,0.0,0.1,0.0,0.0
HCRTR2,OX2R,ENSG00000137252,Hypocretin receptor 2,O43614,6,55106460-55282617,"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,5.0,brain: 3.6,Cell type enhanced,Detected in some,,Excitatory neurons: 11.7;Inhibitory neurons: 18.3;Peritubular cells: 3.8,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,5.0,AF22: 1.1,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA054516,Enhanced,,,,,,,,,,,HPA054516: AB_2682513,,,,,,unprognostic (4.86e-1),,unprognostic (2.69e-2),,unprognostic (1.86e-2),unprognostic (2.32e-1),,,unprognostic (7.45e-2),unprognostic (7.39e-2),,,0.0,0.0,1.1,0.0,0.9,0.0,0.0,1.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,1.5,1.4,0.6,0.0,0.0,0.0,2.1,2.5,0.5,0.3,0.0,0.0,0.0,0.4,3.6,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.3,2.1,0.0,0.0,0.0,0.0,0.0,0.0,2.6,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.9,1.2,1.0,1.5,1.4,2.1,2.5,0.5,3.6,0.4,2.1,2.6,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.2,0.0,0.1,0.0,0.0,0.0,11.7,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,18.3,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,3.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0
HMX3,NKX5-1,ENSG00000188620,H6 family homeobox 3,A6NHT5,10,123135970-123139423,"Predicted intracellular proteins, Transcription factors","Differentiation, Neurogenesis, Transcription, Transcription regulation","Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 5.8,Cell type enriched,Detected in single,10.0,Cardiomyocytes: 1.0,Cancer enhanced,Detected in single,,stomach cancer: 0.5,Region enhanced,Detected in many,,hypothalamus: 5.8,Low immune cell specificity,Detected in single,,,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in some,,HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7,Region enriched,Detected in single,4.0,hypothalamus: 1.1,Group enriched,Detected in some,5.0,basal ganglia: 1.4;hypothalamus: 4.8,HPA069659,,,Approved,"Nucleoplasm,Centriolar satellite",,Yes,No,,,Nucleoplasm,Centriolar satellite,HPA069659: AB_2686165,,,unprognostic (1.79e-1),,,,,,,,unprognostic (9.65e-2),,,unprognostic (6.07e-2),,,,0.9,0.1,0.6,0.1,0.2,0.1,0.0,0.2,0.2,0.0,0.2,0.4,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.8,0.1,0.0,0.0,0.1,1.4,2.0,0.1,0.0,0.1,0.0,0.2,0.0,1.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.5,0.0,0.1,0.0,0.1,0.2,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.9,0.0,0.1,0.0,8.1,0.0,0.0,0.7,0.4,6.1,7.0,0.2,0.1,0.2,1.3,0.0,0.0,0.0,0.0,0.0,0.0,2.9,17.9,0.1,0.0,0.0,0.0,13.4,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.4,0.2,0.0,7.0,0.0,0.1,0.0,0.0,5.7,0.1,0.0,0.8,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.4,1.6,0.3,0.4,0.2,0.2,0.2,0.3,0.2,0.2,0.1,0.5,0.2,0.3,0.9,0.4,0.2,0.4,0.2,0.1,0.6,0.2,0.2,0.2,0.0,5.8,1.4,2.0,0.1,1.0,0.1,2.6,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
HRNR,"FLG3, S100A16, S100a18",ENSG00000197915,Hornerin,Q86YZ3,1,152212076-152224193,"Plasma proteins, Predicted intracellular proteins",Keratinization,Developmental protein,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.6,Cell type enhanced,Detected in some,,Endometrial stromal cells: 1.0;Horizontal cells: 1.7;Rod photoreceptor cells: 3.5,Cancer enriched,Detected in single,4.0,melanoma: 1.0,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,NTERA-2: 1.9,Not detected,Not detected,,,,,,,HPA031469,Uncertain,,Approved,Mitochondria,,No,No,,180000000.0,Mitochondria,,HPA031469: AB_10603771,unprognostic (1.34e-1),unprognostic (4.51e-2),unprognostic (3.01e-2),unprognostic (8.72e-4),unprognostic (1.61e-2),unprognostic (1.45e-1),unprognostic (2.11e-1),unprognostic (1.79e-1),unprognostic (6.09e-2),unprognostic (3.38e-2),unprognostic (1.87e-2),unprognostic (1.59e-2),unprognostic (1.65e-2),unprognostic (2.49e-2),unprognostic (1.71e-1),unprognostic (2.07e-1),unprognostic (3.64e-2),0.1,0.2,1.0,0.0,0.5,0.0,0.1,0.1,0.7,0.2,0.3,0.1,0.0,0.2,0.0,0.5,0.2,0.0,0.1,0.8,1.2,0.3,0.1,0.1,0.0,1.3,0.9,0.1,0.4,0.4,0.0,0.2,0.0,1.0,0.2,0.0,0.3,0.1,0.0,0.0,0.6,0.1,0.0,0.3,0.1,0.1,0.4,0.7,0.0,0.3,0.0,0.0,0.1,0.3,1.6,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.2,0.4,0.0,0.4,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,1.0,0.5,0.1,0.7,0.8,1.2,1.3,0.9,0.1,1.0,0.3,0.7,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,1.0,0.1,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.2,0.0,1.7,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.5,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.5,0.0,0.2,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0
HTR3B,5-HT3B,ENSG00000149305,5-hydroxytryptamine receptor 3B,O95264,11,113904677-113949078,"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins","Ion transport, Transport","Ion channel, Ligand-gated ion channel, Receptor",FDA approved drug targets,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.3,Cell type enhanced,Detected in some,,Excitatory neurons: 4.4;Oligodendrocytes: 1.2,Not detected,Not detected,,,Low region specificity,Detected in some,,,Low immune cell specificity,Detected in single,,,Low lineage specificity,Detected in single,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,HPA039559,Approved,,,,,,,,,,,HPA039559: AB_10672779,,,,,unprognostic (1.60e-2),unprognostic (8.37e-2),,,unprognostic (2.84e-1),unprognostic (3.28e-1),,,,unprognostic (1.71e-1),unprognostic (2.46e-1),,,0.0,0.1,0.8,0.2,0.6,0.5,0.0,0.0,2.3,0.0,0.0,0.1,0.1,0.1,0.2,0.5,0.0,0.1,0.0,1.3,1.0,0.3,0.0,0.0,0.1,0.0,0.0,0.7,0.1,0.1,0.0,0.0,0.1,0.3,0.0,0.1,0.2,0.1,0.1,0.3,0.3,0.1,0.0,0.0,0.1,0.1,0.4,0.0,0.0,0.1,0.1,0.1,0.0,0.1,1.2,0.0,0.1,0.1,0.1,0.2,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.1,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.3,0.3,0.0,0.1,0.1,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.1,0.2,0.1,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.3,0.0,0.1,0.2,0.1,0.0,0.0,0.2,0.1,0.1,0.2,0.1,0.1,0.0,0.1,0.1,0.1,0.1,1.0,0.2,0.1,0.1,0.1,0.1,0.2,0.1,0.1,0.1,0.3,0.1,0.2,0.9,0.4,0.1,0.3,0.2,0.1,0.8,0.6,0.0,2.3,1.3,1.0,0.0,0.0,0.7,0.3,0.0,0.0,1.2,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.4,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
HTR5A,5-HT5A,ENSG00000157219,5-hydroxytryptamine receptor 5A,P47898,7,155070324-155087392,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,5.0,brain: 3.9,Group enriched,Detected in some,4.0,Early spermatids: 8.7;Excitatory neurons: 7.6;Inhibitory neurons: 10.0;Late spermatids: 12.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,,,,,CAB017467,Approved,,,,,,,,,,,CAB017467: AB_2122566,,,,,unprognostic (1.62e-2),,,,,,,,,,unprognostic (1.15e-1),,,0.0,0.0,1.2,0.0,1.7,0.0,0.0,3.9,2.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,1.5,0.0,0.0,0.0,0.0,0.9,1.2,1.6,0.0,0.0,0.0,0.3,0.0,1.8,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.6,1.5,0.8,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,1.7,3.9,2.9,1.2,1.5,0.9,1.2,1.6,1.8,0.2,1.5,2.2,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.7,0.0,0.0,0.0,0.0,0.0,7.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,12.4,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
HTR6,"5-HT6, 5-HT6R",ENSG00000158748,5-hydroxytryptamine receptor 6,P50406,1,19664875-19680966,"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,14.0,brain: 7.7,Cell type enhanced,Detected in single,,Excitatory neurons: 1.6,Cancer enhanced,Detected in single,,renal cancer: 0.6,Region enhanced,Detected in many,,basal ganglia: 7.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,SH-SY5Y: 2.0,Low region specificity,Detected in many,,,,,,,HPA068165,Uncertain,,,,,,,,,,,HPA068165: ,unprognostic (2.34e-2),unprognostic (1.84e-1),unprognostic (7.19e-3),unprognostic (3.84e-5),unprognostic (1.38e-4),unprognostic (2.69e-2),,unprognostic (1.36e-1),unprognostic (2.80e-2),unprognostic (1.03e-1),unprognostic (5.33e-3),unprognostic (8.63e-2),unprognostic (5.47e-4),unprognostic (1.28e-1),unprognostic (2.49e-1),unprognostic (6.13e-3),unprognostic (2.02e-1),0.0,0.0,0.7,0.2,7.7,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,1.5,0.0,0.0,0.0,0.2,1.9,0.0,1.8,0.0,0.0,0.0,0.1,0.0,3.7,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.8,0.0,0.0,0.0,0.5,0.0,0.0,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.8,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.2,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,7.7,0.0,2.2,0.6,1.5,1.9,0.0,1.8,3.7,0.0,0.8,0.6,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
IFNA13,,ENSG00000233816,Interferon alpha 13,P01562,9,21367424-21368962,"Cancer-related genes, Plasma proteins, Predicted secreted proteins",Antiviral defense,Cytokine,Cancer-related genes,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.3,Cell type enriched,Detected in single,17.0,Granulosa cells: 1.7,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA047557,Uncertain,,,,Secreted to blood,,,,,,,HPA047557: AB_2680087,,,,,,,,,,,,,,,,,,0.0,0.0,0.5,0.0,1.3,0.0,0.0,0.1,1.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.5,0.3,0.0,0.0,0.0,0.0,0.8,0.6,0.4,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.3,0.1,1.0,0.5,0.3,0.8,0.6,0.4,0.9,0.0,1.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
IFNA2,"IFN-alphaA, IFNA",ENSG00000188379,Interferon alpha 2,P01563,9,21384255-21385398,Predicted secreted proteins,Antiviral defense,Cytokine,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,14.0,brain: 1.3,Group enriched,Detected in some,6.0,Cardiomyocytes: 2.5;Granulosa cells: 1.7;Oligodendrocytes: 1.8,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA047557,Uncertain,,,,Secreted to blood,,,253000.0,,,,HPA047557: AB_2680087,,,,,,,,,,,,,,,,,,0.0,0.0,0.6,0.0,1.3,0.0,0.0,0.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.5,0.0,0.0,0.0,0.0,0.7,0.6,0.4,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,1.3,0.1,0.7,0.5,0.5,0.7,0.6,0.4,0.9,0.1,0.8,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
IL1RAPL1,"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2",ENSG00000169306,Interleukin 1 receptor accessory protein like 1,Q9NZN1,X,28587446-29956718,"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins",,"Hydrolase, Receptor",Mental retardation,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,73.0,brain: 33.6,Cell type enhanced,Detected in some,,Excitatory neurons: 1315.7;Inhibitory neurons: 2598.6;Oligodendrocyte precursor cells: 1954.3;Oligodendrocytes: 6420.8,Not detected,Not detected,,,Region enhanced,Detected in all,,white matter: 33.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4.0,GAMG: 8.7;WM-115: 2.6,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,,,,,,,,,,,,,,unprognostic (2.51e-2),unprognostic (1.67e-1),unprognostic (1.45e-2),unprognostic (3.75e-3),unprognostic (1.17e-1),unprognostic (3.98e-1),unprognostic (2.25e-2),unprognostic (4.45e-2),unprognostic (1.29e-1),unprognostic (5.85e-2),unprognostic (3.95e-2),unprognostic (8.02e-2),unprognostic (1.08e-2),unprognostic (5.74e-4),unprognostic (2.29e-1),unprognostic (5.22e-2),unprognostic (3.58e-3),0.1,0.0,2.8,0.0,10.6,0.0,0.1,1.4,9.5,0.0,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.1,0.4,2.9,4.8,0.0,0.2,0.0,0.0,7.5,4.8,2.9,0.3,0.1,0.0,0.0,0.1,10.2,0.2,0.1,0.2,0.0,0.2,0.4,0.0,0.2,0.0,2.9,0.0,0.1,0.1,5.4,0.0,0.1,0.1,0.0,0.4,0.0,33.6,0.0,0.0,0.1,0.0,0.2,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,8.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,1.2,0.4,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,10.6,1.4,9.5,2.9,4.8,7.5,4.8,2.9,10.2,2.9,5.4,33.6,0.5,0.0,0.5,64.6,0.0,0.1,0.2,0.0,0.6,2.4,0.0,0.6,3.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.4,0.0,0.0,1315.7,0.0,0.0,1.6,0.0,0.0,26.1,0.1,0.0,0.0,0.1,0.0,2598.6,0.0,0.0,0.0,0.9,0.2,0.3,0.0,1.8,42.2,0.0,0.3,0.0,1954.3,6420.8,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.4,1.9,0.7,1.5,0.0,0.1,0.1,1.1,0.4,0.1,0.0
IQCJ,,ENSG00000214216,IQ motif containing J,Q1A5X6,3,158962928-159266307,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,8.0,brain: 6.3,Group enriched,Detected in some,97.0,Early spermatids: 27.3;Late spermatids: 50.6,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,21.0,Daudi: 5.2,Not detected,Not detected,,,Low region specificity,Detected in many,,,HPA052835,Uncertain,,,,,,,,,,,HPA052835: AB_2681970,unprognostic (1.99e-2),,,,,,,,,,,,,,,,,0.0,0.0,6.3,0.0,4.5,0.0,0.1,0.0,4.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.1,2.9,0.0,0.0,0.0,0.0,1.3,0.3,4.5,0.0,0.0,0.0,0.5,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,1.4,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.3,4.5,0.0,4.4,5.1,2.9,1.3,0.3,4.5,1.4,0.0,1.4,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.6,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0
IRGM,"IFI1, IRGM1, LRG-47, LRG47",ENSG00000237693,Immunity related GTPase M,A1A4Y4,5,150846523-150900736,"Disease related genes, Human disease related genes, Predicted intracellular proteins","Autophagy, Immunity, Inflammatory response, Innate immunity",Hydrolase,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.1,Cell type enhanced,Detected in some,,dendritic cells: 1.4;granulocytes: 4.5;T-cells: 2.3,Not detected,Not detected,,,Low region specificity,Detected in single,,,Immune cell enriched,Detected in single,5.0,basophil: 2.1,Lineage enriched,Detected in single,5.0,granulocytes: 2.1,Cell line enhanced,Detected in some,,HL-60: 1.4;JURKAT: 1.8;NB-4: 2.4;THP-1: 1.2;U-937: 3.1,,,,,,,,,,,,,,,,,,,,,,unprognostic (8.73e-2),unprognostic (2.28e-2),unprognostic (2.96e-2),unprognostic (2.29e-1),unprognostic (4.71e-2),unprognostic (9.62e-2),unprognostic (2.25e-1),unprognostic (4.79e-3),unprognostic (1.43e-1),unprognostic (9.36e-2),unprognostic (1.38e-1),unprognostic (1.28e-3),unprognostic (1.12e-10),unprognostic (5.93e-2),unprognostic (8.28e-2),unprognostic (2.53e-1),unprognostic (1.11e-1),0.0,0.1,0.3,0.3,0.4,0.5,0.1,1.1,0.5,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.2,0.1,0.5,0.1,0.1,0.0,0.1,0.3,0.4,0.2,0.2,0.2,0.2,0.0,0.0,0.0,0.7,0.1,0.1,0.4,0.0,0.1,0.1,0.4,0.2,0.0,0.0,0.3,0.2,0.7,0.3,0.2,0.2,0.0,0.1,0.1,0.0,0.9,0.0,0.0,0.1,0.0,0.1,0.0,0.3,0.0,0.0,0.2,0.0,0.3,0.0,0.0,0.1,0.0,0.2,0.1,0.1,0.1,0.0,0.5,0.1,0.1,0.3,0.1,0.0,1.4,0.4,0.1,0.1,0.0,0.0,0.0,0.0,1.8,0.1,0.7,0.0,0.2,0.4,2.4,1.1,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.1,0.1,0.1,0.3,0.2,0.1,0.1,1.2,0.0,0.1,0.4,0.2,0.1,0.2,0.2,0.2,0.2,3.1,0.0,2.1,0.1,0.1,0.2,0.1,0.4,0.1,0.2,0.2,0.0,0.2,0.2,0.2,0.4,0.2,0.1,0.1,0.1,0.2,0.3,0.4,1.1,0.5,0.5,0.1,0.4,0.2,0.2,0.7,0.0,0.3,0.9,0.1,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.4,0.7,0.0,0.0,0.0,0.0,0.0,4.5,0.0,0.4,0.3,0.1,0.0,0.2,0.0,0.0,0.0,0.3,0.4,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.4,0.3,0.6,0.0,0.1,0.1,2.3,0.1,0.0,0.1
KCNG2,"KCNF2, Kv6.2",ENSG00000178342,Potassium voltage-gated channel modifier subfamily G member 2,Q9UJ96,18,79863668-79900184,"Predicted membrane proteins, Voltage-gated ion channels","Ion transport, Potassium transport, Transport","Ion channel, Potassium channel, Voltage-gated channel",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,5.0,brain: 3.4,Cell type enhanced,Detected in some,,Excitatory neurons: 19.2;Horizontal cells: 114.4;Inhibitory neurons: 31.3,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Region enriched,Detected in some,5.0,hippocampal formation: 10.3,HPA048628,Enhanced,,,,,,,,,,,HPA048628: AB_2680466,unprognostic (1.07e-2),unprognostic (1.34e-2),unprognostic (8.39e-2),unprognostic (4.41e-1),unprognostic (1.99e-1),unprognostic (9.69e-2),unprognostic (1.79e-1),unprognostic (1.99e-1),unprognostic (2.40e-1),unprognostic (3.78e-1),unprognostic (3.61e-3),unprognostic (1.09e-1),unprognostic (3.18e-5),unprognostic (1.05e-1),unprognostic (7.72e-2),unprognostic (4.08e-2),unprognostic (3.63e-2),0.1,0.0,0.5,0.0,1.3,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,3.4,1.1,0.3,0.0,0.2,0.0,0.2,1.5,0.6,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.3,0.2,0.0,0.6,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.3,0.0,3.0,3.4,1.1,0.2,1.5,0.6,0.2,0.3,0.5,0.6,0.0,0.0,0.0,1.6,0.1,0.0,0.0,0.0,0.0,0.7,0.0,0.1,0.5,0.0,0.0,0.0,0.0,6.9,0.5,0.0,0.0,0.0,0.4,0.0,0.0,0.2,0.0,0.0,19.2,0.0,8.9,0.3,0.0,0.0,0.0,0.0,0.0,0.0,1.6,114.4,31.3,0.1,0.0,1.5,0.0,0.0,0.3,0.8,0.0,6.5,0.0,0.0,0.0,2.0,0.9,0.0,0.0,0.0,0.1,0.0,1.2,0.6,0.0,0.9,0.0,0.0,0.0,1.2,2.1,0.0,0.0,6.3,0.0,0.1,0.2,0.0
KCNG3,Kv6.3,ENSG00000171126,Potassium voltage-gated channel modifier subfamily G member 3,Q8TAE7,2,42442017-42493982,"Predicted membrane proteins, Voltage-gated ion channels","Ion transport, Potassium transport, Transport","Ion channel, Potassium channel, Voltage-gated channel",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 5.3,Group enriched,Detected in some,4.0,Endometrial ciliated cells: 12.1;Excitatory neurons: 16.4;Glandular and luminal cells: 12.8,Cancer enhanced,Detected in some,,prostate cancer: 1.1,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4.0,HAP1: 4.7;HMC-1: 16.2;NTERA-2: 10.3,Not detected,Not detected,,,Low region specificity,Detected in many,,,HPA041625,,,Approved,Cytoplasmic bodies,,,,,,Cytoplasmic bodies,,HPA041625: ,unprognostic (1.56e-1),unprognostic (4.22e-3),unprognostic (2.48e-1),unprognostic (7.67e-3),unprognostic (7.95e-2),unprognostic (9.14e-3),,unprognostic (4.83e-3),unprognostic (6.59e-2),unprognostic (1.33e-1),unprognostic (1.75e-1),unprognostic (2.56e-1),unprognostic (2.17e-1),unprognostic (1.67e-2),unprognostic (2.76e-1),unprognostic (6.47e-2),unprognostic (1.23e-1),0.0,0.9,2.0,0.1,2.5,0.0,0.0,0.0,3.3,0.0,0.0,0.4,0.0,0.2,0.0,0.0,0.0,0.0,0.0,5.3,1.0,0.1,0.0,0.1,0.0,0.6,1.2,3.5,0.2,0.5,0.0,0.4,0.0,0.9,0.1,0.2,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.6,0.2,0.6,0.0,0.0,0.0,0.1,0.0,1.0,0.2,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.6,0.0,0.2,0.0,4.7,0.0,0.0,0.0,2.5,0.0,0.5,0.9,0.0,0.0,16.2,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.2,0.0,0.0,0.1,0.9,0.0,10.3,0.0,0.7,0.0,0.0,0.0,0.0,0.0,1.5,0.6,1.0,1.6,0.4,1.6,0.1,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.5,0.0,3.3,5.3,1.0,0.6,1.2,3.5,0.9,0.0,0.2,1.0,0.1,3.2,1.1,0.7,0.0,1.3,0.3,0.0,0.0,1.6,0.1,0.0,0.5,0.0,0.6,0.0,0.0,0.0,0.1,0.4,0.0,0.2,0.6,12.1,1.5,0.2,1.8,0.0,16.4,0.0,0.0,0.5,0.0,12.8,0.0,0.3,0.0,0.0,0.1,0.0,1.4,0.4,0.0,0.0,0.3,0.2,1.8,0.1,0.0,0.0,0.0,2.0,0.0,1.5,0.4,0.2,0.2,2.6,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.3,1.4,1.1,0.0,1.1,0.1,0.1,1.8,0.3,0.3
KCNK4,"K2p4.1, TRAAK",ENSG00000182450,Potassium two pore domain channel subfamily K member 4,Q9NYG8,11,64291302-64300031,"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels","Ion transport, Potassium transport, Transport","Ion channel, Potassium channel, Voltage-gated channel","Disease variant, Epilepsy, Mental retardation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,28.0,brain: 7.0,Cell type enhanced,Detected in some,,Astrocytes: 2.9;Endometrial stromal cells: 9.8;Excitatory neurons: 9.0;Extravillous trophoblasts: 3.6;Horizontal cells: 3.3;Muller glia cells: 4.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,,,,,,,,,,,,,,,,,,unprognostic (1.85e-1),,,,,unprognostic (1.58e-1),,,,unprognostic (1.21e-1),unprognostic (2.84e-1),,,0.0,0.0,5.4,0.0,3.9,0.0,0.0,0.5,7.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,5.3,1.4,0.0,0.0,0.0,0.0,0.9,0.6,4.1,0.0,0.0,0.0,0.1,0.1,2.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,2.9,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.4,3.9,0.5,7.0,5.3,1.4,0.9,0.6,4.1,2.0,0.0,1.2,2.9,0.0,0.0,0.0,2.9,0.0,0.5,0.0,0.0,0.0,0.9,0.1,0.3,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.4,9.8,0.1,0.0,0.0,9.0,0.0,3.6,0.4,0.0,0.2,0.0,0.0,0.0,0.0,0.2,3.3,2.4,0.0,0.0,0.0,0.9,0.0,0.0,1.0,0.0,1.0,0.0,4.4,0.0,0.5,0.7,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.5,0.1,0.0,0.1,0.1,0.8,0.0,0.0,0.0,0.0
KCNV1,Kv8.1,ENSG00000164794,Potassium voltage-gated channel modifier subfamily V member 1,Q6PIU1,8,109963636-109975771,"Predicted membrane proteins, Voltage-gated ion channels","Ion transport, Potassium transport, Transport","Ion channel, Potassium channel, Voltage-gated channel",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 4.5,Group enriched,Detected in some,6.0,Enteroendocrine cells: 7.1;Excitatory neurons: 28.2,Cancer enhanced,Detected in single,,renal cancer: 0.5,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Region enhanced,Detected in many,,cerebral cortex: 36.6,HPA067233,,,Supported,"Plasma membrane,Cytokinetic bridge",,Yes,,,,"Plasma membrane, Cytokinetic bridge",,HPA067233: ,,,unprognostic (1.41e-1),,unprognostic (1.81e-2),,,unprognostic (5.01e-4),,unprognostic (2.30e-1),unprognostic (3.76e-2),,unprognostic (1.13e-2),unprognostic (3.89e-2),unprognostic (2.27e-1),unprognostic (4.17e-2),,0.1,0.1,2.1,0.1,4.3,0.5,0.1,0.0,4.5,0.0,0.0,0.5,0.1,0.1,0.5,0.1,0.1,0.1,0.1,3.1,1.2,0.1,0.1,0.1,0.2,1.2,0.3,3.2,0.3,0.4,0.1,0.3,0.2,1.4,0.2,0.4,0.7,0.2,0.1,0.1,0.4,0.3,0.1,0.0,0.1,0.1,0.2,0.2,0.1,0.3,0.0,0.1,0.0,0.0,2.9,0.5,0.6,0.4,0.2,0.0,0.0,0.1,0.1,0.0,0.1,0.1,0.1,0.1,0.1,0.1,0.0,0.4,0.5,0.1,0.0,0.1,0.2,0.1,0.3,0.6,0.1,0.0,0.2,0.3,0.0,0.1,0.1,0.1,0.1,0.1,0.2,0.2,0.6,0.0,0.1,0.2,0.2,0.2,0.1,0.2,0.0,0.2,0.0,0.8,0.2,0.3,0.1,0.1,0.0,0.1,0.4,0.2,0.0,0.2,0.5,0.4,0.3,0.1,0.2,0.1,0.1,0.2,0.1,0.2,0.5,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,2.1,4.3,0.0,4.5,3.1,1.2,1.2,0.3,3.2,1.4,0.0,0.2,2.9,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.4,0.0,0.0,0.0,7.1,0.0,28.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,1.3,0.0,0.0,0.0,0.4,0.0,0.0,0.0,2.8,0.0,0.0,0.0,1.5,1.7,0.0,0.0,0.0,0.0,0.0,0.3,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,1.3,0.0
KNCN,"FLJ32011, KINO, L5",ENSG00000162456,Kinocilin,A6PVL3,1,46545641-46551647,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,11.0,brain: 3.5,Group enriched,Detected in some,46.0,Early spermatids: 15.1;Late spermatids: 31.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,unprognostic (6.99e-3),unprognostic (2.28e-2),,,,,unprognostic (2.80e-2),,,,,,,,0.0,0.0,0.9,0.0,0.2,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,3.5,0.0,0.0,0.0,0.0,1.9,1.6,0.1,0.0,0.0,0.0,0.2,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.3,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.2,0.2,0.2,0.5,3.5,1.9,1.6,0.1,1.1,0.3,1.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.1,0.3,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0
LRRC53,,ENSG00000162621,Leucine rich repeat containing 53,A6NM62,1,74469376-74512611,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,6.0,brain: 1.1,Cell type enriched,Detected in single,8.0,Enteroendocrine cells: 6.7,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,HPA054062,Uncertain,,,,,,,,,,,HPA054062: AB_2682364,,,,,unprognostic (3.67e-1),,,,,,,,,,,,,0.0,0.0,0.3,0.0,1.1,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.2,0.0,0.0,0.0,0.0,0.2,0.1,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,1.1,0.0,0.5,0.2,0.2,0.2,0.1,0.4,0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,6.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAGED4,"KIAA1859, MAGE-E1, MAGE1, MGC3210",ENSG00000154545,MAGE family member D4,Q96JG8,X,52184823-52192268,"Predicted intracellular proteins, Predicted membrane proteins",Ubl conjugation pathway,Tumor antigen,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,4.0,brain: 3.9,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 3.0;ASC TERT1: 2.7;Hep G2: 7.7,,,,,,,,,HPA003554,Uncertain,,,,,,,,,,,HPA003554: AB_1853497,,,,,unprognostic (7.71e-2),,,,,unprognostic (8.21e-2),,,,unprognostic (4.07e-4),unprognostic (6.15e-2),,,0.1,0.2,2.0,0.1,1.9,0.0,0.3,0.7,3.9,0.2,0.9,0.0,0.0,0.4,0.0,0.0,0.3,0.2,0.1,1.7,3.0,0.0,0.0,0.0,0.0,1.4,1.6,2.3,0.2,0.1,0.0,0.3,0.1,1.2,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.2,1.2,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,3.0,0.5,0.5,0.0,2.7,0.0,0.0,0.0,1.0,0.0,0.0,0.2,0.0,0.1,0.0,1.0,0.0,0.8,0.0,0.0,0.0,0.5,0.0,0.0,7.7,0.0,0.0,0.2,1.2,0.0,0.0,0.0,0.0,1.0,0.9,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.6,1.5,0.0,0.0,0.0,0.0,0.1,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.3,0.0,0.7,0.1,0.0,0.0,0.0,0.0,0.3,0.4,0.0,2.0,1.9,0.7,3.9,1.7,3.0,1.4,1.6,2.3,1.2,1.2,3.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.4,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MAS1,,ENSG00000130368,"MAS1 proto-oncogene, G protein-coupled receptor",P04201,6,159890988-159917447,"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",Proto-oncogene,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,18.0,brain: 8.4,Cell type enhanced,Detected in some,,Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9,Not detected,Not detected,,,Group enriched,Detected in some,4.0,cerebral cortex: 5.2;hippocampal formation: 8.4,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,8.0,HMC-1: 7.5,Group enriched,Detected in many,22.0,amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1,Group enriched,Detected in some,4.0,amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1,HPA079325,Uncertain,,,,,,,,,,,HPA079325: ,unprognostic (3.31e-1),unprognostic (2.25e-3),,unprognostic (2.91e-1),unprognostic (2.22e-3),unprognostic (8.15e-3),,unprognostic (7.05e-2),,unprognostic (1.88e-1),unprognostic (5.53e-2),unprognostic (6.52e-2),unprognostic (1.48e-5),unprognostic (1.69e-1),unprognostic (7.67e-2),unprognostic (6.28e-1),,0.0,0.0,1.6,0.0,0.7,0.3,0.0,0.0,5.2,0.4,0.0,0.0,0.0,0.1,0.2,0.0,0.1,0.0,0.0,8.4,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.1,0.3,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.2,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.6,0.7,0.0,5.2,8.4,0.0,0.0,0.0,0.5,0.3,0.0,0.3,0.6,0.3,3.2,0.6,0.0,2.0,0.0,1.4,0.0,0.0,1.2,0.1,0.3,0.8,0.0,0.6,0.0,2.1,0.2,0.2,0.0,0.0,0.0,0.1,0.4,0.3,0.8,0.0,0.0,0.1,0.0,0.3,0.7,0.0,0.3,0.0,0.4,1.1,0.4,0.2,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.9,0.7,0.0,0.0,0.5,0.7,1.0,0.0,0.0,0.1,0.0,0.7,0.0,1.4,0.0,0.3,0.0,2.1,0.0,1.3,1.0,0.4,0.5,0.0,0.0,0.3,0.5,0.2,0.2,1.9
MC3R,MC3,ENSG00000124089,Melanocortin 3 receptor,P41968,20,56248732-56249815,"G-protein coupled receptors, Human disease related genes, Predicted membrane proteins",Biological rhythms,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,80.0,brain: 10.2,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,hypothalamus: 10.2;thalamus: 8.4,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,basal ganglia: 4.8;hypothalamus: 4.5;thalamus: 1.3,Group enriched,Detected in some,5.0,basal ganglia: 3.2;hypothalamus: 2.2;thalamus: 2.6,HPA074739,Uncertain,,,,,,,,,,,HPA074739: ,,,,,,,,,,,,,,,,,,0.0,0.0,1.4,0.0,0.3,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,10.2,0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,8.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.3,0.0,0.1,0.6,10.2,0.2,0.5,0.0,0.1,0.0,8.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MEPE,,ENSG00000152595,Matrix extracellular phosphoglycoprotein,Q9NQ76,4,87821411-87846817,"Predicted intracellular proteins, Predicted secreted proteins",Biomineralization,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,86.0,brain: 8.6,Cell type enriched,Detected in single,18.0,Inhibitory neurons: 12.7,Not detected,Not detected,,,Region enhanced,Detected in many,,cerebral cortex: 8.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,"HPA038003, HPA038004",Uncertain,,,,Secreted to extracellular matrix,,,,810000.0,,,"HPA038003: AB_2675780, HPA038004: AB_10670537",unprognostic (2.88e-1),,,,unprognostic (8.15e-2),unprognostic (3.62e-1),unprognostic (1.91e-1),unprognostic (1.61e-1),,unprognostic (4.76e-2),unprognostic (1.11e-1),,unprognostic (3.14e-2),unprognostic (1.98e-1),unprognostic (2.41e-1),,unprognostic (5.64e-4),0.0,0.0,4.8,0.0,1.2,0.0,0.0,0.1,8.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.3,0.0,0.0,0.0,0.0,0.4,0.3,1.1,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,2.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.8,1.2,0.1,8.6,1.0,4.3,0.4,0.3,1.1,1.0,0.5,0.8,2.3,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,12.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0
MESP2,"bHLHc6, SCDO2",ENSG00000188095,Mesoderm posterior bHLH transcription factor 2,Q0VG99,15,89760591-89778754,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors","Notch signaling pathway, Transcription, Transcription regulation","Developmental protein, DNA-binding",Dwarfism,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Low tissue specificity,Detected in single,,,Cell type enhanced,Detected in some,,Breast glandular cells: 3.7;Exocrine glandular cells: 3.8;Rod photoreceptor cells: 7.0;Spermatogonia: 2.1,Low cancer specificity,Detected in many,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HaCaT: 1.1;U-2197: 3.5,Not detected,Not detected,,,Low region specificity,Detected in all,,,,,,,,,,,,,,,,unprognostic (1.13e-1),unprognostic (1.76e-2),unprognostic (3.75e-2),unprognostic (8.64e-2),unprognostic (2.39e-1),unprognostic (1.50e-3),unprognostic (6.59e-4),unprognostic (5.58e-2),unprognostic (4.00e-1),unprognostic (5.90e-2),unprognostic (3.14e-5),unprognostic (2.69e-1),unprognostic (1.01e-2),unprognostic (2.50e-1),unprognostic (3.81e-2),unprognostic (2.76e-1),unprognostic (1.11e-1),0.5,0.2,0.8,0.0,0.9,0.0,0.5,0.6,1.2,0.8,0.4,0.5,0.1,0.0,0.7,0.4,0.1,0.3,0.1,0.8,0.9,0.1,0.0,0.0,0.1,0.9,0.8,0.9,0.0,0.1,0.1,0.0,0.0,1.0,0.3,0.4,0.9,0.5,0.2,0.0,0.4,0.2,0.0,0.7,0.0,0.1,0.7,0.7,0.0,0.1,0.0,0.0,0.0,0.5,0.8,0.0,1.1,0.0,0.4,0.6,0.1,0.2,0.2,0.1,0.5,0.1,0.3,0.5,0.0,0.1,0.1,0.0,1.1,0.3,0.5,0.1,0.0,0.2,0.0,0.0,0.1,0.1,0.0,0.2,0.6,0.2,0.4,0.2,0.0,0.3,0.5,0.3,0.0,0.1,0.2,0.0,0.1,0.2,0.0,1.0,0.0,0.0,0.7,0.0,0.0,0.5,0.1,0.5,0.1,0.0,0.2,0.0,0.1,0.0,0.0,0.0,3.5,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.8,0.9,0.6,1.2,0.8,0.9,0.9,0.8,0.9,1.0,0.7,0.7,0.8,0.1,0.0,0.0,0.0,0.0,0.0,0.5,0.1,0.0,0.2,3.7,1.5,0.4,0.0,1.3,0.0,0.0,0.6,0.1,1.2,1.9,1.2,0.0,0.0,0.2,0.1,0.0,0.0,0.3,3.8,0.0,0.8,0.0,0.0,0.0,0.4,0.4,0.2,0.5,0.0,0.3,0.8,0.0,0.3,0.0,0.1,0.3,0.2,0.0,0.0,0.0,0.6,1.0,0.0,0.0,0.5,0.2,0.4,0.0,0.6,0.0,0.7,0.7,7.0,0.0,0.3,0.3,1.2,2.1,0.2,0.0,0.1,0.0,0.9,0.7,0.9
MINDY4B,"C3orf76, FAM188B2",ENSG00000214237,MINDY family member 4B,A8MYZ0,3,150870376-150905439,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.3,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in single,,basal ganglia: 1.3,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,T-47d: 1.0,Low region specificity,Detected in many,,,Not detected,Not detected,,,,,,,,,,,,,,,,unprognostic (1.91e-4),unprognostic (6.32e-3),unprognostic (6.09e-3),unprognostic (3.14e-1),unprognostic (3.96e-1),unprognostic (1.01e-2),unprognostic (3.25e-2),unprognostic (2.07e-3),,unprognostic (3.36e-1),unprognostic (8.66e-3),unprognostic (1.43e-1),unprognostic (2.22e-1),unprognostic (4.70e-1),unprognostic (2.54e-1),unprognostic (4.77e-1),unprognostic (2.16e-1),0.0,0.2,0.0,0.0,1.3,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.1,0.3,0.1,0.2,0.2,0.0,0.1,0.5,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MRGPRE,"GPR167, mrgE",ENSG00000184350,MAS related GPR family member E,Q86SM8,11,3225030-3232417,"G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,34.0,brain: 26.4,Not detected,Not detected,,,Cancer enriched,Detected in single,5.0,thyroid cancer: 0.9,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,NB-4: 1.0;RPMI-8226: 2.7;SCLC-21H: 3.9,Low region specificity,Detected in all,,,,,,,HPA046556,Uncertain,,,,,,,,,,,HPA046556: AB_10961404,unprognostic (1.18e-1),,,unprognostic (7.52e-4),unprognostic (1.04e-1),,,unprognostic (9.09e-2),,unprognostic (6.65e-2),unprognostic (1.77e-2),unprognostic (1.27e-1),unprognostic (1.83e-1),unprognostic (2.22e-2),,unprognostic (1.19e-1),,0.0,0.3,1.9,0.0,2.3,0.6,0.1,4.0,5.5,0.7,0.0,0.2,0.0,0.5,0.3,0.1,0.6,0.1,0.4,0.3,6.3,0.0,0.0,0.0,0.0,22.5,5.9,0.2,0.0,0.1,0.0,0.1,0.1,26.4,0.2,0.0,0.6,0.2,0.3,0.0,0.1,0.1,0.2,2.5,0.4,0.0,0.0,3.9,0.0,0.2,0.1,0.0,0.1,0.4,16.9,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.7,0.0,0.0,3.9,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,2.3,4.0,5.5,0.3,6.3,22.5,5.9,0.2,26.4,2.5,3.9,16.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
MTRNR2L5,,ENSG00000249860,MT-RNR2 like 5,P0CJ72,10,55599042-55600728,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.6,Cell type enriched,Detected in some,18.0,Cardiomyocytes: 27.7,Not detected,Not detected,,,Low region specificity,Detected in many,,,Group enriched,Detected in some,4.0,basophil: 1.2;neutrophil: 1.2,Lineage enriched,Detected in single,5.0,granulocytes: 1.2,Not detected,Not detected,,,,,,,,,,,,,,,,Secreted - unknown location,,,,,,,,,,,,,,,,,unprognostic (2.11e-2),,,,unprognostic (1.20e-1),,,,0.0,0.1,1.2,0.1,0.9,0.3,0.0,0.4,1.2,0.0,0.2,0.0,0.2,0.1,0.0,0.1,0.0,0.0,0.2,1.2,1.6,0.1,0.1,0.0,0.2,1.1,1.0,1.0,0.0,0.2,0.0,0.0,0.0,0.9,0.0,0.0,0.1,0.2,0.0,0.7,0.2,0.1,0.0,0.4,0.2,0.1,0.0,1.6,0.0,0.1,0.1,0.0,0.0,0.0,1.1,0.0,0.1,0.0,0.1,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.1,0.1,0.2,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.4,0.4,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.4,0.0,0.1,0.0,0.2,0.1,0.0,0.1,0.1,0.0,0.6,0.0,0.1,0.0,0.0,0.1,0.1,0.0,0.1,0.1,0.1,0.1,0.0,0.0,0.1,0.0,0.3,0.2,0.1,0.0,0.1,0.1,1.2,0.2,0.3,0.1,0.0,0.0,0.1,0.1,0.0,0.0,0.2,0.0,0.1,1.2,0.2,0.1,0.1,0.0,0.1,1.2,0.9,0.4,1.2,1.2,1.6,1.1,1.0,1.0,0.9,0.4,1.6,1.1,0.0,0.0,0.0,0.0,0.0,0.6,0.2,0.0,0.0,0.0,0.0,0.0,27.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.1
MTRNR2L7,,ENSG00000256892,MT-RNR2 like 7,P0CJ74,10,37601440-37602974,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,4.0,brain: 1.7,Cell type enriched,Detected in some,26.0,Cardiomyocytes: 188.3,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,Secreted - unknown location,,,,,,,,,,,,,,,,,unprognostic (2.28e-1),,,,unprognostic (5.87e-2),,,,0.0,0.1,0.4,0.0,0.4,0.1,0.0,0.4,1.7,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.4,0.4,0.1,0.1,0.0,0.0,0.4,0.4,0.3,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.1,0.1,0.0,0.0,0.3,0.1,0.0,0.0,0.4,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.6,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.4,0.4,0.4,1.7,0.4,0.4,0.4,0.4,0.3,0.4,0.4,0.4,0.5,0.0,0.0,0.0,0.0,0.0,0.1,0.5,0.1,0.0,0.0,0.0,0.0,188.3,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.8,0.0,0.0,0.0,0.0,0.0,4.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.7,0.0,0.0,0.0,0.6,7.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.4
MYMK,"TMEM226, TMEM8C",ENSG00000187616,"Myomaker, myoblast fusion factor",A6NI61,9,133514586-133528612,"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters",Myogenesis,,Disease variant,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.7,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,32.0,HSkMC: 15.2;RH-30: 7.0,Low region specificity,Detected in some,,,Not detected,Not detected,,,"HPA051846, HPA055785",Uncertain,,,,,,,,,,,"HPA051846: AB_2681636, HPA055785: AB_2682920",,,,,,unprognostic (9.17e-3),unprognostic (8.63e-2),unprognostic (3.76e-1),,unprognostic (1.13e-1),unprognostic (1.03e-1),unprognostic (5.37e-1),unprognostic (9.32e-2),,,unprognostic (1.91e-1),,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4,0.2,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.1,0.2,0.2,0.0,0.0,0.0,0.4,0.4,0.0,0.0,0.0,0.0,0.0,0.3,1.7,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.2,1.1,0.4,0.0,0.3,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.3,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.4,0.2,0.1,0.2,0.4,0.4,0.0,1.7,0.0,1.1,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0
NANOG,"FLJ12581, FLJ40451",ENSG00000111704,Nanog homeobox,Q9H9S0,12,7787794-7799146,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding, Repressor",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.8,Cell type enhanced,Detected in some,,Cone photoreceptor cells: 8.4;Spermatocytes: 5.5,Cancer enriched,Detected in single,1164.0,testis cancer: 58.1,Low region specificity,Detected in single,,,Immune cell enhanced,Detected in some,,plasmacytoid DC: 1.7,Group enriched,Detected in many,5.0,dendritic cells: 1.7;granulocytes: 1.5,Cell line enriched,Detected in some,5.0,NTERA-2: 125.5,Not detected,Not detected,,,Low region specificity,Detected in all,,,"CAB019380, HPA072117",Supported,,Supported,"Nucleoplasm,Vesicles",,,,,,Nucleoplasm,Vesicles,"CAB019380: , HPA072117: ",unprognostic (1.76e-1),unprognostic (1.86e-1),,unprognostic (1.01e-1),unprognostic (1.78e-1),unprognostic (8.59e-3),unprognostic (3.50e-1),unprognostic (3.46e-2),,unprognostic (6.35e-2),unprognostic (1.10e-1),unprognostic (3.87e-1),unprognostic (4.51e-7),unprognostic (3.46e-2),unprognostic (2.09e-1),unprognostic (1.51e-1),unprognostic (3.85e-2),0.0,0.1,0.3,0.1,0.6,0.4,0.1,1.8,0.5,0.0,0.3,0.0,0.1,0.1,0.0,0.1,0.0,0.1,0.0,0.3,0.2,0.0,0.2,0.4,0.1,0.2,0.1,0.3,0.0,0.1,0.0,0.0,0.0,0.8,0.1,0.0,0.1,0.0,0.0,0.3,0.3,0.0,0.1,0.1,0.2,0.2,0.9,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,125.5,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.3,0.0,0.1,0.1,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.1,1.5,0.2,0.1,0.1,0.1,0.1,0.2,0.1,0.1,0.0,0.3,0.2,0.2,0.7,0.3,0.2,1.7,0.1,0.0,0.3,0.6,1.8,0.5,0.3,0.2,0.2,0.1,0.3,0.8,0.1,0.3,0.7,0.4,0.0,0.0,0.0,0.2,1.7,1.8,0.8,0.0,2.2,0.3,0.1,0.8,0.0,0.3,0.0,8.4,1.6,1.4,0.1,0.0,0.4,1.0,0.3,0.5,0.6,0.0,0.0,0.0,0.4,0.2,0.4,0.0,0.3,0.0,2.1,0.7,0.6,0.5,0.0,0.0,0.3,2.0,0.3,0.0,0.3,1.5,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.1,0.2,0.4,1.5,0.0,0.9,0.0,0.3,0.9,1.0,0.0,1.7,0.4,5.5,0.6,0.0,0.6,0.7,0.7,0.7,0.4,1.8
NANOGP8,,ENSG00000255192,Nanog homeobox retrogene P8,Q6NSW7,15,35083410-35085295,Predicted intracellular proteins,"Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,4.0,brain: 3.2,Not detected,Not detected,,,Cancer enriched,Detected in single,415.0,testis cancer: 20.7,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,69.0,NTERA-2: 33.2;SuSa: 11.6,,,,,,,,,HPA072117,,,Supported,"Nucleoplasm,Vesicles",,,,,,Nucleoplasm,Vesicles,HPA072117: ,,,,,,,,,,unprognostic (1.58e-1),,,unprognostic (9.05e-3),unprognostic (1.48e-1),unprognostic (2.37e-1),,,0.1,0.1,0.4,0.0,3.2,0.2,0.1,2.0,1.4,0.1,0.1,0.1,0.1,0.2,0.1,0.0,0.1,0.0,0.1,0.2,0.9,0.1,0.1,0.1,0.0,0.7,0.3,0.7,0.2,0.2,0.0,0.2,0.0,1.3,0.2,0.0,0.2,0.1,0.0,0.0,0.3,0.0,0.0,0.1,0.1,0.0,0.7,0.7,0.0,0.1,0.0,0.0,0.1,0.1,0.5,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,33.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.6,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.4,3.2,2.0,1.4,0.2,0.9,0.7,0.3,0.7,1.3,0.1,0.7,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NEUROG1,"AKA, bHLHa6, Math4C, NEUROD3, ngn1",ENSG00000181965,Neurogenin 1,Q92886,5,135534282-135535964,"Plasma proteins, Predicted intracellular proteins, Transcription factors","Differentiation, Neurogenesis, Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,5.0,brain: 4.2,Cell type enriched,Detected in single,15.0,Bipolar cells: 9.1,Cancer enriched,Detected in single,12.0,testis cancer: 1.1,Region enriched,Detected in single,10.0,midbrain: 4.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,HPA072232,,,Approved,"Nucleoplasm,Nuclear bodies",,,,,,Nucleoplasm,Nuclear bodies,HPA072232: ,,,,,,,,,,,,,,,unprognostic (3.04e-2),,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,4.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,4.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.1,0.0,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NHLH1,"bHLHa35, HEN1, NSCL, NSCL1",ENSG00000171786,Nescient helix-loop-helix 1,Q02575,1,160367071-160372846,"Predicted intracellular proteins, Transcription factors","Differentiation, Transcription, Transcription regulation","Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.7,Cell type enhanced,Detected in some,,Astrocytes: 8.5;Excitatory neurons: 22.5;Inhibitory neurons: 18.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 48.6,Cancer enhanced,Detected in some,,glioma: 2.4,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,10.0,SCLC-21H: 26.3,Region enhanced,Detected in single,,hippocampal formation: 1.0,Region enriched,Detected in some,12.0,cerebellum: 19.1,HPA017943,,,Approved,Golgi apparatus,,,,,,Golgi apparatus,,HPA017943: AB_2732421,unprognostic (6.95e-2),unprognostic (3.02e-1),unprognostic (3.81e-1),unprognostic (1.35e-3),unprognostic (1.39e-1),unprognostic (1.83e-1),unprognostic (1.77e-1),unprognostic (2.38e-2),unprognostic (2.24e-1),unprognostic (1.75e-2),unprognostic (7.06e-2),unprognostic (1.96e-2),unprognostic (4.21e-8),unprognostic (4.09e-2),unprognostic (2.82e-1),unprognostic (1.38e-2),unprognostic (1.36e-1),0.2,0.1,1.5,0.1,1.7,0.0,0.1,1.5,1.7,0.0,0.9,0.1,0.0,0.1,0.0,0.2,0.1,0.0,0.1,1.6,1.2,0.1,0.2,0.2,0.0,2.3,2.7,1.2,0.1,0.1,0.0,0.3,0.0,1.7,0.1,0.0,0.7,0.2,0.0,0.3,0.6,0.2,0.0,2.7,0.6,0.1,0.3,1.7,0.6,0.1,0.0,0.0,0.1,0.1,2.0,0.0,0.1,2.6,0.0,0.6,0.1,0.4,0.1,0.2,0.0,0.1,0.0,0.0,0.0,0.1,0.1,0.0,0.2,0.4,0.0,0.2,1.2,0.5,0.2,0.6,0.0,0.2,0.1,0.3,0.1,0.1,0.1,0.0,0.1,0.1,0.4,0.4,0.5,0.0,0.0,0.0,0.5,0.6,0.0,0.2,0.0,0.2,0.1,0.0,0.0,26.3,0.2,0.1,0.1,0.2,0.5,0.0,0.0,0.1,0.1,0.2,0.3,0.0,1.9,0.7,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,1.7,1.5,1.7,1.6,1.2,2.3,2.7,1.2,1.7,2.7,1.7,2.0,0.5,0.0,0.0,8.5,0.5,0.3,0.0,0.1,0.6,0.9,0.5,0.8,0.7,0.0,0.1,0.0,2.1,0.1,0.3,0.2,0.0,0.2,0.0,0.2,0.3,0.3,1.8,0.0,22.5,0.2,0.1,0.2,0.0,0.5,0.0,0.2,0.4,0.0,0.2,3.3,18.6,0.6,0.0,1.9,0.6,0.0,0.3,1.1,0.0,9.4,0.4,0.2,0.0,16.6,48.6,0.1,0.1,0.0,0.0,0.2,0.1,0.0,0.1,1.4,0.0,0.5,0.1,1.1,0.6,0.3,0.0,0.3,0.2,0.2,0.0,0.1
NMS,,ENSG00000204640,Neuromedin S,Q5H8A3,2,100470482-100483280,Predicted secreted proteins,,Neuropeptide,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,5.0,brain: 1.8,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,10.0,HL-60: 8.4;HMC-1: 4.8,Group enriched,Detected in some,4.0,basal ganglia: 2.4;hypothalamus: 5.4;pons and medulla: 1.3,,,,,,,,,,Secreted in brain,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,1.8,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.3,0.9,0.0,0.0,0.1,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.4,4.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.1,0.0,0.7,1.8,0.1,0.0,0.3,1.2,0.9,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NPS,,ENSG00000214285,Neuropeptide S,P0C0P6,10,127549309-127553540,Predicted secreted proteins,,Neuropeptide,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,10.0,brain: 1.0,Not detected,Not detected,,,Cancer enriched,Detected in some,8.0,head and neck cancer: 4.0,Region enhanced,Detected in single,,white matter: 1.0,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,19.0,midbrain: 5.4;pons and medulla: 5.1,Group enriched,Detected in some,6.0,cerebral cortex: 4.8;white matter: 2.2,CAB020139,Uncertain,,,,Secreted in brain,,,,,,,CAB020139: AB_776718,,,,,unprognostic (2.83e-1),,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.2,0.3,0.0,0.4,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NPSR1,"GPR154, GPRA, PGR14",ENSG00000187258,Neuropeptide S receptor 1,Q6W5P4,7,34658218-34878332,"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",Asthma,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.5,Cell type enhanced,Detected in some,,Cardiomyocytes: 1.1;Early spermatids: 4.4;Excitatory neurons: 3.8;Inhibitory neurons: 2.2;Late spermatids: 2.1;Oligodendrocyte precursor cells: 1.0,Group enriched,Detected in some,5.0,colorectal cancer: 2.3;pancreatic cancer: 2.0;stomach cancer: 2.9,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,HAP1: 1.0,Low region specificity,Detected in many,,,Region enhanced,Detected in many,,midbrain: 6.2,,,,,,,,,,,,,,,unprognostic (3.56e-1),unprognostic (9.34e-2),unprognostic (7.55e-2),unprognostic (1.80e-1),unprognostic (2.00e-2),,unprognostic (9.35e-2),,,unprognostic (6.34e-3),,,unprognostic (2.85e-1),unprognostic (1.36e-2),,unprognostic (2.08e-2),0.0,0.0,0.5,0.0,0.3,0.0,0.0,0.1,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,1.5,0.0,0.0,0.0,0.0,0.7,1.3,0.1,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.5,0.2,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.3,0.1,0.3,0.4,1.5,0.7,1.3,0.1,0.3,0.1,1.3,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.3,0.0,0.2,0.0,0.0,4.4,0.0,0.0,0.1,0.0,0.0,3.8,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,2.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.3,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.4,0.0,0.0,0.3,0.0
NTN3,NTN2L,ENSG00000162068,Netrin 3,O00634,16,2471297-2474145,Predicted secreted proteins,,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,10.0,brain: 3.2,Not detected,Not detected,,,Low cancer specificity,Detected in single,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4.0,HeLa: 1.7;REH: 5.0;SCLC-21H: 5.8;SH-SY5Y: 3.3,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA050817,Uncertain,,,,Secreted in brain,,,,,,,HPA050817: AB_2681247,unprognostic (2.60e-2),unprognostic (1.95e-2),unprognostic (1.79e-1),unprognostic (9.17e-2),unprognostic (6.44e-2),unprognostic (2.23e-2),unprognostic (9.62e-3),unprognostic (2.11e-1),unprognostic (4.55e-2),unprognostic (6.95e-2),unprognostic (5.58e-2),unprognostic (2.34e-1),unprognostic (1.35e-2),unprognostic (3.26e-2),unprognostic (6.68e-2),unprognostic (2.39e-2),unprognostic (6.61e-2),0.1,0.0,2.4,0.0,1.3,0.0,0.0,0.9,2.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.5,2.3,0.0,0.2,0.0,0.0,3.2,2.3,1.4,0.0,0.1,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.3,2.1,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.2,0.1,0.5,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.1,0.3,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.8,0.7,0.0,1.7,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.1,0.0,0.7,0.1,0.0,0.0,5.0,0.1,0.1,0.0,0.0,5.8,3.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.8,0.0,0.0,0.3,0.2,0.4,0.0,0.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.4,1.3,0.9,2.0,1.5,2.3,3.2,2.3,1.4,1.3,1.7,2.1,1.2,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
NUTM2E,FAM22E,ENSG00000228570,NUT family member 2E,B1AL46,10,79841358-79850878,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at protein level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 2.0,Cell type enhanced,Detected in some,,Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2,,,,,,,,,HPA064635,,,Approved,Nuclear bodies,,,,,,Nuclear bodies,,HPA064635: ,unprognostic (2.82e-1),unprognostic (3.95e-1),,unprognostic (1.90e-1),unprognostic (1.00e-2),unprognostic (1.16e-1),unprognostic (2.12e-2),unprognostic (1.11e-1),unprognostic (4.19e-1),unprognostic (1.96e-2),unprognostic (2.51e-1),unprognostic (2.33e-1),unprognostic (1.03e-1),unprognostic (2.58e-1),unprognostic (3.66e-1),unprognostic (4.35e-1),unprognostic (4.09e-1),0.1,0.1,0.6,0.0,0.6,0.1,0.1,1.1,0.7,0.2,0.1,0.1,0.2,0.2,0.6,0.1,0.2,0.1,0.2,0.6,0.4,0.1,0.2,0.2,0.3,0.7,0.5,0.4,0.2,0.3,0.0,0.5,0.1,0.9,0.2,0.1,0.2,0.1,0.2,0.1,0.2,0.2,0.1,0.4,0.3,0.1,0.7,0.6,0.5,0.3,0.3,0.0,0.1,0.1,2.0,0.0,0.5,0.0,0.3,0.0,0.0,0.1,0.0,0.5,0.2,0.3,0.1,0.0,0.0,0.0,0.2,0.0,0.2,0.2,0.1,0.0,0.0,0.0,0.1,0.2,0.0,0.1,0.5,2.0,0.1,0.1,0.0,0.1,0.1,0.3,0.1,0.1,0.0,0.0,0.0,0.6,1.6,0.0,0.4,0.1,0.5,0.0,0.0,0.0,0.1,0.0,0.2,0.1,0.2,0.1,0.0,0.0,0.0,0.1,0.1,0.0,0.3,0.0,0.7,1.2,0.1,0.3,0.7,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.6,1.1,0.7,0.6,0.4,0.7,0.5,0.4,0.9,0.4,0.6,2.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.4,0.0,0.0,0.0,0.1,1.2,0.0,0.0,1.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0
NYAP2,KIAA1486,ENSG00000144460,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2,Q9P242,2,225399710-225654018,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 3.2,Group enriched,Detected in some,8.0,Excitatory neurons: 136.8;Inhibitory neurons: 238.3,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,SiHa: 1.9,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,"HPA045531, HPA056945",Uncertain,,Approved,"Mitochondria,Cytosol",,,,,,Mitochondria,Cytosol,"HPA045531: AB_10960749, HPA056945: ",unprognostic (2.49e-1),unprognostic (3.34e-1),,unprognostic (1.24e-1),unprognostic (2.63e-1),unprognostic (2.35e-1),,unprognostic (6.13e-3),,unprognostic (3.33e-1),unprognostic (2.08e-1),,unprognostic (1.32e-8),unprognostic (9.83e-2),unprognostic (2.92e-1),unprognostic (6.46e-2),unprognostic (1.27e-1),0.0,0.0,0.9,0.0,1.6,0.0,0.0,0.9,3.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.7,1.5,0.0,0.0,0.2,0.0,0.6,2.0,0.9,0.0,0.0,0.0,0.3,0.0,0.8,0.0,0.0,0.9,0.0,0.0,0.4,0.0,0.0,0.0,0.9,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.2,0.3,0.6,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.9,1.6,0.9,3.2,1.7,1.5,0.6,2.0,0.9,0.8,0.9,1.4,0.7,0.1,0.0,2.3,4.9,0.1,1.3,1.7,0.0,0.0,21.8,0.2,0.0,0.5,0.0,0.6,0.0,2.1,0.2,0.2,0.1,0.0,0.3,0.6,0.2,0.1,0.4,0.0,0.0,136.8,1.2,0.3,0.5,0.0,0.2,0.0,0.0,0.0,0.3,0.1,0.0,238.3,0.0,0.0,0.8,1.8,0.8,0.0,0.6,0.0,1.0,0.2,0.5,0.0,1.5,2.5,1.2,0.0,0.0,0.1,1.1,0.0,0.1,0.0,1.5,0.0,3.6,0.5,0.2,0.1,0.0,1.0,0.1,0.5,0.0,0.0,0.8
OR10H5,,ENSG00000172519,Olfactory receptor family 10 subfamily H member 5,Q8NGA6,19,15787661-15800357,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.2,Cell type enhanced,Detected in some,,Alveolar cells type 2: 1.7;Respiratory ciliated cells: 1.5,Not detected,Not detected,,,Low region specificity,Detected in some,,,Immune cell enhanced,Detected in some,,basophil: 1.4,Low lineage specificity,Detected in single,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.1,1.1,0.1,0.6,0.7,0.1,1.0,1.2,0.0,0.2,0.1,0.2,0.1,0.2,0.1,0.0,0.1,0.0,0.8,0.2,0.1,0.0,0.1,0.2,0.5,0.4,0.8,0.1,0.1,0.0,0.0,0.1,0.9,0.0,0.2,0.4,0.1,0.0,0.7,0.4,0.2,0.1,0.1,0.1,0.1,0.2,0.5,0.0,0.1,0.0,0.1,0.0,0.0,1.1,0.1,0.1,0.1,0.2,0.1,0.0,0.3,0.1,0.0,0.0,0.0,0.1,0.2,0.2,0.0,0.0,0.0,0.1,0.1,0.1,0.0,0.1,0.1,0.2,0.4,0.1,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.2,0.0,0.3,0.1,0.2,0.1,0.0,0.1,0.1,0.0,0.1,0.0,0.2,0.1,0.1,0.2,0.1,0.0,0.1,0.1,0.1,0.1,0.2,0.2,0.2,0.1,0.2,0.1,0.1,0.1,0.3,0.1,1.4,0.2,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.0,0.4,0.1,0.2,1.0,0.3,0.1,0.3,0.1,0.0,1.1,0.6,1.0,1.2,0.8,0.2,0.5,0.4,0.8,0.9,0.1,0.5,1.1,0.1,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0
OR10K1,,ENSG00000173285,Olfactory receptor family 10 subfamily K member 1,Q8NGX5,1,158461574-158470857,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,5.0,brain: 4.6,Cell type enhanced,Detected in some,,Alveolar cells type 1: 22.4;Alveolar cells type 2: 14.2;Club cells: 5.0;granulocytes: 8.8;Respiratory ciliated cells: 12.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,HPA059125,Uncertain,,,,,,,,,,,HPA059125: AB_2683913,,,,,,,,,,,,,,,,,,0.1,0.2,1.8,0.3,1.8,0.6,0.1,4.4,4.6,0.0,0.2,0.1,0.1,0.1,0.3,0.8,0.0,0.1,0.0,1.7,0.7,0.1,0.2,0.1,0.1,1.9,2.4,1.6,0.1,0.1,0.0,0.0,0.1,3.7,0.1,0.1,0.8,0.1,0.0,0.6,0.2,0.1,0.1,0.2,0.2,0.1,0.3,1.1,0.0,0.0,0.0,0.4,0.0,0.0,3.4,0.2,0.2,0.2,0.2,0.1,0.0,0.2,0.1,0.0,0.0,0.0,0.1,0.1,0.2,0.3,0.0,0.2,0.2,0.1,0.1,0.2,0.3,0.0,0.2,0.2,0.2,0.0,0.2,0.3,0.0,0.0,0.1,0.1,0.1,0.0,0.1,0.2,0.8,0.0,0.0,0.3,0.3,0.4,0.0,0.0,0.2,0.0,0.1,0.0,0.1,0.1,0.2,0.1,0.0,0.4,0.1,0.1,0.2,0.0,0.2,0.4,0.3,0.2,0.4,0.3,0.2,0.1,0.2,0.3,0.2,0.0,0.0,0.1,0.0,0.1,0.1,0.1,0.1,0.0,0.1,0.1,0.1,0.3,0.1,0.0,0.0,0.1,0.0,1.8,1.8,4.4,4.6,1.7,0.7,1.9,2.4,1.6,3.7,0.2,1.1,3.4,0.0,22.4,14.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.9,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.1,8.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0
OR1E2,"OR17-135, OR17-93, OR1E4",ENSG00000127780,Olfactory receptor family 1 subfamily E member 2,P47887,17,3432870-3433841,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,12.0,brain: 1.1,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in single,6.0,white matter: 1.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR1F1,"Olfmf, OR16-36, OR16-37, OR16-88, OR16-89, OR16-90, OR1F10, OR1F13P, OR1F4, OR1F5, OR1F6, OR1F7, OR1F8, OR1F9, OR3-145",ENSG00000168124,Olfactory receptor family 1 subfamily F member 1,O43749,16,3204247-3205188,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 2.6,Cell type enhanced,Detected in some,,Early spermatids: 4.0;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 5.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,THP-1: 1.0,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,unprognostic (3.72e-1),,unprognostic (2.99e-2),unprognostic (1.22e-1),unprognostic (4.94e-2),,,unprognostic (4.88e-1),unprognostic (4.16e-1),,,,,unprognostic (1.26e-1),,,0.0,0.0,0.4,0.0,0.8,0.0,0.0,2.6,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.5,0.0,0.0,0.0,0.0,1.0,0.5,0.3,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.7,0.6,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.6,0.3,0.0,0.0,0.0,0.0,0.3,0.0,0.3,0.2,0.6,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.5,0.1,0.2,0.0,0.3,0.3,0.1,0.0,0.0,0.0,0.4,0.0,0.0,0.2,0.4,0.2,0.2,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.4,0.1,0.0,0.0,0.3,0.2,0.6,0.0,0.0,0.4,0.0,0.0,0.3,0.0,0.0,1.0,0.6,0.0,0.3,0.1,0.0,0.1,0.0,0.0,0.3,0.3,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.4,0.8,2.6,1.9,1.8,0.5,1.0,0.5,0.3,1.2,0.0,0.6,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,5.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR1M1,OR19-6,ENSG00000170929,Olfactory receptor family 1 subfamily M member 1,Q8NGA1,19,9087061-9095669,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,4.0,brain: 3.5,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low immune cell specificity,Detected in single,,,Low lineage specificity,Detected in single,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (3.29e-2),,,,,,,,0.1,0.1,0.2,0.2,1.4,0.8,0.1,1.1,1.2,0.1,0.8,0.1,0.2,0.1,0.2,0.1,0.1,0.2,0.1,0.3,0.4,0.0,0.1,0.1,0.2,1.4,0.9,0.4,0.2,0.2,0.0,0.0,0.1,1.8,0.1,0.1,0.4,0.3,0.0,0.2,0.6,0.2,0.0,0.4,0.1,0.1,0.2,1.0,0.0,0.4,0.0,0.1,0.0,0.0,3.5,0.1,0.1,0.1,0.2,0.1,0.0,0.4,0.0,0.0,0.0,0.1,0.2,0.3,0.2,0.0,0.0,0.1,0.2,0.0,0.0,0.1,0.1,0.1,0.0,0.3,0.1,0.0,0.1,0.2,0.1,0.0,0.1,0.1,0.0,0.0,0.2,0.0,0.5,0.0,0.2,0.2,0.1,0.1,0.1,0.0,0.1,0.2,0.1,0.1,0.3,0.1,0.2,0.0,0.1,0.0,0.1,0.2,0.0,0.1,0.4,0.1,0.3,0.1,0.2,0.1,0.1,0.1,0.2,0.1,0.9,0.2,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.0,0.4,0.2,0.2,1.0,0.2,0.3,0.2,0.1,0.0,0.2,1.4,1.1,1.2,0.3,0.4,1.4,0.9,0.4,1.8,0.4,1.0,3.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR2L8,,ENSG00000279263,Olfactory receptor family 2 subfamily L member 8,Q8NGY9,1,247948858-247949796,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,10.0,brain: 1.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.4,0.3,0.0,0.0,0.0,0.0,,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.6,0.1,0.3,0.4,0.3,0.0,0.7,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR2M4,"HSHTPCRX18, HTPCRX18, OST710, TPCR100",ENSG00000171180,Olfactory receptor family 2 subfamily M member 4,Q96R27,1,248231417-248244679,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,HPA051308,Uncertain,,,,,,,,,,,HPA051308: AB_2681435,,,,,,,,,,,,,,,,,,0.1,0.1,0.5,0.1,0.5,0.7,0.2,0.8,0.8,0.0,0.2,0.1,0.1,0.1,0.3,0.0,0.1,0.2,0.1,0.4,0.1,0.0,0.4,0.1,0.1,0.3,0.2,0.3,0.2,0.3,0.1,0.0,0.0,0.4,0.0,0.1,0.9,0.2,0.0,0.1,0.2,0.1,0.0,0.0,0.1,0.1,0.2,0.2,0.0,0.1,0.1,0.0,0.1,0.0,1.0,0.1,0.0,0.0,0.1,0.2,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.3,0.1,0.0,0.2,0.1,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.2,0.0,0.1,0.0,0.1,0.1,0.0,0.1,0.3,0.0,0.1,0.0,0.2,0.2,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.2,0.1,0.1,0.1,0.0,0.2,0.1,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.1,0.0,0.1,0.0,0.0,0.5,0.5,0.8,0.8,0.4,0.1,0.3,0.2,0.3,0.4,0.0,0.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR2T12,,ENSG00000177201,Olfactory receptor family 2 subfamily T member 12,Q8NG77,1,248290139-248303424,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.7,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,HeLa: 1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.1,0.3,0.1,1.0,0.4,0.0,1.4,1.6,0.0,0.0,0.1,0.1,0.0,0.2,0.0,0.0,0.1,0.0,0.6,0.6,0.0,0.1,0.0,0.1,0.2,0.3,0.5,0.1,0.1,0.0,0.0,0.0,0.5,0.0,0.1,0.5,0.1,0.0,0.1,0.2,0.1,0.0,0.0,0.1,0.1,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.2,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.1,0.2,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.2,1.2,0.1,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.5,0.0,0.1,0.3,0.2,0.3,0.1,0.0,0.1,0.1,0.1,0.0,0.2,0.1,0.1,0.1,0.1,0.0,0.2,0.1,0.2,0.2,0.2,0.2,0.8,0.1,0.2,0.2,0.1,0.1,0.1,0.2,0.5,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.3,1.0,1.4,1.6,0.6,0.6,0.2,0.3,0.5,0.5,0.0,0.2,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR4D9,,ENSG00000172742,Olfactory receptor family 4 subfamily D member 9,Q8NGE8,11,59511368-59520703,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.8,Cell type enhanced,Detected in some,,Alveolar cells type 2: 1.7;Collecting duct cells: 1.8;granulocytes: 1.3,Not detected,Not detected,,,Low region specificity,Detected in single,,,Immune cell enhanced,Detected in some,,basophil: 1.4,Low lineage specificity,Detected in single,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.1,0.4,0.2,0.5,0.9,0.1,1.8,0.7,0.0,0.3,0.1,0.4,0.1,0.1,0.1,0.0,0.1,0.1,0.4,0.1,0.0,0.0,0.1,0.2,0.2,0.1,0.5,0.0,0.1,0.0,0.0,0.1,0.8,0.1,0.1,0.4,0.2,0.0,0.2,0.4,0.2,0.0,0.0,0.2,0.1,0.2,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.7,0.1,0.1,0.1,0.2,0.0,0.1,0.1,0.1,0.0,0.0,0.1,0.2,0.2,0.1,0.1,0.0,0.1,0.2,0.1,0.1,0.0,0.1,0.1,0.2,0.7,0.1,0.0,0.1,0.2,0.0,0.0,0.1,0.0,0.1,0.0,0.2,0.2,0.5,0.0,0.2,0.1,0.3,0.1,0.0,0.1,0.2,0.0,0.0,0.0,0.2,0.2,0.1,0.1,0.1,0.3,0.1,0.2,0.1,0.2,0.2,0.2,0.2,0.1,0.2,0.1,0.2,0.1,0.2,0.2,1.4,0.3,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.1,0.4,0.2,0.2,1.2,0.4,0.1,0.2,0.1,0.2,0.4,0.5,1.8,0.7,0.4,0.1,0.2,0.1,0.5,0.8,0.0,0.2,0.7,0.3,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0,0.0,1.8,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.3,1.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.1,0.7,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0
OR52E4,,ENSG00000180974,Olfactory receptor family 52 subfamily E member 4,Q8NGH9,11,5880629-5887079,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.0,Cell type enhanced,Detected in single,,Early spermatids: 1.1,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.1,0.3,0.1,0.4,0.2,0.1,1.0,0.9,0.0,0.0,0.0,0.1,0.1,0.5,0.1,0.0,0.2,0.1,0.4,0.0,0.1,0.2,0.0,0.1,0.1,0.1,0.6,0.1,0.1,0.1,0.0,0.1,0.5,0.1,0.1,0.6,0.1,0.0,0.2,0.5,0.1,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.3,0.0,0.1,0.1,0.0,0.9,0.6,0.0,0.1,0.2,0.0,0.1,0.2,0.2,0.0,0.0,0.0,0.5,0.1,0.1,0.1,0.0,0.0,0.1,0.0,0.5,0.0,0.2,0.1,0.1,0.5,0.3,0.0,0.1,0.1,0.0,0.3,0.0,0.1,0.1,0.1,0.2,0.1,0.2,0.0,0.2,0.1,0.2,0.2,0.1,0.1,0.1,0.1,0.1,0.1,0.2,0.4,0.1,0.1,0.2,0.1,0.2,0.2,0.0,0.1,0.1,0.1,0.2,0.1,0.2,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.4,1.0,0.9,0.4,0.0,0.1,0.1,0.6,0.5,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR52I1,,ENSG00000232268,Olfactory receptor family 52 subfamily I member 1,Q8NGK6,11,4593614-4596574,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,5.0,brain: 2.9,Group enriched,Detected in some,4.0,Alveolar cells type 1: 9.6;Alveolar cells type 2: 6.5;Club cells: 8.6;granulocytes: 8.8;Respiratory ciliated cells: 5.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (2.95e-1),,,,,,0.1,0.1,1.9,0.2,2.0,0.6,0.2,2.8,2.9,0.0,0.1,0.1,0.2,0.1,0.2,0.1,0.1,0.2,0.1,1.7,1.3,0.1,0.1,0.1,0.2,1.8,1.1,2.0,0.1,0.1,0.1,0.0,0.1,2.3,0.2,0.1,0.5,0.1,0.0,0.1,0.6,0.2,0.1,0.5,0.3,0.2,0.3,1.4,0.0,0.1,0.0,0.1,0.0,0.0,2.4,0.1,0.0,0.1,0.2,0.0,0.1,0.1,0.1,0.0,0.0,0.0,0.0,0.2,0.2,0.1,0.0,0.0,0.2,0.1,0.0,0.0,0.1,0.1,0.0,0.2,0.1,0.0,0.2,0.3,0.0,0.0,0.0,0.2,0.1,0.0,0.1,0.2,0.3,0.1,0.0,0.1,0.4,0.1,0.1,0.2,0.4,0.3,0.3,0.0,0.1,0.2,0.2,0.3,0.1,0.0,0.0,0.2,0.3,0.0,0.3,0.2,0.3,0.1,0.2,0.3,0.2,0.2,0.3,0.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.9,2.0,2.8,2.9,1.7,1.3,1.8,1.1,2.0,2.3,0.5,1.4,2.4,0.2,9.6,6.5,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,8.6,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.2,0.3,1.8,0.0,0.0,0.0,0.2,0.0,1.6,0.0,0.2,8.8,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,5.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.4,0.1,0.0,0.0
OR5A1,"OR5A1P, OST181",ENSG00000172320,Olfactory receptor family 5 subfamily A member 1,Q8NGJ0,11,59436469-59451380,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 2.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (1.73e-2),,0.1,0.2,0.6,0.2,1.0,0.7,0.1,2.0,1.8,0.0,0.0,0.1,0.1,0.1,0.3,0.0,0.1,0.1,0.1,0.9,0.4,0.0,0.1,0.1,0.2,0.4,0.3,0.8,0.2,0.2,0.0,0.0,0.1,0.9,0.1,0.1,0.9,0.2,0.0,0.2,0.5,0.1,0.0,0.0,0.2,0.1,0.4,0.3,0.0,0.2,0.0,0.1,0.0,0.0,2.0,0.1,0.0,0.1,0.2,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.1,0.2,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.2,0.1,0.6,0.1,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.2,0.7,0.0,0.1,0.1,0.2,0.2,0.0,0.1,0.1,0.1,0.3,0.0,0.2,0.1,0.1,0.1,0.0,0.1,0.2,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.2,0.2,0.1,0.2,0.2,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.6,1.0,2.0,1.8,0.9,0.4,0.4,0.3,0.8,0.9,0.0,0.3,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0
OR6J1,"OR6J1P, OR6J2",ENSG00000255804,Olfactory receptor family 6 subfamily J member 1,Q8NGC5,14,22630929-22644352,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.3,Cell type enhanced,Detected in single,,granulocytes: 2.5,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.1,0.6,0.2,0.5,0.6,0.1,1.3,0.7,0.0,0.2,0.0,0.1,0.1,0.2,0.0,0.1,0.1,0.1,0.6,0.8,0.1,0.0,0.1,0.1,0.6,0.4,0.4,0.1,0.2,0.0,0.0,0.1,0.7,0.1,0.0,0.8,0.2,0.0,0.3,0.3,0.1,0.0,0.2,0.2,0.1,0.1,0.5,0.0,0.1,0.0,0.0,0.0,0.0,1.1,0.1,0.0,0.1,0.1,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.2,0.2,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.3,0.1,0.1,0.5,0.2,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.2,0.1,0.1,0.2,0.0,0.1,0.2,0.1,0.0,0.0,0.2,0.2,0.1,0.2,0.1,0.1,0.1,0.1,0.0,0.2,0.1,0.1,0.2,0.0,0.1,0.1,0.2,0.0,0.1,0.1,0.8,0.1,0.2,0.1,0.1,0.1,0.0,0.1,0.1,0.0,0.1,0.1,0.1,0.6,0.2,0.1,0.1,0.1,0.1,0.6,0.5,1.3,0.7,0.6,0.8,0.6,0.4,0.4,0.7,0.2,0.5,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR6V1,GPR138,ENSG00000225781,Olfactory receptor family 6 subfamily V member 1,Q8N148,7,143052320-143053347,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,27.0,brain: 2.7,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (3.24e-2),,,,,,,,0.0,0.0,0.4,0.0,0.9,0.0,0.0,0.4,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.7,0.0,0.0,0.0,0.0,1.7,0.9,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.9,0.4,0.6,0.2,0.7,1.7,0.9,0.0,1.6,1.0,0.8,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR8A1,OST025,ENSG00000196119,Olfactory receptor family 8 subfamily A member 1,Q8NGG7,11,124566660-124582942,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Low tissue specificity,Detected in single,,,Group enriched,Detected in some,7.0,Early spermatids: 1.7;Excitatory neurons: 1.1;granulocytes: 3.8;Late spermatids: 2.6,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.1,0.0,0.5,0.2,0.5,0.9,0.4,1.0,0.8,0.0,0.1,0.1,0.1,0.1,0.2,0.1,0.0,0.2,0.1,0.4,0.3,0.1,0.8,0.1,0.2,0.4,0.2,0.2,0.2,0.2,0.2,0.0,0.1,0.5,0.2,0.1,0.5,0.2,0.0,0.0,0.6,0.3,0.1,0.1,0.2,0.2,0.3,0.4,0.0,0.2,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.1,0.2,0.1,0.1,0.5,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.1,0.2,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.1,0.1,0.0,0.2,0.2,0.5,0.1,0.3,0.1,0.2,0.1,0.1,0.1,0.1,0.0,0.1,0.0,0.1,0.3,0.1,0.1,0.1,0.0,0.1,0.1,0.0,0.2,0.1,0.1,0.1,0.1,0.3,0.1,0.1,0.1,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.5,0.5,1.0,0.8,0.4,0.3,0.4,0.2,0.2,0.5,0.1,0.4,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.1,0.0,0.0,0.0,3.8,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OR9A2,,ENSG00000179468,Olfactory receptor family 9 subfamily A member 2,Q8NGT5,7,143026158-143027195,"G-protein coupled receptors, Predicted membrane proteins","Olfaction, Sensory transduction","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,51.0,brain: 5.0,Cell type enriched,Detected in some,40.0,Oligodendrocytes: 76.5,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1.1,0.0,1.9,0.0,0.0,1.2,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,1.2,0.0,0.0,0.0,0.0,3.2,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,1.9,1.2,1.0,0.2,1.2,3.2,2.0,0.0,2.8,2.5,2.0,5.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5,76.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
OTP,,ENSG00000171540,Orthopedia homeobox,Q5XKR4,5,77628712-77638713,"Predicted intracellular proteins, Transcription factors","Differentiation, Neurogenesis, Transcription, Transcription regulation","Developmental protein, DNA-binding",,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,91.0,brain: 19.8,Cell type enhanced,Detected in some,,Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5,Cancer enriched,Detected in single,6.0,glioma: 1.2,Region enhanced,Detected in many,,hypothalamus: 19.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in many,7.0,hypothalamus: 20.0,Region enhanced,Detected in some,,hypothalamus: 15.5,HPA059342,Enhanced,Supported,Approved,"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies",,,,,,Nucleoplasm,"Nucleoli fibrillar center, Nuclear bodies",HPA059342: AB_2732635,unprognostic (1.00e-1),unprognostic (2.40e-2),,unprognostic (6.25e-2),unprognostic (8.06e-3),unprognostic (1.16e-1),,unprognostic (7.77e-2),unprognostic (7.77e-2),unprognostic (2.39e-2),unprognostic (9.66e-2),unprognostic (4.64e-2),unprognostic (7.76e-14),unprognostic (3.38e-2),unprognostic (1.84e-1),,unprognostic (9.49e-3),0.0,0.0,4.5,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.8,0.0,0.0,0.1,0.0,7.7,2.8,0.0,0.0,0.0,0.0,0.0,0.0,4.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.2,5.7,0.0,0.0,0.0,0.0,0.0,0.0,5.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.5,0.0,0.0,0.5,0.0,19.8,7.7,2.8,0.0,4.8,0.7,5.7,5.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.6,0.0,0.0,2.2,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PBOV1,"UC28, UROC28",ENSG00000254440,Prostate and breast cancer overexpressed 1,Q9GZY1,6,138215986-138218491,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,13.0,brain: 3.2,Cell type enhanced,Detected in single,,Bipolar cells: 1.2,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,"HPA063021, HPA069649",Uncertain,,Approved,"Nucleoplasm,Cytosol",,,,,,Nucleoplasm,Cytosol,"HPA063021: AB_2684923, HPA069649: ",unprognostic (3.32e-3),,,,,,,unprognostic (8.23e-2),,unprognostic (9.35e-2),unprognostic (1.22e-1),unprognostic (4.77e-2),,unprognostic (2.51e-1),,,unprognostic (1.35e-4),0.0,0.0,0.8,0.0,1.2,0.2,0.0,2.6,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.7,0.1,0.0,0.0,0.0,0.9,0.5,0.9,0.0,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,3.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.2,0.0,0.0,0.0,0.0,0.8,1.2,2.6,1.0,1.2,0.7,0.9,0.5,0.9,1.1,0.6,0.9,3.2,0.0,0.0,0.5,0.3,0.0,0.0,0.3,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.7,0.3,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.2
PCDH11Y,"PCDH22, PCDHY",ENSG00000099715,Protocadherin 11 Y-linked,Q9BZA8,Y,5000226-5742224,"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins",Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 5.4,Cell type enhanced,Detected in many,,Alveolar cells type 2: 29.1;Excitatory neurons: 52.9;Horizontal cells: 47.1;Inhibitory neurons: 88.1;Oligodendrocyte precursor cells: 54.8,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (9.26e-2),,,,,,,unprognostic (1.84e-1),unprognostic (7.64e-3),unprognostic (2.36e-2),unprognostic (3.55e-2),,,0.0,0.0,3.1,0.1,3.3,0.0,0.0,0.0,4.5,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,4.0,1.3,0.0,0.0,0.0,0.0,1.1,0.3,0.8,0.0,0.0,0.0,0.0,0.5,4.9,0.1,0.2,0.8,0.0,0.5,0.0,0.0,0.2,0.0,0.3,0.0,0.0,0.0,4.5,0.0,0.0,0.0,0.0,0.2,0.0,5.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.2,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.1,3.1,3.3,0.0,4.5,4.0,1.3,1.1,0.3,0.8,4.9,0.3,4.5,5.4,0.3,6.4,29.1,1.6,0.5,1.8,1.0,0.0,0.6,3.0,0.3,0.0,0.6,0.0,13.6,14.7,0.0,5.2,0.0,0.1,0.0,0.0,0.3,0.5,0.2,3.9,0.0,0.0,52.9,0.0,0.3,2.7,0.0,0.5,18.9,0.1,3.6,0.0,0.3,47.1,88.1,0.2,2.0,0.0,4.8,0.1,0.3,2.7,0.0,21.5,0.0,0.3,0.0,54.8,4.4,0.1,0.0,0.0,0.4,0.9,0.0,0.7,9.5,3.6,0.0,1.2,0.4,0.3,2.0,0.2,1.6,2.2,2.5,0.0,0.0,1.5
PCDHA5,"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5",ENSG00000204965,Protocadherin alpha 5,Q9Y5H7,5,140821604-141012347,Predicted membrane proteins,Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 3.4,Cell type enriched,Detected in some,4.0,Horizontal cells: 6.7,Not detected,Not detected,,,Region enhanced,Detected in some,,cerebellum: 3.4,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 1.3;EFO-21: 3.4;T-47d: 3.7;WM-115: 1.3,Low region specificity,Detected in many,,,,,,,HPA044557,Approved,,Approved,"Nuclear speckles,Plasma membrane,Mitochondria",,,,,,Plasma membrane,"Nuclear speckles, Mitochondria",HPA044557: AB_10970597,unprognostic (4.95e-2),unprognostic (6.23e-2),unprognostic (2.06e-1),unprognostic (8.81e-4),unprognostic (5.10e-2),unprognostic (6.25e-3),unprognostic (6.74e-2),unprognostic (9.79e-2),unprognostic (2.46e-2),unprognostic (4.49e-2),unprognostic (1.44e-2),unprognostic (1.10e-4),unprognostic (9.30e-4),unprognostic (1.07e-1),unprognostic (1.39e-1),unprognostic (8.17e-5),unprognostic (2.11e-1),0.1,0.1,0.3,0.0,1.0,0.0,0.1,3.4,1.1,0.1,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.8,0.3,0.1,0.0,0.1,0.0,0.1,0.2,0.8,0.1,0.2,0.0,0.5,0.0,1.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,1.3,0.4,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.7,0.8,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.0,3.7,0.0,0.0,0.0,0.6,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.3,1.0,3.4,1.1,0.8,0.3,0.1,0.2,0.8,1.0,0.3,0.1,0.8,0.3,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.3,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.0,0.0,0.0,6.7,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.2,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PCDHA7,"CNR4, CNRS4, CRNR4",ENSG00000204963,Protocadherin alpha 7,Q9UN72,5,140834248-141012347,Predicted membrane proteins,Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 3.2,Cell type enhanced,Detected in some,,Horizontal cells: 1.7;Spermatocytes: 1.7,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,NTERA-2: 1.0;SK-MEL-30: 1.2;WM-115: 1.1,,,,,,,,,,,,,,,,,,,,,,unprognostic (1.99e-1),unprognostic (8.54e-2),unprognostic (2.67e-1),unprognostic (5.28e-2),unprognostic (3.05e-1),unprognostic (7.08e-2),unprognostic (9.29e-3),unprognostic (4.11e-3),unprognostic (7.20e-2),unprognostic (3.18e-3),unprognostic (3.12e-4),unprognostic (9.54e-4),unprognostic (6.86e-5),unprognostic (5.34e-4),unprognostic (2.88e-1),unprognostic (3.72e-1),unprognostic (1.14e-1),0.1,0.1,0.4,0.0,0.6,0.0,0.2,3.2,0.9,0.2,0.0,0.2,0.1,0.3,0.1,0.0,0.1,0.2,0.0,0.4,0.5,0.2,0.0,0.2,0.0,1.2,0.9,0.5,0.3,0.3,0.1,0.4,0.0,1.0,0.1,0.0,0.4,0.1,0.0,0.0,0.0,0.1,0.1,0.5,0.1,0.1,0.9,0.2,0.0,0.1,0.0,0.0,0.1,0.1,2.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.1,0.0,0.8,1.2,0.3,0.2,0.0,0.1,0.1,0.7,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.6,3.2,0.9,0.4,0.5,1.2,0.9,0.5,1.0,0.5,0.2,2.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.1,0.3,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.8,0.1,0.3,0.0,0.0,0.0,0.0,0.6,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.7,0.4,0.0,0.0,0.2,1.7,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1
PCDHA8,,ENSG00000204962,Protocadherin alpha 8,Q9Y5H6,5,140841187-141012347,Predicted membrane proteins,Cell adhesion,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,7.0,brain: 3.7,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in some,,cerebellum: 3.7,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,6.0,AN3-CA: 12.6;SCLC-21H: 3.6,,,,,,,,,HPA044585,Uncertain,,,,,,,,,,,HPA044585: AB_10793953,unprognostic (1.11e-2),,,unprognostic (1.15e-2),unprognostic (1.35e-1),,,unprognostic (1.95e-1),unprognostic (4.20e-2),unprognostic (9.67e-2),unprognostic (8.58e-3),unprognostic (7.87e-4),unprognostic (5.62e-3),unprognostic (2.22e-2),unprognostic (5.48e-1),unprognostic (1.20e-2),,0.0,0.1,0.3,0.0,0.5,0.0,0.0,3.7,0.6,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.4,0.2,0.0,0.0,0.0,0.0,0.7,0.8,0.6,0.0,0.1,0.0,0.4,0.0,1.2,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.2,12.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.1,0.0,0.4,0.0,0.0,0.0,0.0,0.0,3.6,1.4,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.5,3.7,0.6,0.4,0.2,0.7,0.8,0.6,1.2,0.3,0.2,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PCDHGA8,"KIAA0327, PCDH-GAMMA-A8",ENSG00000253767,"Protocadherin gamma subfamily A, 8",Q9Y5G5,5,141390157-141512975,Predicted membrane proteins,Cell adhesion,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,7.0,brain: 3.9,Cell type enhanced,Detected in some,,Bipolar cells: 11.4;Cardiomyocytes: 3.5;Horizontal cells: 3.3;Skeletal myocytes: 5.2,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in all,,,,,,,"HPA008755, HPA010580",Uncertain,,Uncertain,"Nucleoplasm,Vesicles,Plasma membrane,Cytosol",,,,,,"Vesicles, Plasma membrane","Nucleoplasm, Cytosol","HPA008755: AB_1079577, HPA010580: AB_2732401",unprognostic (3.28e-2),unprognostic (2.27e-2),unprognostic (4.86e-2),unprognostic (3.38e-2),unprognostic (2.80e-1),unprognostic (4.10e-2),unprognostic (7.68e-2),unprognostic (2.30e-2),unprognostic (1.83e-2),unprognostic (2.23e-1),unprognostic (1.24e-1),unprognostic (1.35e-2),unprognostic (1.49e-3),unprognostic (7.59e-2),unprognostic (3.92e-2),unprognostic (3.38e-1),unprognostic (1.99e-3),0.1,0.1,0.7,0.1,0.7,0.4,0.1,3.9,0.9,0.2,0.3,0.1,0.0,0.2,0.2,0.1,0.1,0.1,0.3,0.9,0.6,0.1,0.1,0.1,0.1,1.1,0.7,0.5,0.3,0.1,0.0,0.2,0.2,1.3,0.1,0.1,0.5,0.1,0.0,0.3,0.3,0.1,0.1,0.4,0.1,0.1,0.1,0.8,0.1,0.4,0.1,0.1,0.1,0.1,1.9,0.0,0.0,0.3,0.1,0.2,0.6,0.1,0.6,0.4,0.4,0.1,0.0,0.1,0.3,0.2,0.4,0.1,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.3,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.2,0.0,0.0,0.1,0.2,0.7,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.6,0.2,0.4,0.6,0.6,0.2,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.3,0.7,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.4,0.1,0.0,0.1,0.0,0.0,0.7,0.7,3.9,0.9,0.9,0.6,1.1,0.7,0.5,1.3,0.4,0.8,1.9,1.2,0.0,0.6,0.0,0.1,0.0,0.9,0.0,0.0,11.4,0.3,0.3,3.5,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.6,0.1,2.1,1.2,0.0,0.0,0.0,0.6,0.0,1.1,0.0,0.2,0.0,0.3,0.4,0.7,0.1,3.3,0.0,0.0,0.0,0.3,0.0,0.0,2.1,0.2,0.0,0.0,0.0,1.3,1.0,0.0,0.0,0.1,0.1,1.5,0.0,0.7,0.0,0.2,0.0,1.7,0.0,5.2,0.9,0.7,1.1,0.0,0.0,0.0,0.1,0.5,0.0,0.5
PLPP4,"DPPL2, PPAPDC1, PPAPDC1A",ENSG00000203805,Phospholipid phosphatase 4,Q5VZY2,10,120457227-120592065,"Enzymes, Metabolic proteins, Predicted membrane proteins",Lipid metabolism,Hydrolase,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,13.0,brain: 12.0,Cell type enhanced,Detected in some,,Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0,Low cancer specificity,Detected in many,,,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,4.0,hTERT-RPE1: 14.2;U-251 MG: 10.4,Low region specificity,Detected in all,,,Low region specificity,Detected in all,,,HPA045188,Approved,,Approved,"Nucleoplasm,Nucleoli,Nucleoli rim",,,,,,"Nucleoli, Nucleoli rim",Nucleoplasm,HPA045188: AB_2679246,unprognostic (8.19e-2),unprognostic (2.94e-2),unprognostic (8.86e-2),unprognostic (1.90e-3),unprognostic (3.45e-1),unprognostic (2.92e-2),unprognostic (2.69e-1),unprognostic (2.26e-3),unprognostic (1.55e-1),unprognostic (8.62e-3),unprognostic (2.70e-3),unprognostic (1.89e-1),unprognostic (2.40e-3),unprognostic (3.49e-2),unprognostic (3.75e-2),unprognostic (1.11e-1),unprognostic (1.21e-3),0.0,0.0,3.9,0.1,3.1,0.4,0.1,6.1,3.5,0.2,0.3,0.2,0.0,0.1,0.0,0.0,0.0,0.6,0.0,4.6,7.3,0.8,0.1,0.0,0.0,9.3,4.8,1.6,0.0,0.0,0.0,0.0,0.0,12.0,0.2,0.0,0.1,0.0,0.2,0.1,0.2,0.1,0.1,4.0,0.0,0.0,0.9,3.8,0.1,0.0,0.0,0.0,0.0,0.1,6.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.3,0.2,0.0,0.3,0.1,0.0,1.7,1.4,0.0,0.1,0.1,0.1,0.1,0.5,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,14.2,1.3,0.0,0.3,0.3,0.0,0.0,0.0,0.0,0.2,0.0,0.7,0.0,0.0,0.0,0.6,0.0,0.3,0.0,0.1,0.0,0.1,0.9,0.2,0.0,2.8,1.7,1.2,0.1,10.4,0.0,0.0,0.0,2.3,0.0,0.6,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.0,3.9,3.1,6.1,3.5,4.6,7.3,9.3,4.8,1.6,12.0,4.0,3.8,6.9,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.1,0.0,0.0,11.5,0.0,3.7,0.0,0.0,0.0,0.0,7.9,0.3,10.9,0.1,2.5,0.0,0.0,9.7,0.0,0.2,0.1,0.3,0.0,0.1,0.0,0.2,1.8,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,10.7,19.3,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.4,0.0,7.9,0.0,0.5,0.0,9.0,0.0,0.0,0.0,0.0,4.9,1.5,2.1,0.0,0.0,0.0,0.1,0.0,0.0,0.4
PMIS2,IFITMD9,ENSG00000283758,PMIS2 transmembrane protein,A0A1W2PS18,19,35586161-35587296,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.5,Not detected,Not detected,,,,,,,Region enriched,Detected in single,4.0,cerebellum: 1.5,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PNMA6F,PNMA6BL,ENSG00000225110,PNMA family member 6F,A0A0J9YX94,X,153317680-153321767,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,26.0,brain: 19.9,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (6.52e-2),,,,,,,,,,unprognostic (7.19e-2),,,0.0,0.7,9.3,0.0,8.6,0.0,0.0,0.1,4.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.4,17.7,0.0,0.0,0.0,0.0,5.6,8.1,6.8,0.0,0.0,0.0,0.4,0.0,8.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,0.4,19.9,0.0,0.0,0.0,0.0,0.0,0.0,4.7,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.3,8.6,0.1,4.9,4.4,17.7,5.6,8.1,6.8,8.0,2.2,19.9,4.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
POU6F2,RPF-1,ENSG00000106536,POU class 6 homeobox 2,P78424,7,38977909-39493095,"Disease related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.9,Group enriched,Detected in some,5.0,Astrocytes: 129.3;Excitatory neurons: 471.3;Oligodendrocyte precursor cells: 286.5,Low cancer specificity,Detected in some,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,EFO-21: 1.2;Karpas-707: 1.3;NTERA-2: 2.6;SK-BR-3: 1.1;SuSa: 1.5;T-47d: 2.9;U-266/70: 2.2;U-266/84: 1.7,Low region specificity,Detected in some,,,Low region specificity,Detected in many,,,,,,,,,,,,,,,,unprognostic (6.89e-2),unprognostic (1.04e-1),unprognostic (2.48e-1),unprognostic (1.80e-4),unprognostic (1.26e-1),unprognostic (1.16e-1),unprognostic (8.68e-2),unprognostic (3.36e-1),unprognostic (1.01e-1),unprognostic (1.96e-1),unprognostic (7.22e-3),unprognostic (2.32e-1),unprognostic (1.60e-2),unprognostic (5.00e-3),unprognostic (4.46e-2),unprognostic (1.03e-1),unprognostic (1.99e-1),0.0,0.0,0.3,0.0,0.6,0.0,0.0,0.0,1.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.8,0.3,0.0,0.4,0.0,0.0,0.2,0.5,0.4,0.1,0.8,0.0,0.1,0.6,0.3,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.7,0.1,1.9,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.3,0.0,0.0,0.0,0.0,2.6,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,1.1,0.0,1.5,2.9,0.0,0.0,0.0,0.2,0.0,0.0,2.2,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.6,0.0,1.1,0.8,0.3,0.2,0.5,0.4,0.3,0.0,0.2,1.9,0.0,0.0,1.7,129.3,0.0,0.0,0.3,0.0,0.0,4.9,0.0,0.0,2.1,8.6,0.0,0.0,8.4,0.3,0.0,0.2,0.0,1.5,4.1,0.0,0.0,0.4,0.0,0.0,471.3,0.0,0.3,0.7,0.0,0.0,1.3,0.0,0.0,3.5,0.1,0.0,50.3,0.1,0.0,0.0,0.2,4.1,0.0,0.0,0.0,26.2,0.0,0.1,0.0,286.5,5.9,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,1.4,0.3,2.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0
PPIAL4H,,ENSG00000270339,Peptidylprolyl isomerase A like 4H,A0A075B767,1,146344131-146344790,"Enzymes, Predicted intracellular proteins",,"Isomerase, Rotamase",,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.5,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,11.0,THP-1: 1.2,,,,,,,,,HPA058345,Uncertain,,,,,,,,,,,HPA058345: AB_2683685,unprognostic (1.35e-1),,,,unprognostic (2.13e-3),,,unprognostic (2.34e-1),unprognostic (2.76e-2),unprognostic (2.34e-1),,,,unprognostic (2.84e-2),,,,0.0,0.0,1.0,0.0,1.0,0.0,0.1,2.5,1.6,0.0,0.5,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,1.2,1.0,0.0,0.0,0.0,0.1,0.8,1.0,1.0,0.0,0.0,0.0,0.2,0.0,1.3,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.2,0.0,0.7,0.9,0.0,0.0,0.9,0.0,0.0,0.0,0.2,0.0,0.0,1.8,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.5,1.6,1.2,1.0,0.8,1.0,1.0,1.3,0.7,0.9,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PRDM12,PFM9,ENSG00000130711,PR/SET domain 12,Q9H4Q4,9,130664594-130682986,"Disease related genes, Human disease related genes, Predicted intracellular proteins","Transcription, Transcription regulation","DNA-binding, Methyltransferase, Transferase","Disease variant, Neurodegeneration, Neuropathy",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,14.0,brain: 2.6,Cell type enhanced,Detected in some,,Cardiomyocytes: 1.6;Excitatory neurons: 1.1,Not detected,Not detected,,,Region enhanced,Detected in some,,basal ganglia: 2.6,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,23.0,RH-30: 19.1,Region enriched,Detected in some,7.0,basal ganglia: 10.9,Group enriched,Detected in some,26.0,basal ganglia: 3.8;hypothalamus: 1.3,HPA043143,Uncertain,,Approved,Nucleoplasm,Intracellular and membrane,,,,,Nucleoplasm,,HPA043143: AB_10806379,unprognostic (3.25e-2),unprognostic (2.32e-1),unprognostic (3.40e-1),unprognostic (1.81e-4),unprognostic (7.90e-2),unprognostic (4.75e-3),unprognostic (2.48e-3),unprognostic (4.18e-2),unprognostic (4.61e-1),unprognostic (2.70e-1),unprognostic (6.43e-2),unprognostic (7.58e-2),unprognostic (4.03e-3),unprognostic (3.01e-2),unprognostic (4.79e-2),unprognostic (6.30e-4),unprognostic (1.40e-1),0.0,0.0,1.0,0.0,2.6,0.0,0.0,0.3,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,1.3,0.0,0.1,0.0,0.0,0.2,0.2,0.3,0.0,0.1,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.3,0.3,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.3,0.1,0.0,0.2,0.2,0.1,0.0,0.4,0.0,0.2,0.0,0.0,0.0,0.0,0.2,0.1,0.2,0.0,0.8,0.0,0.7,0.0,0.1,0.1,0.0,19.1,0.4,0.0,0.0,0.8,0.2,0.3,0.1,0.1,0.0,0.3,0.2,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.6,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.6,0.3,0.4,0.3,1.3,0.2,0.2,0.3,0.3,0.1,0.9,0.2,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.2,0.3,1.6,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,1.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.6,0.0,0.6,0.4,0.0,0.0,0.0,0.1,0.0,0.1,0.0
PRDM13,PFM10,ENSG00000112238,PR/SET domain 13,Q9H4Q3,6,99606774-99615578,"Cancer-related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","DNA-binding, Methyltransferase, Transferase",Cancer-related genes,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.0,Group enriched,Detected in some,5.0,Bipolar cells: 4.8;Horizontal cells: 1.7;Spermatogonia: 1.8,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HEK 293: 1.8;HMC-1: 1.1;JURKAT: 2.7;RPMI-8226: 2.0;SCLC-21H: 2.3;U-266/70: 2.7;U-266/84: 1.4;WM-115: 1.3,Not detected,Not detected,,,Not detected,Not detected,,,HPA070592,Uncertain,,,,,,,,,,,HPA070592: AB_2686283,,unprognostic (4.09e-1),unprognostic (1.68e-2),unprognostic (4.30e-1),unprognostic (3.65e-1),unprognostic (1.55e-1),,unprognostic (3.16e-2),unprognostic (1.24e-2),unprognostic (2.93e-1),,,,unprognostic (1.86e-2),unprognostic (7.54e-2),,unprognostic (1.29e-1),0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.2,0.0,0.0,0.5,1.1,0.0,0.0,0.0,0.0,0.0,0.0,2.7,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.3,0.0,1.1,0.0,0.6,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,2.7,1.4,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,1.0,0.0,0.0,0.0,0.5,0.3,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.8,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PROKR2,"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2",ENSG00000101292,Prokineticin receptor 2,Q8NFJ6,20,5299218-5316954,"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer","Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.4,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Low immune cell specificity,Detected in some,,,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in some,,NTERA-2: 1.2;SH-SY5Y: 1.7,Region enhanced,Detected in many,,olfactory bulb: 17.0,Low region specificity,Detected in all,,,HPA047281,Uncertain,,,,,,,,,,,HPA047281: AB_10960057,,,,,,,,,,unprognostic (1.36e-1),,,,,unprognostic (1.69e-1),,,0.0,0.0,0.7,0.1,1.4,0.8,0.1,0.2,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.2,0.2,0.0,0.0,0.0,0.5,0.0,0.3,0.8,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.6,0.2,0.2,0.1,0.2,0.1,0.0,0.0,0.2,0.1,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.1,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,1.7,0.2,0.1,0.0,0.1,0.1,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,1.3,0.2,0.2,0.2,0.2,0.1,0.2,0.1,0.2,0.1,0.3,0.2,0.2,1.0,0.1,0.1,0.4,0.2,0.0,0.7,1.4,0.2,0.9,1.2,0.2,0.0,0.3,0.8,0.3,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PTH2,TIP39,ENSG00000142538,Parathyroid hormone 2,Q96A98,19,49422419-49423441,Predicted secreted proteins,,Neuropeptide,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,16.0,brain: 4.8,Cell type enhanced,Detected in some,,Early spermatids: 2.4;Late spermatids: 3.1;Muller glia cells: 2.4;Spermatocytes: 2.0;Spermatogonia: 2.0,Not detected,Not detected,,,Region enhanced,Detected in some,,midbrain: 4.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in single,10.0,olfactory bulb: 2.9,Low region specificity,Detected in all,,,,,,,,Secreted in brain,,,,,,,,,,,,,,,,,,,,,,unprognostic (3.41e-1),,,0.0,0.0,0.1,0.0,0.0,0.0,0.0,2.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.1,4.8,0.1,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.2,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,2.1,0.7,0.3,0.0,0.1,4.8,0.1,0.6,0.0,1.2,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.1,0.1,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,2.4,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,0.0,0.0,0.0,0.0,0.0,2.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0
PTX4,C16orf38,ENSG00000251692,Pentraxin 4,Q96A99,16,1485886-1488981,"Predicted intracellular proteins, Predicted secreted proteins",,,,Evidence at protein level,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.8,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,7.0,HL-60: 21.2;NB-4: 15.7,Region enhanced,Detected in single,,hypothalamus: 1.0,Low region specificity,Detected in all,,,HPA073694,Supported,,,,Secreted - unknown location,,,,,,,HPA073694: AB_2732237,unprognostic (1.04e-1),unprognostic (2.66e-1),unprognostic (1.54e-2),unprognostic (1.55e-2),unprognostic (1.12e-1),unprognostic (1.84e-4),unprognostic (3.98e-2),unprognostic (5.66e-2),unprognostic (1.10e-1),unprognostic (3.09e-1),unprognostic (1.39e-2),unprognostic (3.54e-1),unprognostic (1.52e-4),unprognostic (2.23e-3),unprognostic (4.53e-1),unprognostic (1.71e-1),unprognostic (1.03e-1),0.0,0.2,0.5,0.0,0.2,0.7,0.0,0.7,0.3,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.7,0.0,0.0,0.0,0.0,1.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.5,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,21.2,0.1,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.0,15.7,0.1,0.0,0.1,0.8,0.0,0.0,0.0,0.0,0.4,0.0,0.2,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,2.8,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.5,0.2,0.7,0.3,0.2,0.7,1.0,1.2,0.0,1.8,0.0,1.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
PYDC2,POP2,ENSG00000253548,Pyrin domain containing 2,Q56P42,3,191461163-191461456,Predicted intracellular proteins,"Immunity, Inflammatory response, Innate immunity",Signal transduction inhibitor,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,22.0,brain: 2.1,Not detected,Not detected,,,Not detected,Not detected,,,Region enhanced,Detected in some,,cerebral cortex: 2.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,11.0,A549: 1.1,,,,,Not detected,Not detected,,,HPA055895,Uncertain,,,,,,,,,,,HPA055895: AB_2682962,,,,,,,,,,,,,,,,,,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,2.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.6,0.0,0.0,0.0,0.0,0.1,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,2.1,0.6,0.6,0.1,0.0,1.1,0.1,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0
RAB40AL,"RAR2, RLGP",ENSG00000102128,RAB40A like,P0C0E4,X,102937272-102938300,"Disease related genes, Predicted intracellular proteins",Ubl conjugation pathway,,"Deafness, Disease variant, Mental retardation",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.1,Cell type enhanced,Detected in some,,Bipolar cells: 1.8;Cone photoreceptor cells: 2.1;Enteroendocrine cells: 3.0;Hepatic stellate cells: 2.2;Horizontal cells: 1.7,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA076172,,,Uncertain,Vesicles,,,,,,Vesicles,,HPA076172: ,unprognostic (1.99e-1),unprognostic (3.05e-1),unprognostic (1.31e-1),unprognostic (1.11e-2),unprognostic (1.24e-1),unprognostic (1.04e-1),unprognostic (2.91e-1),unprognostic (1.39e-1),unprognostic (3.49e-1),unprognostic (1.83e-1),unprognostic (1.15e-1),unprognostic (2.18e-2),unprognostic (5.90e-10),unprognostic (4.74e-1),unprognostic (1.32e-1),unprognostic (5.02e-3),unprognostic (2.64e-2),0.1,0.1,0.5,0.0,0.4,0.0,0.1,0.1,1.1,0.1,0.2,0.1,0.1,0.2,0.3,0.1,0.1,0.0,0.1,0.5,0.2,0.1,0.2,0.1,0.0,0.3,0.0,0.3,0.2,0.1,0.0,0.2,0.0,0.5,0.2,0.0,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.1,0.1,0.1,0.0,0.2,0.0,0.0,0.1,0.1,0.8,0.1,0.1,0.1,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.1,0.0,0.2,0.0,0.1,0.0,0.3,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.2,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.5,0.4,0.1,1.1,0.5,0.2,0.3,0.0,0.3,0.5,0.0,0.1,0.8,0.2,0.0,0.0,0.0,0.4,0.1,0.1,0.0,1.2,1.8,0.1,0.1,0.1,0.0,0.0,0.0,2.1,0.9,1.3,0.6,0.0,0.0,0.1,0.1,0.2,0.4,3.0,0.4,0.0,0.0,0.3,0.3,0.0,0.1,0.0,0.1,2.2,0.9,0.4,1.7,0.0,0.2,0.0,0.8,0.0,1.0,1.5,0.2,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.1,0.3,1.5,0.0,0.5,0.4,0.0,0.0,0.6,0.0,1.2,0.1,0.3,0.3,0.1,0.0,0.7,0.0,0.1,0.6,0.3
RTP1,"MGC35450, Z3CXXC1",ENSG00000175077,Receptor transporter protein 1,P59025,3,187197486-187201462,Predicted membrane proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.3,Cell type enhanced,Detected in some,,Early spermatids: 3.3;Late spermatids: 1.9;Spermatocytes: 4.5,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,32.0,SuSa: 4.0;T-47d: 2.6,Low region specificity,Detected in some,,,Low region specificity,Detected in many,,,,,,,,,,,,,,,,,,,unprognostic (2.90e-1),unprognostic (1.60e-1),unprognostic (3.29e-1),,unprognostic (1.91e-1),,,,unprognostic (2.63e-1),,,unprognostic (2.89e-1),,,0.0,0.0,1.2,0.0,1.3,0.0,0.0,0.3,1.1,0.0,0.3,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.9,2.3,0.0,0.0,0.0,0.0,0.5,1.0,0.8,0.0,0.0,0.0,0.0,0.0,0.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.5,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.6,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,1.3,0.3,1.1,0.9,2.3,0.5,1.0,0.8,0.4,0.4,2.0,1.9,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.3,0.1,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
RXFP3,"GPCR135, RLN3R1, RXFPR3, SALPR",ENSG00000182631,Relaxin family peptide receptor 3,Q9NSD7,5,33936386-33938918,"G-protein coupled receptors, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.8,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA027833,Uncertain,,,,,,,,,,,HPA027833: AB_1849247,unprognostic (1.93e-2),,,,,unprognostic (3.66e-1),,unprognostic (2.89e-1),,unprognostic (2.86e-1),unprognostic (9.68e-2),unprognostic (1.72e-1),,unprognostic (8.67e-3),,,,0.0,0.9,0.9,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,2.8,0.0,0.0,0.0,0.0,0.9,2.1,0.0,0.0,0.1,0.0,0.1,0.0,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.1,0.0,0.1,0.1,2.8,0.9,2.1,0.0,0.6,0.1,1.6,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SCART1,CD163c-alpha,ENSG00000214279,Scavenger receptor family member expressed on T cells 1,Q4G0T1,10,133453928-133523558,Predicted membrane proteins,Immunity,,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.1,Cell type enriched,Detected in some,4.0,Cardiomyocytes: 7.4,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,HMC-1: 3.7;NB-4: 3.6;THP-1: 1.1;U-266/84: 4.0,Not detected,Not detected,,,Not detected,Not detected,,,HPA043101,Supported,,,,,,,,,,,HPA043101: AB_10797026,unprognostic (4.32e-2),unprognostic (2.15e-2),unprognostic (1.13e-2),unprognostic (2.40e-2),unprognostic (7.42e-2),unprognostic (8.20e-4),unprognostic (1.29e-3),unprognostic (4.28e-3),unprognostic (2.63e-2),unprognostic (1.68e-1),unprognostic (2.91e-1),unprognostic (2.24e-2),unprognostic (6.24e-5),unprognostic (8.53e-2),unprognostic (1.25e-1),unprognostic (5.03e-2),unprognostic (1.94e-1),0.0,0.1,0.3,0.0,0.5,0.2,0.1,1.0,1.1,0.1,0.6,0.1,0.1,0.1,0.0,0.0,0.2,0.0,0.0,0.8,0.4,0.1,0.1,0.1,0.0,0.3,0.3,0.3,0.0,0.1,0.0,0.1,0.0,0.3,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.2,0.1,0.1,0.1,0.4,0.0,0.1,0.0,0.0,0.1,0.0,0.6,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.3,0.1,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.2,0.2,0.4,0.0,0.0,0.0,0.1,3.7,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.2,3.6,0.1,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.2,0.0,0.2,0.2,4.0,0.5,0.0,0.0,0.2,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.5,1.0,1.1,0.8,0.4,0.3,0.3,0.3,0.3,0.2,0.4,0.6,0.8,0.0,1.5,1.0,0.1,0.0,0.0,0.0,0.0,0.0,0.5,0.6,7.4,0.0,0.0,0.0,0.0,0.0,0.8,0.2,0.0,0.2,0.0,0.9,0.8,0.5,0.0,0.0,1.3,0.2,0.0,0.4,0.0,0.6,0.0,1.1,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.2,1.1,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,1.5,0.6,0.1,0.0
SCYGR1,KRTAP28-1,ENSG00000284629,Small cysteine and glycine repeat containing 1,A0A286YEY9,2,227387683-227387949,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.4,Not detected,Not detected,,,,,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,0.4,0.0,0.8,0.0,0.0,0.4,0.7,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.4,0.0,0.0,0.0,0.0,0.7,0.6,0.3,0.0,0.0,0.0,,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.8,0.4,0.7,0.4,0.4,0.7,0.6,0.3,0.9,0.5,0.5,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SKOR2,"CORL2, Fussel-18, FUSSEL18",ENSG00000215474,SKI family transcriptional corepressor 2,Q2VWA4,18,47206169-47251660,Predicted intracellular proteins,"Transcription, Transcription regulation",Repressor,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.0,Group enriched,Detected in some,4.0,Bipolar cells: 1.8;Spermatocytes: 2.5;Spermatogonia: 5.7,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,5.0,NTERA-2: 3.9,Region enriched,Detected in single,5.0,cerebellum: 2.4,Not detected,Not detected,,,HPA046206,Uncertain,,,,,,,,,,,HPA046206: AB_2679588,,,,,unprognostic (1.53e-1),,,,,unprognostic (1.93e-1),,,,unprognostic (1.92e-1),unprognostic (6.31e-2),,,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.5,2.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.5,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.7,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.9,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.5,2.0,0.7,0.5,1.8,0.0,0.0,0.8,1.2,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,2.5,5.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1
SLC26A5,"DFNB61, PRES",ENSG00000170615,Solute carrier family 26 member 5,P58743,7,103352730-103446207,"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters","Cell shape, Hearing",Motor protein,"Deafness, Non-syndromic deafness",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 2.2,Cell type enhanced,Detected in some,,Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2,Low cancer specificity,Detected in single,,,Region enhanced,Detected in some,,cerebellum: 2.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in many,4.0,basal ganglia: 10.4,,,,,,,,,,,,,,unprognostic (3.86e-2),unprognostic (5.13e-2),unprognostic (6.38e-3),unprognostic (2.76e-2),unprognostic (1.02e-2),unprognostic (5.09e-2),unprognostic (2.36e-1),unprognostic (3.56e-4),unprognostic (4.21e-3),unprognostic (8.92e-3),unprognostic (2.82e-1),unprognostic (2.97e-1),unprognostic (3.67e-5),unprognostic (3.05e-1),unprognostic (2.81e-1),unprognostic (2.94e-2),unprognostic (2.69e-3),0.1,0.1,0.3,0.0,0.3,0.0,0.8,2.2,0.2,0.1,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.4,0.0,0.2,0.4,0.1,0.4,0.4,0.0,0.0,0.2,0.3,0.0,0.0,1.2,0.4,0.0,0.1,0.2,0.0,0.0,0.2,0.0,0.0,0.4,0.1,0.6,0.2,0.2,0.0,0.2,0.0,0.0,0.3,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.3,2.2,0.2,0.1,0.4,0.4,0.4,0.0,1.2,0.4,0.2,0.5,0.3,6.4,2.6,5.5,0.2,0.3,0.0,0.0,0.0,0.2,0.3,0.1,0.7,0.0,0.6,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.2,0.4,0.2,0.5,0.0,0.0,4.1,0.0,0.0,2.2,7.1,0.2,0.0,0.0,5.3,0.0,0.0,0.0,3.5,0.0,0.0,0.3,0.3,0.0,0.3,0.0,0.0,6.5,0.0,0.3,0.0,2.0,4.2,0.3,0.0,0.0,0.0,0.8,0.0,0.0,2.2,1.2,0.0,0.2,0.1,0.3,0.5,0.0,0.3,0.0,0.6,0.0,0.0,0.6
SLC35D3,FRCL1,ENSG00000182747,Solute carrier family 35 member D3,Q5M8T2,6,136922301-136925660,"Predicted membrane proteins, Transporters","Sugar transport, Transport",,,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 3.4,Cell type enriched,Detected in single,9.0,Ionocytes: 8.2,Group enriched,Detected in some,5.0,colorectal cancer: 3.3;stomach cancer: 0.9,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,4.0,SH-SY5Y: 15.4,Group enriched,Detected in many,5.0,basal ganglia: 29.6;olfactory bulb: 8.5,Region enriched,Detected in many,6.0,basal ganglia: 20.1,"HPA030431, HPA067497",Uncertain,,Approved,Centriolar satellite,,,,,,Centriolar satellite,,"HPA030431: AB_10601716, HPA067497: AB_2685854",unprognostic (6.56e-2),unprognostic (2.97e-1),unprognostic (1.43e-1),unprognostic (5.45e-2),unprognostic (1.08e-1),unprognostic (5.84e-2),,unprognostic (2.48e-1),,unprognostic (9.94e-2),unprognostic (7.36e-2),unprognostic (4.65e-2),,unprognostic (1.37e-1),unprognostic (1.62e-1),unprognostic (4.45e-1),unprognostic (1.03e-1),0.0,0.9,0.3,0.0,2.2,0.2,0.0,0.0,1.2,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.2,0.0,0.0,0.4,0.0,1.1,2.0,0.2,0.0,0.4,0.0,0.0,0.0,1.7,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.6,0.0,3.4,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,3.6,15.4,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.3,2.2,0.0,1.2,0.0,3.2,1.1,2.0,0.2,1.7,0.1,3.4,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,8.2,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.1,0.5,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.1,0.0,0.0,0.3,0.0,0.1,0.1,0.1
SLC38A8,,ENSG00000166558,Solute carrier family 38 member 8,A6NNN8,16,84009667-84042795,"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters","Amino-acid transport, Ion transport, Sodium transport, Transport",,Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at transcript level,Evidence at protein level,Tissue enriched,Detected in single,5.0,brain: 3.7,Cell type enriched,Detected in some,4.0,Late spermatids: 16.1,Cancer enriched,Detected in single,14.0,melanoma: 6.5,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,SCLC-21H: 2.5,Low region specificity,Detected in single,,,Not detected,Not detected,,,,,,,,,,,,,,,,unprognostic (9.69e-2),unprognostic (6.16e-2),,unprognostic (8.00e-3),unprognostic (6.40e-2),unprognostic (1.03e-1),unprognostic (8.20e-3),unprognostic (1.89e-1),unprognostic (7.70e-2),unprognostic (2.59e-1),unprognostic (2.16e-2),,unprognostic (3.54e-2),unprognostic (1.37e-1),unprognostic (1.45e-1),,,0.0,0.1,3.7,0.0,3.0,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.4,1.2,0.7,0.0,0.1,0.0,0.0,1.4,1.6,1.2,0.0,0.2,0.1,0.7,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.3,0.4,2.0,0.5,0.0,0.1,0.0,0.0,0.0,1.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.4,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.7,3.0,0.0,1.3,1.2,0.7,1.4,1.6,1.2,1.3,0.4,2.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.2,0.0,0.1,0.0,0.0,0.6,0.2,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,1.0,0.0,1.4,0.0,0.0,0.0,0.0,16.1,0.6,0.0,0.0,0.0,0.0,0.3,0.0,0.5,0.2,0.0,0.0,0.4,0.0,0.1,0.0,0.0,0.0,0.4,0.0,0.1,0.0,0.7,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SLC6A3,"DAT, DAT1",ENSG00000142319,Solute carrier family 6 member 3,Q01959,5,1392794-1445440,"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",,"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,64.0,brain: 53.8,Cell type enhanced,Detected in some,,Alveolar cells type 2: 2.3;Cardiomyocytes: 1.2;Smooth muscle cells: 1.4,Cancer enriched,Detected in some,18.0,renal cancer: 25.7,Region enriched,Detected in some,17.0,midbrain: 53.8,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,8.0,midbrain: 80.6;thalamus: 29.0,Region enriched,Detected in some,152.0,midbrain: 302.6,"HPA012763, HPA013602, CAB016249, CAB078172",Enhanced,Supported,Approved,Vesicles,,,,,,Vesicles,,"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484",unprognostic (2.25e-4),unprognostic (2.22e-1),unprognostic (8.45e-2),unprognostic (5.24e-2),unprognostic (7.75e-2),unprognostic (1.41e-2),unprognostic (4.64e-5),unprognostic (9.31e-2),unprognostic (7.89e-2),unprognostic (4.81e-2),unprognostic (1.30e-1),unprognostic (2.12e-2),prognostic unfavorable (3.40e-7),unprognostic (6.98e-2),unprognostic (1.64e-1),unprognostic (2.22e-2),unprognostic (4.74e-2),0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.2,0.0,0.0,0.0,0.4,0.0,0.0,0.2,0.0,0.0,0.0,0.3,0.1,0.0,0.3,0.0,3.2,53.8,0.0,0.4,0.0,0.0,0.0,0.0,0.7,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.3,3.0,0.1,0.8,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.3,3.2,53.8,0.0,0.7,0.0,3.0,0.0,0.0,0.0,2.3,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.3,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,0.1,0.5,0.0,0.0,0.0,0.1,0.1,0.0,0.0
SLC6A5,"GLYT2, NET1",ENSG00000165970,Solute carrier family 6 member 5,Q9Y345,11,20599594-20659285,"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters","Neurotransmitter transport, Symport, Transport",,Disease variant,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,20.0,brain: 20.2,Group enriched,Detected in some,39.0,Early spermatids: 20.6;Late spermatids: 66.9,Not detected,Not detected,,,Region enhanced,Detected in many,,medulla oblongata: 20.2,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Region enriched,Detected in some,9.0,pons and medulla: 49.3,Group enriched,Detected in many,8.0,medulla oblongata: 30.5;spinal cord: 18.3,CAB079052,,Supported,,,,,,,,,,CAB079052: ,,,,,unprognostic (6.94e-2),unprognostic (2.28e-1),,,,,,,,,unprognostic (4.75e-2),,,0.0,0.0,3.6,0.0,1.1,0.0,0.0,1.2,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.9,0.0,20.2,0.6,0.0,0.0,0.0,0.0,0.6,0.0,18.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.7,0.0,0.0,0.3,6.3,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.6,1.1,1.2,1.2,0.1,0.0,20.2,0.6,0.0,18.4,7.7,6.3,3.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.6,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,66.9,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.4,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SMCO2,"C12orf70, LOC341346",ENSG00000165935,Single-pass membrane protein with coiled-coil domains 2,A6NFE2,12,27466810-27502185,Predicted membrane proteins,,,,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 1.5,Cell type enhanced,Detected in some,,Early spermatids: 14.8;Excitatory neurons: 9.4;Inhibitory neurons: 3.7;Late spermatids: 5.7;Prostatic glandular cells: 4.4,Low cancer specificity,Detected in some,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,CAPAN-2: 1.4;HDLM-2: 2.2,Not detected,Not detected,,,Not detected,Not detected,,,HPA014366,Uncertain,,,,,,,,,,,HPA014366: AB_1845544,unprognostic (2.64e-2),unprognostic (3.11e-1),unprognostic (1.33e-2),unprognostic (4.10e-2),unprognostic (4.44e-3),unprognostic (1.98e-2),unprognostic (7.86e-3),unprognostic (5.44e-3),unprognostic (2.81e-1),unprognostic (8.86e-2),unprognostic (9.21e-5),unprognostic (2.59e-1),unprognostic (7.02e-3),unprognostic (5.48e-2),unprognostic (3.01e-1),unprognostic (3.65e-1),unprognostic (1.69e-1),0.0,0.1,0.8,0.4,0.7,0.0,0.1,0.4,0.9,0.0,0.4,0.1,0.0,0.0,0.0,0.6,0.0,0.1,0.0,0.7,0.5,0.0,0.2,0.1,0.1,0.5,1.1,0.6,0.0,0.0,0.0,0.0,0.1,0.6,0.0,0.0,0.0,0.1,0.0,0.0,0.5,0.0,0.1,0.4,0.0,0.3,0.9,1.5,0.1,0.0,0.0,0.4,0.2,0.3,0.8,0.9,0.2,0.0,0.0,0.0,0.0,0.9,0.1,0.0,0.0,0.6,0.0,1.4,0.0,0.3,0.0,0.5,0.2,0.1,0.2,0.4,2.2,0.0,0.0,0.5,0.0,0.0,0.8,0.1,0.4,0.2,0.3,1.2,0.3,0.7,0.3,0.0,0.6,0.0,0.1,0.3,0.9,0.3,0.6,0.7,0.3,0.0,0.0,0.2,0.3,0.2,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.3,0.6,0.3,0.7,1.2,0.0,0.1,0.0,0.2,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.7,0.4,0.9,0.7,0.5,0.5,1.1,0.6,0.6,0.4,1.5,0.8,0.2,0.0,0.0,0.3,0.0,0.3,0.6,0.4,0.0,0.0,0.1,0.1,0.3,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,1.7,14.8,0.2,0.0,0.2,0.0,0.0,9.4,0.8,0.1,0.1,0.0,0.4,0.0,0.4,0.0,0.0,0.0,0.0,3.7,0.2,0.0,0.0,1.1,5.7,0.0,0.1,0.0,1.0,0.0,0.0,0.0,0.0,0.1,1.5,0.0,0.4,0.0,4.4,0.2,0.4,0.3,0.0,0.0,0.0,0.3,0.7,0.0,0.0,0.3,0.0,0.0,0.0,0.1,2.3
SMIM43,,ENSG00000164112,Small integral membrane protein 43,Q4W5P6,4,121758881-121765427,Predicted intracellular proteins,,,,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,14.0,brain: 6.3,Group enriched,Detected in some,9.0,Cytotrophoblasts: 16.7;Syncytiotrophoblasts: 4.5,Low cancer specificity,Detected in single,,,Region enhanced,Detected in many,,basal ganglia: 6.3,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,7.0,MOLT-4: 3.2,Region enhanced,Detected in many,,cerebral cortex: 24.8,,,,,,,,,,,,,,,,,,unprognostic (9.67e-3),unprognostic (3.25e-3),unprognostic (3.13e-2),unprognostic (1.09e-1),unprognostic (1.61e-1),unprognostic (5.73e-3),unprognostic (3.63e-2),unprognostic (1.49e-2),unprognostic (1.19e-1),unprognostic (2.42e-3),unprognostic (4.40e-3),unprognostic (1.38e-1),unprognostic (3.82e-7),unprognostic (1.06e-1),unprognostic (1.81e-1),unprognostic (1.02e-2),unprognostic (2.04e-1),0.0,0.0,0.6,0.0,6.3,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.2,2.0,0.3,2.2,0.0,0.0,0.0,,0.4,1.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,3.2,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,6.3,0.0,2.5,1.0,0.0,2.0,0.3,2.2,1.1,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,16.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.9,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.5,0.0,0.0,0.0,0.0
SOX1,,ENSG00000182968,SRY-box transcription factor 1,O00570,13,112067149-112071706,"Cancer-related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Activator, DNA-binding",Cancer-related genes,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,11.0,brain: 9.4,Group enriched,Detected in some,11.0,Cardiomyocytes: 4.0;Melanocytes: 3.6;Spermatogonia: 2.4,Group enriched,Detected in some,6.0,colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,5.0,AF22: 29.3,Low region specificity,Detected in all,,,,,,,,,,,,,,,,,,,,,,unprognostic (1.12e-1),,unprognostic (4.95e-2),unprognostic (1.71e-3),,,unprognostic (6.03e-2),unprognostic (6.41e-2),,,,unprognostic (4.85e-1),unprognostic (5.93e-2),,,0.0,0.0,2.8,0.0,3.9,0.0,0.0,1.5,2.7,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,5.2,0.0,0.0,0.0,0.0,1.9,1.9,1.8,0.0,0.0,0.0,0.1,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,1.1,0.0,0.0,0.8,9.4,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,29.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,3.9,1.5,2.7,1.7,5.2,1.9,1.9,1.8,1.7,1.1,9.4,1.5,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,3.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,2.4,0.0,0.1,0.0,0.0,0.0,0.0,0.1
SOX11,,ENSG00000176887,SRY-box transcription factor 11,P35716,2,5692384-5701385,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors","Differentiation, Neurogenesis, Transcription, Transcription regulation","Activator, Developmental protein, DNA-binding","Disease variant, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 4.4,Cell type enhanced,Detected in some,,Breast glandular cells: 6.4;Breast myoepithelial cells: 8.6;Cardiomyocytes: 13.9;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 21.6;Skeletal myocytes: 38.8,Cancer enhanced,Detected in many,,glioma: 8.5,Low region specificity,Detected in all,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AF22: 47.2;NTERA-2: 23.6;REH: 17.9;RH-30: 18.2;SCLC-21H: 29.1;SH-SY5Y: 44.0,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,"HPA000448, HPA000536, CAB056152, CAB056153",Approved,,Supported,"Nucleoplasm,Plasma membrane",,,,,,Nucleoplasm,Plasma membrane,"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060",unprognostic (2.17e-2),unprognostic (2.02e-2),unprognostic (1.44e-2),unprognostic (7.35e-6),unprognostic (2.79e-1),unprognostic (1.19e-1),unprognostic (4.04e-8),unprognostic (2.79e-2),unprognostic (7.27e-2),unprognostic (3.17e-1),unprognostic (3.35e-3),unprognostic (2.42e-1),unprognostic (8.45e-8),unprognostic (1.35e-1),unprognostic (1.96e-1),unprognostic (5.50e-3),unprognostic (7.47e-2),0.0,0.0,2.4,0.0,3.0,0.0,0.0,1.5,2.0,0.0,0.3,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.3,1.3,4.4,0.0,0.0,0.0,0.0,2.3,3.1,1.2,0.0,0.0,0.0,0.2,0.0,1.9,0.0,0.1,0.2,0.1,0.0,0.1,0.0,0.2,0.2,3.2,0.1,0.0,0.0,3.5,0.0,0.0,0.1,0.0,0.0,0.0,3.1,0.0,0.0,47.2,0.0,0.0,0.0,0.0,2.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.3,0.0,0.0,0.6,0.0,0.0,0.0,1.5,0.0,2.3,0.0,0.0,4.4,0.0,0.0,0.0,23.6,0.0,0.0,17.9,18.2,0.7,0.0,0.0,29.1,44.0,0.0,0.3,0.0,8.2,0.0,0.0,0.0,0.6,0.2,0.0,0.0,3.3,0.6,1.2,0.0,0.0,11.1,0.7,0.1,0.1,0.0,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.1,0.2,0.2,0.2,0.1,0.1,0.1,2.4,3.0,1.5,2.0,1.3,4.4,2.3,3.1,1.2,1.9,3.2,3.5,3.1,0.4,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.1,6.4,8.6,13.9,0.0,0.6,0.0,0.0,0.2,0.0,0.0,0.0,5.7,0.9,0.0,0.8,1.2,0.0,0.0,0.4,0.0,0.2,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,8.4,0.0,0.0,0.0,0.3,0.2,0.0,0.2,0.0,1.0,0.0,0.5,0.0,21.6,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.3,0.0,38.8,1.1,0.0,0.2,0.0,0.0,0.3,0.1,0.1,0.0,0.0
SP9,ZNF990,ENSG00000217236,Sp9 transcription factor,P0CG40,2,174334954-174338500,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 3.0,Cell type enriched,Detected in some,5.0,Inhibitory neurons: 11.1,Cancer enhanced,Detected in some,,endometrial cancer: 1.0,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,A549: 7.2;fHDF/TERT166: 5.5;HEK 293: 2.2;THP-1: 11.6,Group enriched,Detected in many,6.0,basal ganglia: 5.8;olfactory bulb: 11.7,Group enriched,Detected in many,4.0,basal ganglia: 5.6;olfactory bulb: 21.6,HPA062616,Uncertain,,Approved,Mitochondria,,,,,,Mitochondria,,HPA062616: AB_2684808,unprognostic (2.04e-2),unprognostic (6.94e-3),,unprognostic (1.44e-1),unprognostic (3.95e-1),unprognostic (7.55e-3),,unprognostic (8.54e-2),unprognostic (3.12e-1),,,,,,unprognostic (1.01e-1),,,0.0,0.0,2.5,0.0,3.0,0.0,0.2,0.0,2.8,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.8,0.0,0.0,0.6,0.9,0.0,0.0,0.0,0.0,1.3,0.3,1.2,0.0,0.0,0.0,0.0,0.1,0.7,0.0,0.0,0.0,0.3,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.4,0.6,0.0,0.0,0.6,0.0,0.0,0.0,0.4,0.2,7.2,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,5.5,0.0,0.1,0.2,0.0,0.0,0.0,2.2,0.5,0.0,0.0,0.0,0.4,0.0,0.4,0.0,0.0,0.0,0.0,0.0,1.1,0.6,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.3,1.0,0.0,0.0,0.0,1.1,0.0,0.1,0.0,0.0,0.0,0.0,11.6,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.5,3.0,0.0,2.8,0.6,0.9,1.3,0.3,1.2,0.7,0.0,0.6,0.4,0.2,0.0,0.0,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.1,0.2,0.1,0.0,0.0,0.1,0.0,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.1,0.0,0.0,0.0,1.3,0.5,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.7,0.5,0.0,0.1,0.0,0.1,0.1,0.0,0.0
SSTR4,,ENSG00000132671,Somatostatin receptor 4,P31391,20,23035312-23039237,"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins",,"G-protein coupled receptor, Receptor, Transducer",FDA approved drug targets,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,10.0,brain: 1.1,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA064252,Uncertain,,,,,,,,,,,HPA064252: AB_2685227,,,,,,,,,,,,,,,,,,0.0,0.0,0.6,0.0,0.7,0.0,0.0,0.6,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.2,0.0,0.0,0.1,0.0,0.2,0.1,0.5,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.7,0.6,0.8,1.1,0.2,0.2,0.1,0.5,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SSX5,,ENSG00000165583,SSX family member 5,O60225,X,48186220-48196795,Predicted intracellular proteins,"Transcription, Transcription regulation",,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.1,Cell type enriched,Detected in single,7.0,Spermatogonia: 5.8,Not detected,Not detected,,,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,9.0,BEWO: 4.7,,,,,,,,,"HPA045683, HPA071685",Supported,,Approved,"Nucleoplasm,Nucleoli",,,,,,"Nucleoplasm, Nucleoli",,"HPA045683: AB_2679418, HPA071685: ",,,,,,,,,unprognostic (1.20e-1),,,,,,unprognostic (2.96e-1),unprognostic (1.23e-1),,0.0,0.0,0.7,0.0,0.5,0.2,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.2,0.5,0.2,0.0,0.0,0.0,0.0,0.5,0.3,0.5,0.0,0.0,0.1,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.4,0.7,0.0,0.0,0.1,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.1,0.0,0.0,4.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.5,0.0,0.7,0.5,0.2,0.5,0.3,0.5,0.8,0.0,0.7,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,5.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0
SSX7,,ENSG00000187754,SSX family member 7,Q7RTT5,X,52644061-52654900,Predicted intracellular proteins,"Transcription, Transcription regulation",,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.6,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,HMC-1: 2.3;RT4: 1.7,,,,,,,,,"HPA045683, HPA071685",Approved,,Approved,"Nucleoplasm,Nucleoli",,,,,,"Nucleoplasm, Nucleoli",,"HPA045683: AB_2679418, HPA071685: ",,,,,,,,,,,,,,,,unprognostic (1.29e-1),,0.0,0.0,0.4,0.1,0.4,0.2,0.0,1.0,0.7,0.0,0.0,0.1,0.1,0.0,0.0,0.3,0.1,0.1,0.0,0.2,0.2,0.0,0.0,0.1,0.1,0.7,0.6,0.2,0.2,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.7,0.3,0.0,0.0,0.3,0.0,0.0,0.4,0.1,0.1,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.2,0.1,0.7,0.4,0.1,0.0,0.0,2.3,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.5,0.0,0.4,0.2,0.1,0.0,0.0,0.0,0.1,0.2,0.0,0.0,1.7,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.1,0.0,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.4,1.0,0.7,0.2,0.2,0.7,0.6,0.2,0.8,0.4,0.5,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0
STH,MAPTIT,ENSG00000256762,Saitohin,Q8IWL8,17,45999250-45999694,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,8.0,brain: 4.8,Group enriched,Detected in some,6.0,Bipolar cells: 3.0;Cone photoreceptor cells: 2.1;Horizontal cells: 5.0,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (1.24e-1),,,,unprognostic (3.22e-1),,,,,,,,,,,,,0.0,0.0,1.1,0.0,2.0,0.0,0.3,2.7,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.1,0.0,0.0,0.0,0.0,1.6,0.6,0.3,0.0,0.0,0.0,0.1,0.3,1.6,0.0,0.0,0.5,0.1,0.0,0.6,0.1,0.0,0.0,0.0,0.0,0.0,0.1,1.2,0.0,0.0,0.0,0.0,0.0,0.0,4.8,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,2.0,2.7,1.3,1.2,0.1,1.6,0.6,0.3,1.6,0.0,1.2,4.8,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,3.0,0.3,0.0,0.0,0.0,0.0,0.0,2.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.4,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TAS2R3,T2R3,ENSG00000127362,Taste 2 receptor member 3,Q9NYW6,7,141764097-141765197,"G-protein coupled receptors, Predicted membrane proteins","Sensory transduction, Taste","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,7.0,brain: 3.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,unprognostic (4.11e-2),,,,,,,unprognostic (2.27e-1),,unprognostic (4.40e-2),unprognostic (7.38e-2),,unprognostic (4.04e-1),unprognostic (1.51e-2),unprognostic (3.62e-2),unprognostic (1.53e-1),,0.0,0.0,1.3,0.0,1.7,0.0,0.3,3.0,1.4,0.1,0.0,0.0,0.0,0.1,0.3,0.0,0.1,0.0,0.0,1.2,1.5,0.0,0.0,0.0,0.2,1.1,1.2,0.8,0.4,0.1,0.0,0.0,0.0,1.9,0.0,0.0,0.3,0.1,0.0,0.0,0.3,0.1,0.0,0.5,0.0,0.0,0.0,1.2,0.1,0.1,0.0,0.1,0.0,0.1,1.4,0.0,0.1,0.1,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.7,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,1.3,1.7,3.0,1.4,1.2,1.5,1.1,1.2,0.8,1.9,0.5,1.2,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TAS2R30,"T2R30, TAS2R47",ENSG00000256188,Taste 2 receptor member 30,P59541,12,11132958-11134644,"G-protein coupled receptors, Predicted membrane proteins","Sensory transduction, Taste","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enhanced,Detected in single,,brain: 2.9,Cell type enhanced,Detected in some,,Cone photoreceptor cells: 8.4;Endothelial cells: 2.3;Granulosa cells: 2.0;Horizontal cells: 3.3,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (7.19e-3),unprognostic (2.15e-2),,,unprognostic (1.19e-1),,,unprognostic (3.17e-1),,unprognostic (1.71e-1),,unprognostic (4.02e-1),unprognostic (7.01e-6),unprognostic (4.48e-2),unprognostic (1.26e-1),unprognostic (1.11e-1),unprognostic (4.14e-1),0.0,0.0,0.5,0.0,0.9,0.1,0.1,2.9,1.1,0.1,0.7,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.6,0.9,0.0,0.0,0.0,0.0,0.8,0.9,0.2,0.2,0.0,0.0,0.0,0.0,1.2,0.1,0.0,0.3,0.0,0.0,0.0,0.1,0.0,0.0,0.5,0.0,0.0,0.1,0.7,0.1,0.1,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.3,0.1,0.0,0.2,0.0,0.1,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.9,2.9,1.1,0.6,0.9,0.8,0.9,0.2,1.2,0.5,0.7,1.7,0.8,0.0,1.1,0.0,0.9,0.1,0.1,0.2,0.0,1.2,0.3,0.3,0.3,0.0,0.7,0.0,8.4,0.1,0.9,0.3,0.0,0.1,0.0,0.4,1.0,2.3,0.0,0.0,0.0,0.2,0.0,0.4,0.0,0.5,0.0,2.0,0.0,0.4,0.1,3.3,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.4,0.0,0.0,0.6,0.4,0.0,0.0,0.0,0.1,0.0,0.0,0.9,0.2,0.0,0.3,0.1,1.5,0.0,0.8,0.5,0.5,0.2,0.0,0.0,0.0,0.4,0.7,0.2,0.1
TAS2R39,,ENSG00000236398,Taste 2 receptor member 39,P59534,7,143183419-143184435,"G-protein coupled receptors, Predicted membrane proteins","Sensory transduction, Taste","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,86.0,brain: 8.6,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,HPA060680,Uncertain,,,,,,,,,,,HPA060680: AB_2684341,,,,,,,,,,,,,,,,,,0.0,0.0,1.5,0.0,3.3,0.0,0.0,1.8,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,2.5,0.0,0.0,0.0,0.0,5.4,3.2,0.0,0.0,0.0,0.0,0.0,0.0,5.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.5,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,8.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,3.3,1.8,1.9,0.5,2.5,5.4,3.2,0.0,5.5,3.5,3.0,8.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TAS2R40,GPR60,ENSG00000221937,Taste 2 receptor member 40,P59535,7,143222037-143223079,"G-protein coupled receptors, Predicted membrane proteins","Sensory transduction, Taste","G-protein coupled receptor, Receptor, Transducer",,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Evidence at transcript level,Tissue enriched,Detected in single,14.0,brain: 11.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Immune cell enriched,Detected in single,11.0,neutrophil: 2.8,Lineage enriched,Detected in single,11.0,granulocytes: 2.8,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1.4,0.6,3.6,0.0,0.0,2.1,2.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.5,2.9,0.0,0.0,0.1,0.0,5.6,3.2,0.1,0.0,0.0,0.0,0.0,0.0,5.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.2,0.8,0.0,0.0,3.5,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.0,0.0,0.0,0.0,0.0,1.4,3.6,2.1,2.3,0.5,2.9,5.6,3.2,0.1,5.9,4.2,3.5,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TBR1,,ENSG00000136535,T-box brain transcription factor 1,Q16650,2,161416297-161425870,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,"Autism spectrum disorder, Disease variant, Mental retardation",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,32.0,brain: 28.1,Group enriched,Detected in some,5.0,Early spermatids: 32.3;Late spermatids: 65.1,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,6.0,amygdala: 44.6;basal ganglia: 28.3;cerebral cortex: 70.8;hippocampal formation: 45.7;white matter: 43.9,Region enhanced,Detected in many,,cerebral cortex: 66.9,"HPA051256, HPA078644, HPA078657",Enhanced,Supported,,,,,,,,,,"HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388",unprognostic (3.08e-2),unprognostic (5.45e-2),,unprognostic (1.13e-1),unprognostic (1.35e-2),unprognostic (7.43e-3),,unprognostic (1.95e-1),unprognostic (1.83e-2),unprognostic (1.14e-1),,,unprognostic (1.39e-9),unprognostic (5.72e-2),unprognostic (1.72e-1),,unprognostic (5.37e-2),0.0,0.0,6.0,0.0,22.0,0.0,0.0,0.0,28.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.2,1.0,0.0,0.0,0.0,0.0,7.2,2.1,16.3,0.0,0.0,0.0,0.1,0.0,8.1,0.0,0.0,0.6,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,22.0,0.0,28.1,13.2,1.0,7.2,2.1,16.3,8.1,0.0,0.0,19.3,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.5,0.2,0.0,0.9,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,32.3,0.2,0.3,0.4,0.0,0.0,9.3,0.0,0.1,0.1,0.0,0.5,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.0,65.1,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.4,0.0,0.2,0.0,0.1,0.0,0.5,0.0,0.3,0.2,0.5,1.0,0.0,0.0,0.8,0.0,0.1,0.0,0.0
TFAP2D,TFAP2BL1,ENSG00000008197,Transcription factor AP-2 delta,Q7Z6R9,6,50713526-50773033,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Activator, DNA-binding",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,15.0,brain: 5.3,Cell type enhanced,Detected in single,,Horizontal cells: 1.7,Cancer enriched,Detected in single,10.0,lung cancer: 0.5,Region enriched,Detected in some,5.0,midbrain: 5.3,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in single,,HAP1: 1.0,Region enriched,Detected in many,4.0,midbrain: 11.8,Region enriched,Detected in some,6.0,midbrain: 9.4,HPA048962,,,Uncertain,"Nucleoplasm,Golgi apparatus,Vesicles",,,,,,Nucleoplasm,"Golgi apparatus, Vesicles",HPA048962: AB_2680573,,,,,,,,,,,,,,,,,,0.0,0.0,0.6,0.0,0.6,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.5,5.3,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.6,0.0,0.2,0.2,0.0,0.5,5.3,0.2,0.1,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.2,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TLX3,"HOX11L2, RNX",ENSG00000164438,T cell leukemia homeobox 3,O43711,5,171309248-171312139,"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors",,"Developmental protein, DNA-binding",Cancer-related genes,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,24.0,brain: 7.9,Cell type enriched,Detected in some,6.0,Extravillous trophoblasts: 7.7,Cancer enhanced,Detected in some,,cervical cancer: 1.7,Region enhanced,Detected in many,,cerebellum: 7.9,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,5.0,SH-SY5Y: 25.9,Region enriched,Detected in single,7.0,cerebellum: 2.2,Region enriched,Detected in some,8.0,cerebellum: 15.5,"HPA030504, HPA060957, HPA069359",Enhanced,,Enhanced,Nucleoplasm,,,,,,Nucleoplasm,,"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130",,unprognostic (3.52e-2),,unprognostic (2.43e-2),,,,,unprognostic (2.09e-1),unprognostic (3.11e-1),,,,unprognostic (9.80e-2),unprognostic (2.76e-2),,unprognostic (4.48e-2),0.0,0.0,0.0,0.0,0.4,0.0,0.0,7.9,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,2.1,0.3,0.0,0.0,0.0,0.0,0.3,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.7,0.0,0.0,0.0,0.3,0.0,0.0,0.0,1.4,0.0,4.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,0.0,0.2,0.0,0.0,25.9,0.0,0.0,0.0,0.0,0.0,1.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,7.9,0.3,0.0,0.1,2.1,0.3,0.0,1.1,2.8,0.5,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,1.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.0,0.0,0.0,7.7,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.5,0.0,0.0,0.3,0.0,0.0,0.0,0.0
TMEM132D,"KIAA1944, MOLT, PPP1R153",ENSG00000151952,Transmembrane protein 132D,Q14C87,12,129071725-129904025,Predicted membrane proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,6.0,brain: 5.0,Group enriched,Detected in some,60.0,Excitatory neurons: 448.6;Inhibitory neurons: 523.0;Oligodendrocyte precursor cells: 573.0,Cancer enhanced,Detected in some,,thyroid cancer: 0.7,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enhanced,Detected in some,,AF22: 2.5;MOLT-4: 4.6;NTERA-2: 1.7,Low region specificity,Detected in many,,,Low region specificity,Detected in all,,,HPA010739,Approved,,,,,,,,110000.0,,,HPA010739: AB_2204753,,,unprognostic (1.69e-1),,unprognostic (1.21e-1),,unprognostic (1.19e-1),unprognostic (2.07e-2),unprognostic (5.39e-1),,unprognostic (1.47e-2),unprognostic (2.89e-1),unprognostic (3.07e-2),unprognostic (1.55e-2),unprognostic (1.55e-1),unprognostic (4.31e-4),,0.0,0.1,1.1,0.1,5.0,0.1,0.0,0.0,4.8,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.9,0.0,0.1,0.1,0.0,1.0,0.3,4.1,0.0,0.3,0.0,0.4,0.0,1.4,0.3,0.1,0.8,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.2,0.7,1.8,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.8,0.0,0.0,4.6,0.0,1.7,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,5.0,0.0,4.8,2.5,0.9,1.0,0.3,4.1,1.4,0.0,1.8,1.8,0.0,0.0,0.0,8.5,0.0,0.0,0.0,0.0,0.0,3.1,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.9,0.0,0.1,0.0,1.8,0.0,448.6,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,523.0,0.2,0.0,0.0,0.0,1.4,0.0,0.0,0.0,8.4,0.0,0.2,0.0,573.0,7.1,0.0,0.0,0.0,0.0,0.0,0.5,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.5,0.1,0.0
TMEM275,,ENSG00000282881,Transmembrane protein 275,A0A0U1RQS6,1,46532166-46543969,Predicted membrane proteins,,,,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,7.0,brain: 2.2,Not detected,Not detected,,,,,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,5.0,amygdala: 1.2;basal ganglia: 1.6;hypothalamus: 1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,0.0,1.4,0.0,1.2,0.0,0.0,0.1,0.8,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.8,1.5,0.0,0.0,0.0,0.0,2.2,0.7,1.3,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.2,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.4,1.2,0.1,0.8,1.8,1.5,2.2,0.7,1.3,0.6,0.7,1.1,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TPH2,"FLJ37295, NTPH",ENSG00000139287,Tryptophan hydroxylase 2,Q8IWU9,12,71938845-72186618,"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins",Serotonin biosynthesis,"Monooxygenase, Oxidoreductase","Disease variant, FDA approved drug targets",Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,256.0,brain: 117.3,Group enriched,Detected in some,5.0,Early spermatids: 8.0;Inhibitory neurons: 3.2;Late spermatids: 7.4;Spermatogonia: 3.7,Not detected,Not detected,,,Group enriched,Detected in many,9.0,medulla oblongata: 45.3;midbrain: 117.3;pons: 53.5;thalamus: 31.8;white matter: 32.1,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in many,31.0,midbrain: 106.7;pons and medulla: 34.9,Group enriched,Detected in some,5.0,midbrain: 49.9;pons: 49.6,CAB078198,Enhanced,,,,,,,,,,,CAB078198: AB_2665804,unprognostic (1.19e-1),unprognostic (6.01e-1),,unprognostic (3.46e-2),unprognostic (2.31e-1),,,,unprognostic (5.91e-2),unprognostic (2.02e-1),unprognostic (5.01e-2),,,unprognostic (7.32e-2),unprognostic (1.34e-1),,,0.0,0.0,0.7,0.0,0.4,0.0,0.0,0.0,5.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.8,0.4,0.0,0.0,0.0,0.0,45.3,117.3,0.1,0.0,0.2,0.0,0.4,0.0,53.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,31.8,0.0,0.0,0.0,0.0,0.0,0.0,32.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.4,0.0,5.9,0.8,0.4,45.3,117.3,0.1,53.5,0.1,31.8,32.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.2,0.1,0.1,0.0,0.0,1.0,0.0,0.0,0.2,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,3.2,0.0,0.0,0.0,0.0,7.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.3,0.1,0.7,3.7,0.0,0.0,0.0,0.0,0.0,0.0,0.1
TRHR,,ENSG00000174417,Thyrotropin releasing hormone receptor,P34981,8,109086585-109121565,"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters",,"G-protein coupled receptor, Receptor, Transducer","Congenital hypothyroidism, Disease variant, FDA approved drug targets",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,9.0,brain: 5.5,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Low region specificity,Detected in many,,,HPA055162,Approved,,,,,,,,,,,HPA055162: AB_2732592,,,,,,,,,,unprognostic (1.92e-2),,,,unprognostic (8.58e-2),,unprognostic (1.17e-1),,0.0,0.0,3.4,0.0,0.8,0.0,0.0,0.0,5.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.6,1.3,0.0,0.0,0.0,0.0,1.0,0.8,0.8,0.0,0.0,0.0,0.6,0.0,1.2,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.5,0.0,0.1,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.8,0.0,5.5,3.6,1.3,1.0,0.8,0.8,1.2,1.1,0.5,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
TRPC5,PPP1R159,ENSG00000072315,Transient receptor potential cation channel subfamily C member 5,Q9UL62,X,111768011-112082776,"Predicted membrane proteins, Transporters, Voltage-gated ion channels","Calcium transport, Ion transport, Transport","Calcium channel, Ion channel",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,5.0,brain: 3.7,Group enriched,Detected in some,11.0,Excitatory neurons: 46.3;Inhibitory neurons: 78.5;Oligodendrocytes: 38.3,Group enriched,Detected in some,23.0,testis cancer: 0.8;thyroid cancer: 2.8,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,6.0,NTERA-2: 1.2,Low region specificity,Detected in all,,,Low region specificity,Detected in many,,,,,,,,,,,,,,,,,,,,unprognostic (3.29e-2),,unprognostic (6.15e-2),unprognostic (7.32e-2),,,unprognostic (2.60e-3),,unprognostic (3.68e-2),unprognostic (5.69e-2),unprognostic (5.09e-2),unprognostic (2.78e-2),,0.0,0.1,1.1,0.0,2.1,0.1,0.0,0.9,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,1.8,0.1,0.8,0.0,0.0,1.9,3.7,1.4,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,3.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.1,2.1,0.9,1.3,1.2,1.8,1.9,3.7,1.4,1.9,0.3,1.8,3.3,0.0,0.0,0.0,4.9,0.2,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.3,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.3,0.0,0.0,78.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,4.5,38.3,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1
UNCX,Uncx4.1,ENSG00000164853,UNC homeobox,A6NJT0,7,1232872-1237326,"Predicted intracellular proteins, Transcription factors","Differentiation, Neurogenesis, Transcription, Transcription regulation","Developmental protein, DNA-binding",,Evidence at protein level,Evidence at transcript level,No human protein/transcript evidence,Evidence at protein level,Tissue enriched,Detected in single,35.0,brain: 17.4,Cell type enriched,Detected in single,10.0,Cardiomyocytes: 1.0,Not detected,Not detected,,,Region enhanced,Detected in many,,cerebellum: 17.4,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,21.0,NB-4: 98.5,Region enriched,Detected in single,5.0,cerebellum: 3.2,Region enriched,Detected in single,8.0,cerebellum: 7.5,HPA063294,,,Approved,Nucleoplasm,,,,,,Nucleoplasm,,HPA063294: AB_2684977,,,,,unprognostic (1.15e-1),,,,,,,,,,unprognostic (9.71e-2),,,0.0,0.0,0.7,0.0,0.3,0.0,0.0,17.4,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.8,0.4,0.0,0.0,0.0,1.8,3.0,0.0,0.0,0.0,0.0,0.4,0.0,5.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,1.8,0.0,0.0,0.0,0.0,0.0,0.0,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,98.5,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.3,17.4,0.6,0.0,2.8,1.8,3.0,0.0,5.4,0.7,1.8,2.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
USP17L11,,ENSG00000233136,Ubiquitin specific peptidase 17 like family member 11,C9JVI0,4,9215405-9216997,"Enzymes, Predicted intracellular proteins",Ubl conjugation pathway,"Hydrolase, Protease, Thiol protease",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,40.0,brain: 3.9,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA045642,Uncertain,,,,,,,,,,,HPA045642: AB_2679403,,,,,,,,,,,,,,,,,,0.0,0.0,2.9,0.0,1.8,0.0,0.0,0.1,2.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.5,2.7,0.0,0.0,0.0,0.0,2.4,0.9,1.0,0.0,0.0,0.0,0.0,0.0,3.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.9,1.8,0.1,2.4,1.5,2.7,2.4,0.9,1.0,3.9,0.1,1.9,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
USP17L15,,ENSG00000223569,Ubiquitin specific peptidase 17 like family member 15,C9J2P7,4,9234385-9236046,"Enzymes, Predicted intracellular proteins",Ubl conjugation pathway,"Hydrolase, Protease, Thiol protease",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,102.0,brain: 14.6,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA045642,Uncertain,,,,,,,,,,,HPA045642: AB_2679403,,,,,,,,,,,,,,,,,,0.0,0.0,7.5,0.0,4.7,0.0,0.0,0.4,9.8,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,8.4,5.7,0.0,0.0,0.0,0.0,12.8,6.1,5.8,0.0,0.0,0.0,0.0,0.0,14.6,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,1.3,0.0,0.0,0.0,8.4,0.0,0.0,0.0,0.0,0.0,0.0,7.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.5,4.7,0.4,9.8,8.4,5.7,12.8,6.1,5.8,14.6,1.3,8.4,7.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
USP17L2,DUB3,ENSG00000223443,Ubiquitin specific peptidase 17 like family member 2,Q6R6M4,8,12137168-12139077,"Enzymes, Metabolic proteins, Predicted intracellular proteins","Apoptosis, Cell cycle, Ubl conjugation pathway","Hydrolase, Protease, Thiol protease",,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,22.0,brain: 2.2,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA045642,Uncertain,,,,,,,,,,,HPA045642: AB_2679403,,,,,,,,,,,,,,,unprognostic (2.01e-1),,,0.0,0.0,0.3,0.0,0.4,0.0,0.0,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,1.3,0.0,0.0,0.0,0.0,0.9,1.5,0.0,0.1,0.0,0.0,0.0,0.0,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.4,0.0,0.6,0.4,1.3,0.9,1.5,0.0,1.1,0.0,0.4,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
USP17L20,,ENSG00000250745,Ubiquitin specific peptidase 17 like family member 20,D6RJB6,4,9258124-9259716,"Enzymes, Predicted intracellular proteins",Ubl conjugation pathway,"Hydrolase, Protease, Thiol protease",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,17.0,brain: 1.7,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA045642,Uncertain,,,,,,,,,,,HPA045642: AB_2679403,,,,,,,,,,,,,,,,,,0.0,0.0,0.6,0.0,0.4,0.0,0.0,0.1,1.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.6,0.0,0.0,0.0,0.0,1.7,0.6,0.7,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.0,0.0,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.6,0.4,0.1,1.1,1.3,0.6,1.7,0.6,0.7,1.0,0.5,0.7,1.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
USP17L22,,ENSG00000248933,Ubiquitin specific peptidase 17 like family member 22,D6RA61,4,9267619-9269211,"Enzymes, Metabolic proteins, Predicted intracellular proteins",Ubl conjugation pathway,"Hydrolase, Protease, Thiol protease",,Evidence at transcript level,Evidence at transcript level,No human protein/transcript evidence,Evidence at transcript level,Tissue enriched,Detected in single,21.0,brain: 2.0,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,HPA045642,Uncertain,,,,,,,,,,,HPA045642: AB_2679403,,,,,,,,,,,,,,,,,,0.0,0.0,1.2,0.0,0.8,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,0.7,0.8,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.2,0.8,0.0,1.6,1.0,1.0,2.0,0.7,0.8,2.0,0.1,0.8,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VAX1,,ENSG00000148704,Ventral anterior homeobox 1,Q5SQQ9,10,117128521-117138301,"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation","Developmental protein, DNA-binding","Disease variant, Microphthalmia",Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,7.0,brain: 3.7,Cell type enriched,Detected in some,4.0,Inhibitory neurons: 7.4,Not detected,Not detected,,,Low region specificity,Detected in many,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Group enriched,Detected in some,8.0,A-431: 3.1;WM-115: 2.3,Group enriched,Detected in some,6.0,basal ganglia: 5.6;hypothalamus: 3.2;olfactory bulb: 1.5,Low region specificity,Detected in some,,,HPA028946,Uncertain,,Approved,"Nucleoplasm,Nucleoli rim",,Yes,,,,Nucleoli rim,Nucleoplasm,HPA028946: AB_10602679,,unprognostic (1.08e-2),,unprognostic (1.92e-2),unprognostic (1.46e-1),unprognostic (2.96e-2),,unprognostic (5.77e-3),unprognostic (2.19e-1),,,unprognostic (1.17e-1),,unprognostic (5.72e-2),unprognostic (2.09e-1),,unprognostic (2.99e-1),0.0,0.0,3.1,0.0,2.8,0.0,0.0,0.0,2.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,3.7,0.0,0.0,0.0,0.0,1.2,0.4,0.6,0.0,0.0,0.0,0.2,0.0,1.4,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,2.6,0.0,0.0,0.0,0.0,0.0,0.0,2.8,3.1,0.3,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.1,2.8,0.0,2.2,0.2,3.7,1.2,0.4,0.6,1.4,0.0,2.6,2.8,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.6,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.4,0.0,0.0,0.0,0.0,1.5,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.3,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.0,0.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0
VHLL,"VHLP, VLP",ENSG00000189030,VHL like,Q6RSH7,1,156298624-156299307,Predicted intracellular proteins,,,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.5,Not detected,Not detected,,,Not detected,Not detected,,,Low region specificity,Detected in some,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Not detected,Not detected,,,,,,,,,,,,,,,,,,,,,,,,,,,,unprognostic (1.61e-1),,,,,,,,,unprognostic (2.45e-1),,,,0.0,0.0,0.3,0.0,0.4,0.0,0.0,1.5,1.2,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.8,0.3,0.0,0.0,0.0,0.0,0.4,0.3,0.2,0.0,0.1,0.0,0.0,0.0,0.8,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.0,0.1,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.7,0.0,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.5,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.5,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.4,1.5,1.2,0.8,0.3,0.4,0.3,0.2,0.8,0.2,0.3,0.7,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
ZBTB8B,"DKFZp547H154, RP1-27O5.1, ZNF916B",ENSG00000273274,Zinc finger and BTB domain containing 8B,Q8NAP8,1,32465072-32496686,"Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enhanced,Detected in single,,brain: 1.6,Cell type enhanced,Detected in many,,Cone photoreceptor cells: 6.2;Langerhans cells: 4.7;Oligodendrocyte precursor cells: 9.0,Cancer enhanced,Detected in single,,testis cancer: 0.5,Low region specificity,Detected in many,,,Immune cell enhanced,Detected in single,,basophil: 1.0,Low lineage specificity,Detected in single,,,Cell line enhanced,Detected in single,,RT4: 1.0,,,,,,,,,"HPA055553, HPA071427",Enhanced,,Approved,"Nucleoplasm,Cytosol",,,,,,Nucleoplasm,Cytosol,"HPA055553: AB_2682848, HPA071427: ",unprognostic (8.32e-4),unprognostic (1.23e-1),unprognostic (3.83e-1),unprognostic (3.83e-5),unprognostic (1.86e-2),unprognostic (5.65e-2),unprognostic (1.67e-4),unprognostic (1.57e-2),unprognostic (5.94e-2),unprognostic (3.43e-3),unprognostic (9.08e-3),unprognostic (1.35e-1),unprognostic (2.93e-2),unprognostic (3.44e-2),unprognostic (6.11e-2),unprognostic (3.26e-3),unprognostic (5.88e-3),0.0,0.1,1.6,0.1,1.1,0.4,0.1,0.8,1.2,0.0,0.0,0.0,0.0,0.2,0.2,0.1,0.1,0.1,0.0,1.0,1.4,0.0,0.1,0.0,0.1,1.2,0.9,1.1,0.1,0.1,0.1,0.6,0.1,1.1,0.1,0.0,0.5,0.1,0.0,0.6,0.2,0.0,0.0,0.6,0.1,0.0,0.2,1.4,0.0,0.1,0.0,0.1,0.1,0.0,1.3,0.0,0.0,0.5,0.4,0.0,0.1,0.1,0.0,0.0,0.2,0.1,0.0,0.1,0.1,0.2,0.0,0.3,0.2,0.6,0.0,0.1,0.1,0.6,0.0,0.2,0.1,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.1,0.0,0.0,0.0,0.2,0.0,0.1,0.0,0.1,0.5,0.0,0.2,0.0,0.0,0.0,0.1,1.0,0.9,0.5,0.3,0.1,0.0,0.7,0.1,0.0,0.2,0.1,0.0,0.1,0.0,0.2,0.2,0.1,0.1,0.1,0.1,1.0,0.1,0.2,0.1,0.1,0.1,0.2,0.1,0.1,0.0,0.2,0.1,0.1,0.5,0.2,0.1,0.2,0.1,0.0,1.6,1.1,0.8,1.2,1.0,1.4,1.2,0.9,1.1,1.1,0.6,1.4,1.3,0.4,0.0,1.8,0.3,0.2,1.7,1.1,0.1,0.0,2.6,0.3,0.5,0.8,0.0,0.7,0.0,6.2,1.9,1.4,0.3,0.0,0.0,2.1,0.5,1.6,0.7,0.0,0.0,0.8,0.0,1.3,0.8,0.0,0.5,3.8,2.8,0.7,0.2,0.4,3.3,2.2,0.0,0.0,0.3,4.7,2.1,0.6,0.7,1.8,1.9,0.0,1.4,1.0,9.0,0.4,0.0,0.0,0.0,0.3,0.9,0.0,0.1,1.5,2.4,0.0,1.6,0.7,2.2,1.5,0.0,0.6,0.3,0.7,0.9,0.0,0.9
ZP2,ZPA,ENSG00000103310,Zona pellucida glycoprotein 2,Q05996,16,21197450-21214510,"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins",Fertilization,Receptor,,Evidence at protein level,Evidence at protein level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,8.0,brain: 4.9,Cell type enriched,Detected in single,15.0,Proximal enterocytes: 7.6,Not detected,Not detected,,,Region enriched,Detected in single,5.0,cerebellum: 4.9,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in single,37.0,HDLM-2: 3.6,Not detected,Not detected,,,Not detected,Not detected,,,HPA011296,Enhanced,,,,Secreted in female reproductive system,,,,,,,HPA011296: AB_1859485,unprognostic (2.35e-2),,unprognostic (3.12e-2),,,unprognostic (6.60e-2),,unprognostic (9.83e-2),,,unprognostic (3.44e-3),unprognostic (3.12e-1),,unprognostic (1.66e-1),unprognostic (4.41e-2),,,0.0,0.0,0.0,0.0,0.1,0.0,0.1,4.9,0.2,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.1,0.2,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.0,0.0,0.0,0.5,0.9,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.6,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,4.9,0.2,0.1,0.1,0.0,0.2,0.0,0.9,0.0,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.0,0.0,0.1,0.0,0.0,0.3,0.0,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.5,0.0,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.6,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.1,0.1
ZSCAN10,ZNF206,ENSG00000130182,Zinc finger and SCAN domain containing 10,Q96SZ4,16,3088890-3099295,"Plasma proteins, Predicted intracellular proteins, Transcription factors","Transcription, Transcription regulation",DNA-binding,,Evidence at protein level,Evidence at transcript level,Evidence at protein level,Evidence at protein level,Tissue enriched,Detected in single,4.0,brain: 1.8,Cell type enhanced,Detected in some,,Cardiomyocytes: 1.4;Cytotrophoblasts: 1.9,Cancer enriched,Detected in single,207.0,testis cancer: 19.5,Low region specificity,Detected in single,,,Not detected in immune cells,Not detected,,,Not detected,Not detected,,,Cell line enriched,Detected in some,10.0,NTERA-2: 56.8,Not detected,Not detected,,,Not detected,Not detected,,,HPA076826,,,Approved,"Nucleoplasm,Centrosome",,,,,,Nucleoplasm,Centrosome,HPA076826: ,unprognostic (4.37e-2),unprognostic (5.13e-2),,unprognostic (9.15e-2),unprognostic (6.65e-3),unprognostic (6.24e-2),unprognostic (7.60e-2),unprognostic (3.24e-2),,unprognostic (1.15e-1),,unprognostic (1.72e-1),unprognostic (1.85e-11),unprognostic (5.98e-2),unprognostic (2.92e-2),,unprognostic (1.79e-2),0.0,0.0,0.4,0.0,0.5,0.2,0.0,0.9,0.9,0.0,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.4,0.4,0.0,0.0,0.0,0.0,0.4,0.2,0.6,0.1,0.0,0.0,0.1,0.0,0.5,0.0,0.0,0.1,0.0,0.0,0.2,0.4,0.0,0.0,0.1,0.1,0.1,0.2,0.5,0.0,0.0,0.0,0.0,0.0,0.0,1.8,0.0,0.0,0.1,0.2,0.0,0.0,0.3,0.2,0.0,0.0,0.1,0.0,0.2,0.0,0.0,0.0,0.1,0.1,0.0,0.0,0.0,0.1,0.0,0.0,0.5,0.3,0.0,0.1,0.3,0.0,0.2,0.1,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.3,56.8,0.3,0.4,0.0,0.1,0.2,0.0,0.0,0.1,0.2,0.0,0.1,0.0,5.8,0.1,0.6,0.0,0.1,0.0,0.1,0.0,0.1,0.2,0.5,0.3,0.0,0.1,0.6,0.1,0.1,0.0,0.0,0.1,0.1,0.0,0.1,0.0,0.0,0.0,0.0,0.2,0.0,0.1,0.1,0.0,0.0,0.4,0.5,0.9,0.9,0.4,0.4,0.4,0.2,0.6,0.5,0.1,0.5,1.8,0.1,0.0,0.0,0.3,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.3,1.4,0.0,0.0,0.0,0.0,1.9,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.2,0.0,0.0,0.0,0.1,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.2,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.1,0.1,0.7,0.0,0.0,0.1,0.0,0.1,0.0,0.0
